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Abstract

Enzymes involved in phospholipid biosynthesis have been suggested as
possible drug targets to treat Candida infections because several key enzymes, such as
phosphatidylserine synthase, differ from those of the human host.We have found that
phosphatidylserine synthase of C. albicans is required for virulence in a mouse model
of systemic Candida infection.In addition, the C. albicans phosphatidylserine synthase
mutant (cho1∆/∆) has no detectable phosphatidylserine and loss of phosphatidylserine
causes alterations in the fungal cell wall. The cho1∆/∆ mutants’ cell wall defects include
altered calcofluor white staining, resistance to the cell wall perturbing drug Caspofungin,
and an altered physical appearance by transmission electron microscopy..We are using
lipidomic analysis and transcriptomics of phosphatidylserine and
phosphatidylethanolamine biosynthesis mutants to understand the role that
phosphatidylserine and phosphatidylethanolamine play in controlling the cell wall in C.
albicans.The elucidation of downstream effects of disruption of pathways involved in
biosynthesis of phospholipids in C. albicans may validate these phospholipid
biosynthesis enzymes as plausible anti-fungal drug targets. The role of
phosphatidylserine and phosphatidylethanolamine in the maintenance of the fungal cell
wall will also be of interest in determining how phospholipids impact signaling pathways
and affect cell wall composition and architecture.
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CHAPTER ONE
Background and Introduction
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Abstract

Candida albicans remains a major fungal pathogen of humans. The role of phosphatidylserine
and phosphatidylethanolamine in the maintenance of the fungal cell wall will be of interest in
determining how phospholipids impact signaling pathways and affect cell wall composition and
architecture. It is in this light that the examination of basic metabolic processes such as cell wall
generation and lipid biosynthesis may be useful in finding new therapeutic agents to treat
Candida infections and understand the host pathogen relationship.
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Introduction
Candida albicans is a leading cause of fungal infections in humans and fourth most common
cause of nosocomial infections in the United States (Edmond et al., 1999). The
immunocompromised, such as organ transplant and cancer patients are at particularly high risk
of developing life threatening Candida infections. The mortality rate of these systemic fungal
infections can reach as high as 40% (Pittet & Wenzel, 1995). The ability to successfully treat
this fungal pathogen relies on the continued elucidation of drug targets as drug resistance
remains a serious threat (Chiller et al., 2012). It is in this light that the examination of basic
metabolic processes such as cell wall generation and lipid biosynthesis may be useful in finding
new therapeutic agents to treat Candida infections.

Diseases caused by Candida albicans
Candida albicans normally resides in the gastrointestinal tract of healthy individuals and can
establish an infection when the host defenses are compromised. Oropharyngeal candidiasis is
the most common fungal infection in immunocompromised patients. This disease can present
itself in the form of pseudomembranous candidiasis characterized by presence of white plaques
or xerostomia in nearly 30% of HIV-infected patients (Calderone 2002; Cauda et al., 2012).
Esophageal candidiasis occurs in patients undergoing treatments for chronic illnesses and
frequently occurs in patients with advanced HIV infections. C. albicans accounts for more than
50% of vulvovaginal candidiasis episodes and 75% of women experience at least one episode
of this disease in their lifetime (Cauda et al., 2012; Calderone 2002). C. albicans can also cause
superficial infections of the skin and mucous membranes. Mortality rates associated with
systemic candidiasis (bloodstream infections) is high and at least 10% of all bloodstream
infections are caused by Candida species (Pittet, D & Wenzel, R.P. 1995).
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C.albicans infections are a consequence of both the virulence properties of this organism
enabling it to cause invasive infections and the immune status of the host (Singh et al., 2007).
C.albicans is a successful commensal of the human host and is not readily eliminated since it
has evolved to persist on host mucosal surfaces and utilize host resources, causing disease
when host immune deficiencies occur (Cauda et al., 2012). Treatment of candidiasis is
hindered by several factors, including the limited number of antifungals and, the emergence of
drug resistant isolates (Morschhauser J et al., 2012).

Virulence properties of Candida albicans
The virulence of Candida albicans is mediated by a series of factors related to its ability to
survive and colonize the human host (Gow et al., 2011). The ability to survive in the host is a
complex issue for C. albicans in that it must not only acquire essential nutrients from the host,
but must also evade attack and avoid clearance by the host immune system (Brown A.J. et
al.,2012). Some virulence attributes of C.albicans include production of adhesins (which
promote host recognition and colonization) secretion of proteases and phospholipases (which
are digestive enzymes that aid in nutrient acquisition and invasion), and phenotypic switching
associated with invasiveness of the organism (Calderone, 2002).
Many of the studies on virulence properties of C.albicans have been aided by gene deletion
studies that result in the avirulence of the organism in mucosal and systemic animal models of
candidiasis. These studies provide direct evidence that specific proteins are important in host
pathogenesis. A thorough understanding of how these virulence factors contribute to disease
progression, and pathogenesis is crucial so newer drugs can be designed to inhibit these
factors and thus prevent colonization or persistence of the organism in the host.
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Adhesins
One central problem the fungus must encounter in the host is how to adhere to the host when it
comes into contact with host tissues and mucosal surfaces. Adherence to host tissues is
important for disease progression, and Candida albicans is able to adhere to host surfaces via
production of adhesins (Udea M et al.,2012). These are surface-bound polysaccharides or
glycoproteins that bind to specific ligands on the host cell surface. Adhesins were mainly
identified by studies in which the encoding gene was deleted, and the mutant was evaluated for
its adherence to host cell monolayers in vitro. A number of adhesins have been identified in the
organism including, but not limited to – complement receptors, fibrinogen-binding protein,
integrins, lectins and proteins that bind to host proteins such a N-cadherins (Hube et al., 2011).
The importance of adhesins in C. albicans pathogenesis is highlighted by the contribution of
adhesins to binding of plastics and biofilm formation (Filler et al., 2011). Systemic infections are
usually established by contamination of indwelling catheters where (in the case of C.albicans),
yeast cells adhere to the catheter and form a thin film which later develops into a thick layer that
consists predominantly of hyphal cells. Biofilms are inherently resistant to the penetration of
drugs and thus confer resistance to their inhabitants, and moreover the biofilm provides a
means for the constant flow of yeast cells from the film into the bloodstream, thus further
contributing to disease (Williams C et al., 2012).
Phenotypic Switching
C.albicans can exist in three different morphological forms – yeast cells, pseudohyphal cells and
true hyphae. Phenotypic switching refers to the spontaneous interchange between these three
different morphological states. Initially, it was believed that virulence of this organism was
dependent on the hyphal form which can penetrate and invade host tissues better than the
yeast form (Sherwood et al., 1992). However, the yeast cells are better at dissemination and all
5

three morphological forms have been identified in tissues infected with C.albicans (Odds, F.
1988), and these transitions are thought to promote and reflect the different stages of disease
progression (Odds, F. 1994). Morphological transitions are triggered in response to growth
conditions. Hyphal growth is promoted at temperatures above 35⁰C, pH 7, nutrient limitations,
especially carbon and nitrogen starvation, presence of serum, non-fermentable carbon sources,
and low oxygen concentrations (Odds, F. 1988). These conditions are presumed to affect the
signals that regulate cell morphological transitions. Identification of growth-form specific genes
can provide valuable insights into regulation of morphogenesis and the signaling pathways
involved.
Signaling pathways
Signaling pathways that regulate morphogenetic transitions are thought to contribute to the
virulence of Candida albicans by controlling different stages of disease establishment and
progression (Brown, A.J. & Gow, N.A., 1999). In the host, C.albicans can survive in all three
morphological forms, using environmental cues to dictate which form is more favorable in the
particular host niche. Identification of the regulatory circuits that facilitate these transitions is
essential to obtain a detailed understanding of morphogenesis. Many signaling pathways have
been identified in the fungus, such as the Efg1 pathway (Lengeler et al., 2000), the MAP kinase
pathway and a pH signaling pathway(Davis et al. 2010). Inactivation of signaling components
have shown to attenuate virulence in animal models presumably by interfering with expression
of virulence factors and thus influencing disease progression.
Many components of the signaling pathway have been identified using Saccharomyces
cerevisiae as a model fungus, since there is a high degree of sequence conservation with the
signaling cascades between these distantly related species (Gustin et al., 1998; Banuett, F.
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1998)). Moreover, the ease of conducting genetic screens in S.cerevisiae has made this
organism more suitable for dissecting molecular mechanisms specific to signaling.
Proteases
Secreted aspartyl proteases (Sap) are secreted proteins that can proteolytically digest
exogenous host proteins for the simple purpose of acquiring nutrients (Fusek et al., 1994). The
digestion of host proteins aids in host tissue colonization by digesting host cell membranes, thus
facilitating host surface adhesion and penetration into tissues. In addition, secretion of
proteases can also help evade host defenses by damaging cells and molecules of the host
immune system. The Sap family consists of 10 genes with distinct roles in C.albicans virulence.
Sap antigens have been detected in the sera of patients with candidiasis indicating an important
role for Saps during infection (Ruchel, R. 1992; Ruchel et al., 1991). Sap genes are differentially
expressed in vitro, for example, some SAPs are expressed only in hyphal cells (SAP 46)(Schaller et al., 1998), some were found both on yeast and hyphal cells. Sap1- Sap3
contributes to tissue damage (Schaller et al., 1998), Sap 1, 2 and 8 are more prevalent in
vaginal infections (De bernadis et al., 1995). Some studies have suggested that early during
systemic infection, SAP4-6 are important for invasion, and once the infection is established,
SAP1-3 plays an important role (Staib et al.,2000). More compelling evidence for the role of
Saps during infection comes from studies that demonstrate that C.albicans mutants lacking SAP
genes are attenuated for virulence (Schaller et al, 1999). Moreover inhibition of proteinase
activity using inhibitors prevented initial colonization of mucosal surfaces (Fallon et al., 1997).
Thus, Saps contribute to the overall virulence of C.albicans by hydrolyzing host proteins,
proteins of the immune system thus promoting colonization, persistence and dissemination of
infection.
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Phospholipases
Phospholipases are enzymes that hydrolyze ester linkages in glycerophospholipids that have
been implicated in host penetration, and interaction with signal transduction pathways.
C.albicans has two phospholipases, encoded by PLB1 and PLB2 (Hube, B 1998; Sugiyama et
al., 1999). These enzymes are categorized as virulence factors since PLB antigens have been
detected in the sera of patients suffering from candidiasis and they are expressed. Mutants
lacking phospholipases are significantly attenuated in virulence using animal models for
systemic infections ( Leidich et al., 1998; Ghannoum, M.A. 2000).
Lipases
Lipases are the least characterized of all the secreted hydrolases in C.albicans. Lipases are
encoded by a family of 10 genes, LIP1-LIP10 (Hube et al., 2000). Expression of these genes is
usually induced in media containing lipids such as Tween 40 (Fu et al., 1997), but can be
induced in a lipid independent manner too, suggesting lipases may fulfill roles other than
acquisition of nutrients in C.albicans. Some lipases were found to be expressed during infection
in mice further providing evidence that lipases may contribute to the survival and virulence of
C.albicans in the host (Goldman et al., 2011).

Drug Targets in Candida albicans
Elucidating the complex interaction of Candida albicans with the host during infections and
identifying key genes or enzymes that can assist the fungus in the colonization, persistence and
invasion of tissues can lead to the development of new therapeutic strategies, through targeting
these genes/ enzymes, thus extending the limited repertoire of antifungal drugs currently
available. In this section, some of the currently exploited drug targets will be described with a
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brief overview of potential enzymatic or biosynthetic pathways that can provide attractive targets
for the development of antifungals.
Cell Wall
The cell wall is critical to the interaction of Candida albicans with the host, since it the outermost
protective structure for the organism. The C.albicans cell wall is a complex, dynamic structure
that undergoes significant changes in composition during growth. The different morphological
forms of the organism differ in the composition of cell wall components and are also associated
with differential regulation of virulence factors and proteins. The cell wall contributes not only to
the cell morphology, but also protects the cell against physical, osmotic and oxidative stress
and, it promotes cell-cell interactions, adherence to host surfaces, and modulates the immune
response (Ruiz-Herrera et al., 2006).
The cell wall (Fig:1-1) consists of 80-90% carbohydrate in the form of glucan (which are linear
and branched polymers of glucose); β1,4 N-acetylglucosamine (chitin) and mannose polymers.
Chitin and glucans contribute to the rigidity and morphology of the cell wall (Ruiz-Herrera et al.,
2006).
Chitin is synthesized on the cytoplasmic side of the cell membrane, and then gets extruded to
the cell surface where it crystallizes through extensive hydrogen bonding. Chitin synthases
catalyze the polymerization of N-acteylglucosamine (Bulawa, C. E et al., 1993). Chitinase
contributes to the maintenance and plasticity of the yeast cell wall (Cabib E et al, 1987) and
disrupting the chitin synthase gene (CTS1) in S. cerevisiae, results in clumping of the cells and
failure to separate following cell division (Kuranda and Robbins 1991). Thus chitin synthase are
potential drug targets owing to their essential role in cell wall maintenance.
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Glucans are arranged as β-(1,3)-linked residues with β-(1,6)- side chains. The enzyme that
catalyzes the polymerization of glucans is glucan synthase, which links glucan synthesis to the
cell cycle (Kang and Cabib 1986).
Mannoproteins comprise important constituents of the cell wall that determine the surface
properties of the cell, facilitating adhesion and interaction of C.albicans with the host (Chaffin et
al., 1998). These are proteins that are covalently attached to the mannose polymers that
account for about 40% of the total cell wall polysaccharide. Mannoproteins are immunogenic,
with each branch of the polymer corresponding to a specific epitope. The cell wall also consists
of glycosylphosphatidylinositol (GPI) anchored mannoproteins that are covalently linked to β-1,6
glucan via a covalent bond between the GPI remnant and β-1,6 glucan (Klis et al., 2001). Some
mannoporteins can be connected via disulfide bridges to other proteins in the cell wall
(Boisrame et al., 2011; Casanova et al., 1989) or can be non-covalently attached to the cell wall
via hydrogen bonds or hydrophobic interactions (Valentin et al., 1984).
The cell wall consists of the following layers: The inner layer- adjacent to the plasma membrane
is composed of chitin and glucan polysaccharides. This is followed by a three dimensional
matrix of β-1,3 gulcans , to which cell wall proteins are linked via GPI anchors. Mannoproteins
are found adjacent to the membrane and in the outermost layer and can be covalently linked to
glucan chains. β-1,6 glucans act as an interconnector for most of the cell wall components.
Other proteins called ‘proteins with internal repeats’ (PIR coded proteins) are covalently linked
to the β-1,3-glucan scaffold.
GPI anchored proteins account for about 88% of the covalently linked cell wall proteins in
C.albicans (Kaptyen et al., 2000). GPI anchored proteins play an important role in cell wall
synthesis and in modifying cross-linked polymers and thus play an integral role in governing the
physiology and pathogenicity of C.albicans (Richard and Plaine, 2006). Proteins that are linked
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to β-1,6 glucan are incorporated into the wall by a transglycosidation reaction between the
glucan moiety of GPI and β-1,6 glucan (Kaptyen et al., 1995; 1997). GPI can either be present
on the cell surface by itself or it can be transported to the cell surface if it is covalently attached
to a protein via the secretory pathway. Several genes required for GPI biosynthesis have been
identified in Saccharomyces cerevisiae. Mutants lacking some of these biosynthetic genes have
a fragile cell wall (Benachour et al., 1999), aberrant cell morphologies (Leidich et al., 1994) or
have defects in GPI anchoring (Gaynor et al., 1999). GPI mutants also exhibit an altered
composition of their cell wall (Vossen et al., 1997) and increased sensitivity to cell-wall
perturbing agents (Benghezal et al., 1995; Vossen et al., 1995). Thus disruption of GPI
biosynthesis can affect GPI-dependent transport of enzymes involved in cell wall assembly, and
other cell wall proteins. It can also abolish GPI-dependent cross-linking of glycoproteins to the
cell wall (Ram et al., 1994; Richard et al., 2002) thereby affecting cell wall organization (Fonzi
1999; Ram et al., 1998).
Since mammalian cells lack a cell wall, enzymes responsible for its structural organization or
for the biosynthesis of cell wall components provide a convenient target for antifungal drugs.
Few drugs have been developed that target the cell wall, these include: Nikkomycin Z and the
Echinocandin class of drugs.
Nikkomycin Z inhibits chitin synthase activity and thus interferes with the chitin content in the
cell wall. Echinocandins such as caspofungin and micafungin inhibit glucan synthase thereby
affecting the assembly of β-glucan polymers in the cell wall. Both these classes of drugs display
fungicidal activity against C.albicans and are effective in animal models(Calderone, 2002).
Differences in GPI biosynthesis between mammalian and yeast cells (Grimme et al., 2001;
Smith et al., 1997) can also be exploited to design drugs that inhibit fungal-specific GPI
biosynthetic enzymes. Some proteins that are tethered to the wall via GPI anchors are important
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for adhesion to host cells and thus impact the pathogenesis and virulence of C.albicans. Thus,
any defects in the biosynthesis of GPI anchors can have detrimental effects of the pathogenesis
of C.albicans (Richard, M.L. and Plaine, A. 2006; Martinez-Lopez 2004; Richard et al 2002).
GPI anchors also play a contributing role in the morphogenesis of C.albicans, and resistance to
macrophages and/or oxidative stress (Richard et al., 2002). GPI proteins have also been
implicated in pivotal processes such as adhesion, biosynthesis and regeneration of the cell wall
and some have enzymatic functions (Klis et al., 2009; Richard, M.L. and Plaine, A 2007).
Several GPI proteins have also shown to affect the virulence of C.albicans using a murine
model of systemic candidiasis (Gelis et al., 2012; De Boer et al., 2010; Martinez-Lopez et al.,
2004; Laforet et al., 2011). For example, the GPI-anchored protein Hwp1 is important for host
cell attachment (Hoyer, L 2001; Staab et al., 1999). Thus considering the essential role for GPIanchored proteins in cell wall reconstruction (Fonzi, W.A. 1999; Grimme et al., 2004), yeasthyphal transitions, and adhesion (Castano et al., 2006; Staab et al., 1999) or virulence
properties of C.albicans (Martinez-Lopez et al., 2004; Pardini et al., 2006, Staab et al., 1999), a
better understanding of the functions of these proteins and how they influence other signaling
and biosynthetic pathways and interactions with the host is needed. This could extend the
number of potential targets for therapeutic treatment of C.albicans.
Phospholipid Biosynthesis
Phospholipids fulfill a number of vital roles in fungi. For example, in S. cerevisiae, they are
important for cell biology and have roles in signaling and regulatory functions (Strahl and
Thorner 2007), membrane trafficking (Vicinanza et al., 2008), and, anchoring membrane
proteins (Roth et al., 2006; Pittet and Conzelmann 2007) as well as contributing to the
membrane structure. Thus, it would be of interest to elucidate the role of phospholipids in the
survival of C.albicans in the host and in its pathogenesis. The major phospholipids in yeast
include phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylcholine (PC) and
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phosphatidylethanolamine (PE) (Rattray et al., 1975; Paltauf et al., 1992; Guan and Wenk
2006).
In yeast, phospholipid biosynthesis (Fig:1-2) is initiated from phosphatidic acid (PA), which is
partitioned to cytidyldiphosphate-diacylglycerol (CDP-DAG) or DAG by either CDP-DAG
synthase (Carter and Kennedy 1966) or PA phosphatase (Han et al., 2006) respectively. CDPDAG and DAG are then used to synthesize PE and PC by two alternative pathways (Fig:1-2):
the CDP-DAG pathway and the Kennedy pathway. CDP-DAG is converted to PS by PS
synthase (encoded by the Cho1p enzyme) in the CDP-DAG pathway. This process takes place
in the endoplasmic reticulum (Atkinson et al., 1980; Letts et al., 1983; Kiyono et al., 1987; BaeLee and Carman 1984). The PS decarboxylases, the inner mitochondrial membrane-localized
Psd1 and the Golgi-localized Psd2, convert PS to PE (Clancey et al., 1993; Trotter et al., 1995;
Voelker 2003). PE is then converted to PC by three sequential methylation reactions in the ER
catalyzed by PE methyltransferase (encoded by CHO2) and phospholipid methyltransferase
(OPI3 encoded) (Kodaki and Yamashita 1987; Summers et al., 1988; McGraw and Henry 1989).
Mutants that are defective in either of these pathways have choline/ethanolamine auxotrophies
(Atkinson et al., 1980; Trotter and Voelker 1995; McGraw and Henry 1989).
The Kennedy pathway relies on the exogenous transport of ethanolamine and choline by a
transporter encoded by HNM1 (Nikawa et al., 1986). Cytoplasmic located ethanolamine kinase
(Eki1) and choline kinase (Cki1) phosphorylate these with ATP to form ethanolamine-P and
choline-P (Kim et al., 1999; Hosaka et al., 1989). These intermediates are activated by
cytidylyltransferases to form CDP-ethanolamine or CDP-choline (Min-Seok et al., 1996;
Tsukagoshi et al., 1987). Phosphotransferases (Hjelmstad and Bell 1988,1990,1991) then
condense CDP-ethanolamine and CDP-choline with DAG to from to PE and PC.
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The synthesis of phospholipids in fungi is similar to that in mammalian cells, the only difference
being in the synthesis of PS. In mammals, PS is synthesized from PE or PC and serine, and in
fungi it is synthesized from CDP-DAG. This difference can be exploited if phospholipid
biosynthesis is to be explored as a viable antifungal target. Given the ubiquitous presence of
phospholipids in the cell, it is not surprising that defects in phospholipids biosynthesis can have
adverse effects on the growth and proliferation of C.albicans. In S.cerevisiae, PE has been
shown to play an important role in stabilizing mitochondrial protein complexes (Birner et al.,
2003; Osman et al., 2009). This results in the mutant being non-viable with defects in protein
and lipid scaffolding complexes (Osman et al., 2009). This in turn has dire effects on the
functionality and integrity of the mitochondrial inner membrane (van Gestel et al., 2010).
Phospholipids in virulence: The C.albicans cho1∆/∆ mutant is avirulent in a mouse model of
systemic candidiasis (Chen et al., 2010). Loss of de novo PE (through disruption of PSD1 and
PSD2) also attenuates the virulence of C.albicans. These mutants exhibit cell wall defects as
demonstrated by an increased sensitivity to caspofungin and resistance to caffeine (Chen et al.,
2010). Osmostabilizers such as CaCl2, sorbitol and NaCl rescue the growth defect of the
cho1∆/∆ and the psd1∆/∆psd2∆/∆ mutants on YPD medium suggesting that loss of PE and PS
may affect the cell wall (Chen et al. 2010). These findings are further supported by the
observation of a thick, irregular cell wall by transmission electron microscopy in the cho1∆/∆
strain (Chen et al., 2010). Furthermore, defects in PE biosynthesis also impacted the function of
mitochondria, and this is not surprising since mitochondria are enriched in PE as it is the main
site of de novo PE biosynthesis. Mitochondrial defects in the PS and PE deficient mutants have
been demonstrated by an increase in resistance to paraquat (Chen et al., 2010). Paraquat binds
to complex I in the electron transport chain leading to the generation of superoxide radicals and
subsequent oxidative damage in cells with an intact mitochondrial membrane. Thus, resistance
to paraquat is indicative of a defect in the respiratory chain (Cocheme et al., 2008; Blaszczynski
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et al., 1985) more specifically, a defect in oxidative phosphorylation in C.albicans (Cheng et al.,
2007). Mitochondrial respiration defects are further highlighted by the fact that these mutants
take up trypan blue and eosin Y dye more readily than the wild-type strain (Chen et al., 2010;
Nagai, S 1963).
Given these findings, it is clear that phospholipids play vital roles in the cell biology of
C.albicans, but significant gaps lie in our understanding the contribution of phospholipid
metabolic pathways in membrane biogenesis, signaling and cell cycle transitions. A genomewide approach is thus required to gain a global understanding of the different regulatory
networks and cell processes affected by the loss of PS and de novo PE.
Phospholipid structures and polymorphisms: Phospholipid species have been classified as nonlipid bilayer and lipid bilayer forming due to the cross-sectional area and shape of their
respective headgroups and acyl side chains (Frolov et al. 2011; Cullis et al. 1986). Lipid bilayer
forming species, such as PS and PC, are ideally suited to maintain a rigid membrane structure,
whereas, PE forms a conical shape with a small headgroup and large hydrophobic tail and is
thereby conducive to increasing membrane fluidity and curvature (Figure 1-3) (Cullis et al. 2002,
Haque et al.,2001). A mixture of bilayer and non-bilayer forming phospholipids enables
association of the membrane into a semi-permeable barrier and allows appropriate distribution
for the function of integral membrane proteins (Cullis et al 1986, 2002). The dynamic nature of
the lipid bilayer is evidenced by the effect of changes in tail acyl chain lengths and saturation
upon cell stresses such as temperature, divalent cation concentration, and membrane disrupting
detergents (Tumolo et al., 2011). Generally, the higher the saturation number and shorter the
hydrocarbon length within the acyl chains, the more disordered and less rigid the membrane
becomes and membrane fluidity is, therefore, increased (Cullis et al. 1986; Lindbolm et al,.
2004). Diversity in lipid species and function in the membrane is complicated by the presence of
over 100 different lipid species in a eukaryotic membrane (Gerrit van Meer et al., 2011). The
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dynamics of lipid fluidity involve the lateral displacement of lipid acyl tails and interactions of the
headgroups between phospholipids and are dependent upon the phospholipid headgroup,
saturation number, chain length, hydration state, protein interactions, cationic environment and
interaction with other lipids such as cholesterol or ergosterol (Rajendran et al 2005; Tumolo et
al., 2011).
These dynamic interactions are key to a variety of cellular processes including
exocytosis and endocytosis which are thought to be at least partially mediated by the presence
of cone shaped PE molecules (Farge et al., 1999). PS, the least abundant of the phospholipids,
can be negatively charged due to the presence of an electronegative oxygen atom on its serine
residue which affects its molecular properties such as its ability to interact with other lipid
headgroups (Cullis et al. 1986; Marsh et al. 2012) at the surface of the membrane and this in
turn may affect lateral diffusion of side chain packing within the membrane. At pH below 4.0, PS
becomes protonated and loses its electrorepulsive properties that may result in aberrant charge
distribution at the membrane surface and it is hypothesized that this facilitates improper lipid
spacing and can lead to a disordered membrane consequently disrupting binding of proteins at
the surface of the membrane (Cullis et al., 2002; Marsh et al 2012). PS has also been
described as a co-factor for signaling pathways in fungi such as for protein kinase C (PKC)
(Kamada et al., 1996) which controls cell wall integrity, as well as in calcium mediated signaling
via calcinuerin, which controls internal calcium levels (de Lucena et al., 2012). The diversity of
lipid species, their precise functioning, and how they mediate membrane- structure function is
an area of increasing interest that requires close evaluation as much remains to be known
about the properties that phosphatidylserine (PS), phosphatidylethanolamine(PE) ,and
phosphatidylcholine(PC) contribute to lipid interactions and how these interactions ultimately
affect the cell.
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Iron Sensing and Uptake
Candida albicans can colonize and grow in a variety of host environments (Calderone and
Fonzi, 2001). Deep-seated tissues and organs, such as the kidneys, and mucosal surfaces like
the oral and vaginal cavities, present unique environmental niches in terms of the nutrients
available for uptake by microbial colonizers. Iron is an important co-factor for essential cellular
processes and is present in very low amounts in the bloodstream (~10-24M free iron) and deep
tissues. The need to scavenge iron from the host has led to the evolution of distinct iron sensing
and acquisition pathways in C. albicans. In addition, iron acquisition and utilization is tightly
regulated as the organism constantly shuttles between iron -replete and –limited environments
in the host, since high amounts of it can be toxic and low amounts of iron can shut down
respiration and other cellular processes. In fact, in a variety of both prokaryotic and eukaryotic
pathogens the ability to acquire and store iron has been shown to be an important virulence
factor.
The more robust regulation of iron in C. albicans compared to that of S. cerevisiae is
hypothesized to be a direct result of the environments that C. albicans must encounter upon
infection of the host (Chen et al., 2011). Iron uptake systems have been well characterized in
S.cerevisiae and many orthologues of the iron-import system exist in C.albicans (Eck et al.,
1999; Ramanan and Wang, 2000; Weissman et al., 2002). Three iron-import systems have
been identified in C.albicans. In the bloodstream, C.albicans can directly acquire iron from
blood cells by secreting hemolysins (Manns et al., 1994; Luo et al., 2001). Rbt51/Pga10 is
strongly induced in iron-depleted conditions and plays a role in heme-iron utilization (Weissman
et al., 2002). Rbt5 is another GPI-anchored haem receptor (Weissman and Kornitzer, 2004) that
tethers haem at the membrane, followed by uptake or internalization via endocytosis (Weissman
et al., 2008). Iron can also be bound to siderophores and taken up via siderophore transporters
such as Sit1 (Ardon et al., 2001; Hu et al., 2002). Finally, free iron can be taken up by iron
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permeases such as Ftr1 (Knight et al., 2002) following the sequential reduction of Fe 3+ by cell
surface-bound ferric reductases (Hammacott et al., 2000; Knight et al., 2002). The GPIanchored protein Als3 can also mediate the extraction of iron from host ferritin through a similar
reductive system (Almeida et al.,2008).
Iron sensing and response is mediated by Sfu1 and Sef1/2 in C. albicans, in contrast to
S.cerevisiae where ScSef1 acts directly upon ScAft2 to up-regulate iron uptake genes (Chen et
al., 2011). Under iron-limited conditions, iron acquisition genes are activated through
repression of Sfu1. The transcriptional repressor, Hap43 increases iron availability under these
conditions by repressing genes that code for acotinase and cytochrome c both of which are
involved in iron and or haeme utilization (Baek et al., 2008; Chen et al., 2011; Hsu et al., 2011;
Singh et al., 2011). Sef1 is considered the central iron regulator, as it activates HAP43 and
expression and thus indirectly controls SFU1 expression. Sef1 also activates several target
genes that are regulated by Hap43 and Sfu1 such as HAP1 (Chen et al., 2011) and these
genes are involved in iron response or heme biosynthesis (Chen et al., 2011).
Interestingly, it has been shown that SEF1 is overexpressed in human plasma and is essential
for bloodstream infections in a mouse model. In contrast, SFU1 is up-regulated in the gut, and
a sfu1∆/∆ mutant is defective for colonization of the gut (Chen et al., 2011). This differential
regulation of these co-regulated iron-response genes in different host niches highlights how
C.albicans has evolved a tightly regulated iron regulatory circuit to promote its survival in the
host. Amongst the genes regulated by Sef1 are several virulence related genes (Chen et la.,
2011); including cell wall proteins, transporters and transcription factors.
Analysis of the roles of Sfu1 and Sef1 in C.albicans iron regulatory system has revealed that
Sfu1 promotes commensalism and Sef1 promotes pathogenesis in the mammalian host (Chen
et al., 2011). While Sfu1 promotes competitiveness in the gastrointestinal tract and resistance to
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iron toxicity, Sef1 plays a unique role in C.albicans that is not conserved in other fungal species,
i.e. it controls several virulence related genes. This ability to maintain expression of genes
required for the survival of C.albicans in the host while continuously repressing toxicity factors
further underscores the adaptation that this organism has undergone to promote its existence
as both a commensal and pathogen in the iron-limited/ -replete host microniches. Thus any
disruption of iron homeostasis in Candida albicans may alter the way it senses, responds to and
interacts with the host.

Project Overview
In this dissertation, we demonstrate how loss of phosphatidylserine (PS) and de novo
phosphatidylethanolamine (PE) in Candida albicans results in significant changes in the cell wall
that can be attributed to the differential regulation of cell wall protein genes, mainly those
encoding GPI-anchored proteins, and to dysfunctional mitochondria. Iron homeostasis is also
affected in mutants that lackde novo PE but the defects are more severe in the cho1∆/∆ strain
which lacks also lacks PS, as demonstrated by the up-regulation of iron regulators that function
to transcriptionally repress iron-acquisition genes in conditions of low iron availability.
Consequently, the mutants fail to survive in iron-limited conditions and this may also in part
explain the virulence defects in a mouse model of systemic candidiasis associated with the
cho1∆/∆ and psd1∆/∆psd2∆/∆ strains. Furthermore, profiling the phosphlipidome of these
mutants has helped in the identification of key lipids that are altered upon disruption of
phospholipid biosynthesis in C.albicans. This is the first study that links phosphatidylserine (PS)
synthesis to cell wall biogenesis, mitochondrial dysfunction, and iron homeostasis in C.albicans.
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APPENDIX AI : FIGURES

Figure 1-1: The structure of the fungal cell wall with the different polysaccharide and
protein components depicted. (Image adopted from science.kennesw.edu/fungcellwall)
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Figure 1-2: The phospholipid biosynthetic pathways in fungi (Saccharomyces
cerevisiae). Two alternative pathways, the de novo pathway and the Kennedy pathway exist
in both humans and yeast, but there are significant differences in the de novo synthesis of PS
between yeast and humans. For a detailed explanation of the biosynthesis, refer to the text.
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Model of Lipid Shape Polymorphisms
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determined by the cross-sectional area of the headgroup(Ao) versus the cross
sectional area of the hydrophobic tail(Ah). Ao>Ah= inverted cone shape, Ao=Ah=
cylindrical shape, Ao<Ah= cone shaped. PS= phosphatidylserine,
PC=phosphatidylcholine, PE = Phosphatidylethanolamine, PG=phosphatidylglycerol,
PI=phosphatidylinositol, CL= cardiolipin. Ionic stress and low pH can influence these
2+
properties in PS and CL as indicated (+Ca and at pH<4).(Cullis et al., 2001; de Kruijff
B, 1997).
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CHAPTER TWO
Candida albicans cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants exhibit
defects in cell wall protein expression and iron utilization

Some of the experiments in this chapter were done in a collaborartive effort and I am thankful
for the help of those listed in this paragraph. I especially acknowledge John G. Gibbons and
Antonis Rokas (Vanderbilt University) for contributing to the RNA sequencing data. Terry K.
Smith (University of St. Andrews, Scotland) for the mass spectrometry of lipids and all his lipid
advice. Sarah Davis (University of Tennessee), who helped with the mouse infection assays
and immunoflouresence staining as well as Robert Wheeler (University of Maine) for the
Dectin-1 binding data.
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Abstract
We show that a loss of de novo PS and PE biosynthesis has pleiotropic effects on the Candida
albicans cell, including cell wall defects, defects in growth under iron limited conditions,
sensitivity to low pH, sensitivity to the membrane-targeting drug fluconazole and differential
expression of hypoxic, cell wall, and mitochondrial related genes. We also show that changes in
the phospholipidome indicate that PS 16:0/18:2 is the main lipid species trafficked through the
de novo pathway in Candida albicans and that there is a subsequent increase in long acyl side
chain 18:n18n PE species , presumably, from increased Kennedy pathway PE and PC
synthesis. The differential effects observed between the cho1∆/∆ and psd1∆/∆psd2∆/∆ strain
implicate PS as having a direct role in the observed phenotypes. Therefore, we suggest a novel
role for PS in Candida albicans, whereby, PS itself is required for cell wall maintenance and
loss of PS leads to both an altered cell wall and dysfunctional mitochondria.

24

Introduction
The roles of phospholipids and their functions inside eukaryotic cells have been well
characterized, however, there remain significant gaps in our understanding of how
phospholipids affect key biological processes such as their role in the overall structure and
function of organellar membranes, their contribution to protein-enriched lipid rafts and their
affect on cellular metabolism (Osman et al. 2011, Dagley et al. 2011, Bishop et al. 2011).
Recent advances include elucidating key protein complexes that mediate a few of these
interactions, such as the discovery of the ERMES (endoplasmic reticulum-mitochondria
encounter structure) (Michel A.H. & Kornmann B, 2012), which aides in tethering the
mitochondria to the endoplasmic reticulum (ER) to facilitate transfer of phospholipids between
these organelles. Studies of ERMES have raised questions about the structure and function of
phospholipids in eukaryotic cell biology and hints that this class of lipids is underexplored (Voss
et al., 2012; Osman et al., 2011). For example, the roles that different phospholipids and
particular phospholipid species (i.e. lipids that share the same head group, but differ in fatty acid
tail length or saturation) have on organelle structure and metabolism are only beginning to be
understood (Osman et al. 2011, Joshi et al. 2012).
There exist two major pathways for phospholipid biosynthesis in fungi: they are the de novo
pathway and the Kennedy pathway (Kent et al., 1995). Together these two pathways synthesize
all of the cellular phosphatidylserine (PS), phosphatidylethanolamine (PE) and
phosphatidylcholine (PC) (Chen et al., 2010). The de novo pathway begins with the synthesis of
PS from cytidyldiphosphate-diacylglycerol (CDP-DAG) and serine by Cho1p. A pool of PS is
then decarboxylated to PE by the PS decarboxylases Psd1p or Psd2p to produce PE in the
mitochondria or Golgi/endosome, respectively. A pool of PE is then methylated by Opi3 and
Cho2p to make phosphatidylcholine (Kent et al., 1995) (Fig;1-2 p20 ). In contrast to de novo
synthesis, the Kennedy pathway involves utilization of diacylglycerol (DAG) and exogenous
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sources of ethanolamine or choline to synthesize PE or PC, respectively. In the Kennedy
pathway PE can be directly synthesized from ethanolamine by Eki1p, Ect1p, Ept1p or PC can
be synthesized from choline via Cki1p, Cct1p, and Cpt1p (Bergo et al., 2002 Kent et al.
1995)(See figure 1-2). Although the enzymes of the Kennedy pathway are conserved in
mammals, some of the enzymes of the de novo pathway, such as Cho1p and Psd2p, do not
have human homologs, and may be valuable antifungal drug targets. In mammalian cells, PS is
synthesized from PE by Pss2p or directly from PC by Pss1p (Arikketh et al., 2008; Bergo et al.,
2002).
A number of aspects remain unclear about how phospholipid levels and biosynthesis affect the
mitochondria and how they impact other cellular structures, such as the cell wall. Phospholipid
homeostasis has been linked to key cellular processes such as respiration, drug transport, and
metabolism and the effects of disruption of phospholipid homeostasis on these processes
warrant further study. The relationship of phospholipids to the cell wall may be through their
indirect or direct effects on activation of cell wall integrity and signaling pathways such as the
Rim101 pathway, HOG-1 pathway, and/or the calcenuerin pathway. In C. albicans, cell wall
streses such as ionic stress can activate the calcenuerin pathway which can alter transcription
by the transcription factor CRZ1 (Li et al, 2011). In addition, activation of Rim101 can lead to
changes in morpohology and cell wall structure (Mitchelll et al. 2000). Interestingly, the HOG1
pathway has been shown to be activated under conditions of mitochondrial dysfunction and
osmotic stress (Alonso-Monge et al. 2008).
The mitochondria are key in cellular metabolism including oxidative phosphorylation and the
Krebs cycle (Onishi et al., 1967; Fitton et al., 1994; Cortassa & Aon., 1994; Averet et al.,
1998;Celton et al., 2012). The mitochondrion has also been suggested as the major organelle
whereby PS and PE are trafficked and synthesized to be transported to the plasma membrane
(Osman et al., 2011). The mitochondrial outer and inner membranes function as barriers to
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establish a proton motive force for the synthesis of adenosine triphosphate (ATP) as well as to
provide a favorable environment for the activity of proteins involved in the transport of electrons
to the terminal oxygen electron acceptor in the mitochondrial-localized electron transport chain
(Davies et al., 2012). Both membranes are essential in establishing the membrane potential that
enables aerobic respiration via the Krebs cycle (Mitchell 1966; Knorre et al., 2012). Due to the
presence of proteins associated with the electron transport chain, the mitochondrial inner
membrane is also the most protein rich membrane of any biological membrane thus studied
(Davies et al., 2012, Osman et al., 2011). Mitochondria are enriched in the lipids cardiolipin and
PE and normal mitochondrial function is lost when cardiolipin or PE is removed (Joshi et al.,
2012; Gohil et al., 2005; Zhong et al., 2004). In S.cerevisiae, the Psd1p enzyme is localized in
the mitochondrial inner membrane, and functions to decarboxylate PS to PE, thereby increasing
de novo synthesized PE within the mitochondrial inner membrane (Clancy et al., 1993).
However, the contribution of PS in the mitochondria, other than as a substrate for PE synthesis,
is not well understood.
In this chapter, we investigate the effects of disruption of the biosynthesis of PS and de novo PE
on the fungal cell and provide evidence that PS itself has an effect on the mitochondria in
addition to defects associated with downstream de novo PE synthesis. Furthermore, PS loss
leads to cell wall defects in Candida albicans. We suggest that the defects in mitochondrial
function are due to PS loss and cause specific effects on the cell wall. Finally, we demonstrate
evidence that the loss of PS leads to differential phenotypes in Saccharomyces cerevisiae
indicating that the phenotypic role of PS in cell wall maintenance is different in these two fungi.
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Materials and Methods
Strains and Culture conditions
All strains used in this study are listed in Table 2-1. Unless otherwise mentioned, the strains
were grown in (1%) yeast-extract (2%) peptone (2%) dextrose, (YPD) medium (Styles, 2002) at
30ºC with shaking.
Phospholipid profiling
Cells were grown overnight and then inoculated at .4 O.D. / ml in 25 ml of (1%) yeast extract
(2%)peptone (2%) dextrose (YPD) and grown for 6 hours at 30°C with shaking. The cells were
then pelleted at 13,000xG for 1 min and washed with 1ml H20. Next, the cells were suspended
in 1 ml of 100 % methanol. 5 mg of glass beads were added and the sample was bead-beated
five times using a mini-Bead beater-1 Biospec beater on ice with 30 second incubation on ice in
between bead beating. Next, 3 ml of chloroform was added to the cell suspension and the
solution was mixed by vortexing for 30 seconds. Cells were then transferred to a separatory
funnel and washed with 900 µl of 0.9% NaCl solution. The bottom organic layer (1 ml) was then
collected using a separatory funnel and dried under N2 gas for 1 hour. Prior to organic extraction
and separation, internal standards of 10 µg of PE 28:0, PC 28:0 and PS 30:0 were added for
quantification. The lipid pellets were then analyzed by electrospray ionization tandem mass
spectroscopy (ESI-MS/MS) and the relative amounts of each class of phospholipids were
quantified relative to the standard.
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RNA sequencing
Overnight cultures were added to 25 ml of YPD at .4 O.D/ml and allowed to grow with shaking
at 30°C for 5 hours. 10 O.D.(A600)equivalents per strain were collected by centrifugation. Total
RNA was extracted using the phenol method (Dhomedy et al., 1991). Extracted RNA was
treated with DNAse following the manufactures protocol (Ambion® (TurboDnase)). It was then
assayed for purity by gel electrophoresis. DNase treated total RNA was then cleaned with an
RNeasy column (Qiagen) according to the manufacturer’s instructions. mRNA libraries were
constructed and sequenced at the Vanderbilt Genome Technology Core following Illumina®
specifications on an Illumina HiSeq 2000. 50bp read sets from each of the four samples were
independently mapped to the Candida albicans SC5314 reference transcriptome using BLAST.
Over 20 million reads were mapped for each sample (cho1∆/∆: 34,537,503; psd1∆/∆:
21,041,937; psd1∆/∆psd2∆/∆: 21,271,203; and cho1∆/∆::CHO1: 25,147,891). In all samples, 9596% of mapped reads uniquely mapped to a single transcript. The nucleotide content of
mapped reads represented an average 128x coverage of the C. albicans SC5314 reference
transcriptome (cho1∆/∆: 193x; psd1∆/∆: 117x; psd1∆/∆psd2∆/∆ :119x; and cho1∆/∆::CHO1:
140x).Reads were trimmed from 101 bp to 50 bp by removing the first 11 bp and last 40 bp of
each read to maximize overall read quality. Gene expression levels were quantified as
previously described (Gibbons et al. 2012) by mapping reads against the Candid albicans
SC5314 Assembly 19 reference transcriptome using the SeqMap software, version 1.08 (Jiang
and Wong 2008 – doi:10.1093/bioinformatics/btn429) allowing 2 mismatches per read. For each
gene, gene expression levels were quantified in terms of reads per kilobase per million mapped
reads (RPKM) (Mortazavi et al. 2008) using the rSeq software, version 0.0.5 (Jiang and Wong
2009 –doi:10.1093/bioinformatics/btp113). False discovery Rate (FDR) was used to determine
statistical differences between the mutants and the wild type strain. A p-value was set as 1E-10
as statistically significant (Conesa et al., 2011, Mortazavi et al., 2008).The data was then
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normalized to five housekeeping genes ACT1, PMA1, RIP, RPP2B and LSC2 (Nelis et al.,
2006). RNA sequencing results were verified by immunofluorescent staining for ALS and HWP1
genes as described below.
Sensitivity to cell wall and membrane perturbing drugs
For the spot dilution tests, overnight cultures of C.albicans strains were washed twice in 1 ml
phosphate buffered saline (PBS), and resuspended at 1 O.D./ml in 1 ml of H20. The cells were
then serially five-fold diluted and spotted onto minimal media (Yeast Nitrogen Base(YNB) + 2 %
glucose+ histidine +luecine+1mM ethanolamine) containing either calcoflour white (20µg/ml) or
congo red (10µg/ml) or Fluconazole (2µg/ml). All plates were imaged after incubation at 37ºC for
48h.
Fluorescence Microscopy
The C.albicans strains were grown overnight in YPD at 37°C for 24 hours and then collected by
centrifugation at 13,000x g for 1 min, and washed thrice in phosphate buffered saline (PBS),
Next, the cells were diluted to .4 OD/ml in 25 ml of YPD and grown for 5 hours at 30°C. Cells
were collected washed with 1 ml H20 and then stained with monoclonal antibodies against
Als1p, Als3p and Hwp1p obtained from Lois Hoyer (University of Illinois, Urbana-Champagna).
Samples were further stained with a goat anti-mouse secondary antibody conjugated to Cy3.
Microscopic images were then taken under bright field or TRITC filter to observe fluorescent
staining.
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Growth in low pH conditions
For growth in low pH media, cells were grown overnight in YPD then inoculated at .1 O.D./ml
into 5 ml of minimal media (Yeast Nitrogen Base(YNB)+glucose+uracil+luecine+histidine+1 mM
Ethanolamine) plus phosphate citrate buffer to pH 4.0 and pH 2.7 and allowed to grow for 48
hours at 37°C with shaking. The pH was measured before and after the assay using a pH meter
to assure correct pH.
Iron-limitation assay
The cells were inoculated from overnight culture into minimal media with addition of 1 mM of the
Iron chelator bathophenanthroline disulfonate (BPS), or in minimal media containing 1 mM
BPS plus the addition of 100 µM or 300 µM Iron (II) Sulfate. The cells were inoculated into 5 ml
of minimal media and allowed to grow at 37C for 48hours with shaking. Growth was then
measured by optical density at 600 nm. For solid media, cells were inoculated in spot dilutions
from a starting concentration of 1 O.D./ml minimal media (Yeast Nitrogen Base + 2%
glucose+uracil+luecine+histidine+1 mM Ethanolamine +3 % agar) plates with or without 1mM
BPS, or 1mMBPS + 100 µm Iron (II) Sulfate. Images were taken after 48 hours of growth at
37°C.
Chitin Staining
Strains were grown overnight in YPD at 37°C with shaking. 1ml at 5 O.D./ml of cells were
collected and washed with 1 ml of water. Cells were then stained by addition of 1 ml of 1mg/ml
calcofluor white and rocked at room temperature for 5 min. The cells were centrifuged and
washed three additional times and then resuspended in 500 uls water and 5 ul was spotted onto
a slide for microscopy. The cells were visualized at 200X magnification under bright field and
fluorescence (UV-DAPI filter) microscope. Results are expressed as percentage of cells that
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exhibited increased fluorescence out of the total cells counted. The statistics are based on the
average of three different fields of view. Approximately ~400 cells were counted for each strain.
Transmission Electron Microscopy
Cells growing at log phase in 25 ml of YPD were harvested and fixed for electron microscopy
using a modification of a protocol by Wright (Wright, 2000). 1ml of 10 O.D/ ml of cells were
collected and resuspended in a fixative consisting of 3% glutaraldehyde and 3%
paraformaldehyde in 0.1 M phosphate buffer. Cells were centrifuged, then re-suspended in
fixative and incubated overnight at 4°C. Cells were then washed in 0.1 M phosphate buffer for
10 mins. Cells were washed in 1% KMnO4 and re-suspended in fresh KMnO4 for an additional
90 min. Cells were then en-bloc stained in 1% aqueous uranyl acetate for 60 min and then
dehydrated in a graded ethanol series at 15 min intervals. This was repeated twice. Cells were
treated with Spurr resin/ethanol over a 24 h period. Spurr resin was replenished and samples
were heated in a 68°C oven for 24 h. Thin sections were cut with a Reichert OMU3
ultramicrotome, mounted on copper grids, stained with lead citrate, and examined with a
HitachiH800 transmission electron microscope operating at 75 KeV.
Statistical Analysis
Prism 4.0 software (Graph Pad) was used to determine the significance of differences in growth
under low pH and iron-limitation conditions. Statistically significant differences were determined
using the two-tailed unpaired t test. Statistical significance was set at a P value of <0.05.

Results
Lipid profiling of phospholipid biosynthesis mutants
In order to better understand the specific changes associated with disruption of PS and/or de
novo PE biosynthesis, global lipid profiles of cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants were
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compared to wild-type. For the lipidomic analysis, C. albicans strains were grown in YPD
medium for 6 hours at 30°C with shaking and total lipids were extracted as described in the
materials and methods. Extracted lipids were subjected to Electrospray Ionization Tandem
Mass spectrometry (ESI-MS/MS). The total lipids were quantified and normalized to internal
standards PE (14:0/14:0), PC 14:0/14:0 and PS (14:0/14:0) (These lipid standard species are
not found in Candida albicans).
PS species in wild-type were all of the 16:n/18:n variety (16 and 18 indicate the number
of carbons in the sn-1 and sn-2 fatty acid tails, respectively, and “:n” indicates the number of
unsaturated bonds in that particular tail). The most abundant species of PS species in the wildtype were 16:0/18:2 or 16:1/18:2 (Table 2-2); all of these species were completely absent in the
cho1∆/∆ mutant, as expected. In contrast, there is a build-up of PS in the psd1∆/∆ psd2∆/∆
mutant (Table 2-2).
In contrast to PS, PE in wild-type is represented by species that include 16:n/18:n (34%),
18:n/18:n (41%), and 18:n/20:n (25%) (Table 2-2). The most abundant wild-type 16:n/18:n PE
species is 16:0/18:2, which makes up 20% of total PE. In the cho1∆/∆ and psd1∆/∆ psd2∆/∆
mutants, the substantial drop in PE that was noted previously by TLC, appears to be almost
exclusively due to a decrease in 16:n/18:n PE, with the most substantial decrease occurring in
16:0/18:2 PE. Conversely, the other species of PE do not decrease, and instead become a
larger percentage of the total PE. These other species are likely generated by the Kennedy
pathway from exogenous ethanolamine in YPD medium.
PC is also represented by 16:n/18:n (59%), 18:n/18:n (36%), and 18:n/20:n (5%), with a
small percentage of 14:n/16:n in the wild-type (Table 2-2). In cho1∆/∆ and psd1∆/∆ psd2∆/∆
there is a substantial loss of the 16:n/18:n species, but a strong increase in 18:n/18:n species,
that may be due to compensation from the Kennedy pathway.
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Thus, in C. albicans, the majority of species contributed to PS, PE, and PC by the de
novo pathway appear to be 16:n/18:n, and the Kennedy pathway contributes species with
longer fatty acid tails.
Transcriptional profiling of PS- and de novo PE- deficient Candida albicans mutants by
RNA sequencing
The lipidomics data suggested that loss of the de novo pathway specifically blocks synthesis of
16:n/18:2 PS, PE, and PC. The cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants both have a similar
drop in 16:n/18:2 PE and PC, but only the cho1∆/∆ mutant has a complete loss of PS as well.
Both mutants have mitochondrial and cell wall defects and in both cases, the defects seem to
be greatest in the cho1∆/∆ mutant. In order to determine what effects the losses of these
species of PE and/or PS have on the mitochondria, cell wall or other organelles, transcriptional
profiles of the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants were compared to wild-type using RNA
sequencing (RNA seq). Genes in either strain that showed ≥3-fold up or down regulation
compared to wild-type, after normalization, were selected for further analysis.
There are 114 genes that are transcriptionally up-regulated by ≥3-fold in the cho1∆/∆
mutant compared to the WT (SC5314), and 129 genes are up-regulated by ≥3-fold in the
psd1∆/∆psd2∆/∆ double mutant v/s the WT strain (Appendix Tables A-3 and A-5). Of the 114
genes up-regulated in the cho1∆/∆ mutant, 47 (41%) were also up-regulated by ≥3-fold in the
psd1∆/∆ psd2∆/∆ mutant compared to wild-type. The total number of genes up-regulated in
each mutant were sorted according to gene ontology (GO) term corresponding to subcellular
localization (component) using the GO SLIM Mapper function in the Candida Genome Database
(CGD). This analysis revealed that in both mutants, 16-24% of the genes that were upregulated compared to wild-type related to the mitochondria (Fig 2-1).
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As both of these mutants have cell wall defects, we more carefully examined cell wall
genes that were up-regulated in the mutants compared to wild-type (Tables 2-3 to 2-5).
Interestingly, both mutants up-regulated a number of cell wall genes that are involved in hyphal
growth, even though they are being grown in YPD at 30˚C, a condition that is normally not
conducive to forming hyphae. These genes included ALS1-3, PGA6, and PGA10 (Table 2-5).
Some other cell wall genes that are usually associated with hyphal formation like HWP1 and
RBR1 were up-regulated very highly in the cho1∆/∆ mutant (Table 2-3), but were not upregulated in the psd1∆/∆ psd2∆/∆ strain.
In order to further explore the expression changes in the cell wall genes, we focused first
on the ALS genes, which represent a highly conserved family of glycosylphosphatidylinositol
(GPI)-anchored cell wall adhesin genes. This was explored using a set of monoclonal
antibodies specific to the Als1, Als3, and Als4 proteins and Hwp1p (Coleman et al., 2012;
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Figure 2-1: Gene ontology (GO) comparison of all genes UP regulated in the cho1∆/∆ and
psd1∆/∆psd2∆/∆ mutants. Genes were input into the Candida Genome Database (CGD) SLIM
mapping tool and mapped for their cellular components. Gene ontology is expressed as both
component and process and the percentages are displayed comparing the cho1∆/∆ strain and
the psd1∆/∆psd2∆/∆ strain .
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Coleman et al., 2009), which is another GPI-anchored cell wall protein that is not highly
conserved with ALS1-4.
Fluorescence microscopy of wild-type, cho1∆/∆, and psd∆/∆ psd2∆/∆ cultures grown in
YPD at 30˚C for 5 hours (under identical conditions as the RNAseq experiment) revealed that in
wild-type, psd1∆/∆ psd2∆/∆ and cho1∆/∆ strains the Als1p and Als4p were expressed (Fig 2-2,
data not shown), but Als1p was slightly higher in cho1∆/∆ and psd1∆/∆ psd2∆/∆ than wild-type.
In contrast, Als3p was not expressed very strongly in any strain except cho1∆/∆, and this was
primarily associated with a higher number of hyphal-like cells found in the culture (Fig 2-2).
These data, especially regarding Als3p, do not agree with the RNAseq data which
indicates that ALS3 is up-regulated in both cho1∆/∆ and psd1∆/∆ (Table 2-5). However, this
may be because ALS1 was more highly expressed and ALS1 and ALS3 are practically identical
over much of their sequence (data not shown). Thus, the BLAST searches matching the RNA
sequencing library to the database may have generated artifacts due to this close homology.
In order to clear this up, another hyphal cell gene, HWP1 was tested, since it shows
much higher expression in cho1∆/∆ than in the psd1∆/∆ psd2∆/∆ strain (Table 2-3), but has little
homology with the ALS gene family. It was found that Hwp1p was highly expressed in cho1∆/∆
hyphal cells, but not in the other strains, including psd1∆/∆ psd2∆/∆ (Fig 2-2). The wild-type and
psd1∆/∆ psd2∆/∆ cultures grew mainly as yeast cells. Thus, the cho1∆/∆ mutant appears to
have more hyphae in YPD at 30˚C.
In addition to the up-regulation of cell wall genes that are involved in hyphal formation,
the cho1∆/∆ mutant up-regulated several genes involved in cell wall repair including PGA31,
PGA13, IFF11, and ECM331. ECM331 was up-regulated in psd1∆/∆ psd2∆/∆ as well, although
it was more highly expressed in the cho1∆/∆ mutant. Both mutants exhibit cell wall defects,
although the defects are greater in the cho1∆/∆ mutant. These include an altered cell wall
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Figure 2-2: Immunostaining of C.albicans strains to determine expression of Als1, Als3
and Hwp1. Candida cells were grown in YPD medium at 30 °C, washed in saline, counted and
transferred into pre-warmed RPMI medium at a cell density of 5×10 6 cells ml−1. Fixed cells were
immunosatined with anti-Als1 or –Als3 and –Hwp1. Cells were observed by fluorescence
microscopy. The cho1∆/∆ mutants showed increased expression of Als3 and Hwp1 proteins
(middle and last panels) and both the cho1∆/∆ mutant and psd1∆/∆psd2∆/∆ mutant showed
increased expression of Als1 (first panel). (Sarah Davis contributed to this figure).
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structure, based on transmission electron microscopy (TEM) and increased staining for chitin
(Chen, et al 2010).
It was hypothesized that the alterations in the wall in these mutants would result in
increased sensitivity to cell wall stress-inducing agents. This was previously tested and found
not to be the case using YPD media. However, when it was re-examined on minimal media, it
was discovered that the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants display increased sensitivity to
both calcofluor white and congo red compared to the wild-type strain (Fig: 2-3). The cho1∆/∆
mutant shows greater cell wall defects which is consistent with its other cell wall defects (Chen
et al., 2010).
Down-regulated genes in cho1∆/∆ and psd1∆/∆ psd2∆/∆ are enriched for iron uptake
In addition to the genes up-regulated by the loss of PS and de novo PE, there were genes that
were down regulated compared to wild-type as well. There were 29 genes that were downregulated in the cho1∆/∆ mutant compared to wild-type by ≥3-fold (Appendix Table A-4). There
were 103 down-regulated genes (≥3-fold) in the psd1∆/∆ psd2∆/∆ mutant compared to wild-type
(Appendix Table A-6). The genes are summarized based on their categorizations according to
cellular component GO terms (Fig: 2-4).
Among the genes down-regulated in cho1∆/∆ compared to wild-type, there were five
(~17%) that had to do with iron uptake or utilization including CFL2, FRE10, FTR1,
orf19.6873.1, and CHA1 (Table 2-6). Iron related genes make up only 2.4% of the genes in the
whole genome, so the down-regulated genes in cho1∆/∆ are substantially enriched for iron
uptake genes. Of these 5 genes, 2 are down-regulated in psd1∆/∆ psd2∆/∆ compared to wildtype as well, CFL2 and FRE10 (Table2-6).
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psd1∆/∆
cho1∆/∆
WT

No Drug

Calcofluor White Congo Red

Figure 2-3 :Sensitivity to the cell wall perturbing drugs Calcofluor White
and Congo Red. The C .albicans cho1∆/∆, psd1∆/∆, and psd1∆/∆psd2∆/∆
mutants are sensitive to the cell wall perturbing drugs Calcofluor White and
Congo Red but the cho1∆/∆ mutant’s sensitivity is greater as its growth was
highly diminished in the presence of either Calcofluor White or Congo Red
(Panel B and C). Serial dilutions of 5 µl of 1 O.D./ml of overnight cultured
cells were spot inoculated on solid minimal media (Yeast Nitrogen Base
+dextrose, +uracil+histidine+1 mM Ethanolamine) either with (A) no drug (B)
20 µg/ml Calcofluor white, a chitin synthesis inhibitor or (C) 40 µg/ml Congo
Red, a β-1-3 glucan synthesis inhibitor. The plates were incubated at 37°C
and images were taken at 24 hours.
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Figure 2-4: Gene ontology (GO) comparison of all genes DOWN regulated in the cho1∆/∆
and psd1∆/∆psd2∆/∆ mutants. Genes were input into the Candida Genome Database (CGD)
SLIM mapping tool and mapped for there cellular component. Gene ontology is expressed as
both component and the percentages are displayed comparing the cho1∆/∆ mutant (white) and
the psd1∆/∆psd2∆/∆ mutant (black).
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The down-regulation of iron utilization genes suggested that the cho1∆/∆ and psd1∆/∆ psd2∆/∆
mutants might have defects in the ability to grow in iron limiting conditions. Therefore, overnight
growth of the strains was compared in minimal media containing or lacking the iron chelator
bathophenanthroline disulfonate (BPS), and minimal media + BPS with iron sulfate added back
(100 µM or 300µM). This experiment revealed that growth of the cho1∆/∆ and psd1∆/∆ psd2∆/∆
mutants was significantly attenuated compared to wild-type in media where iron was limiting
(100 µM or 300 µM, Fig: 2-5; data not shown). Thus, iron limitation does inhibit the growth of
both the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants.
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Figure 2-5: Growth response to iron limitation in liquid media. Overnight cultures were
diluted to 0.1 OD/ml in 5 ml of minimal media (Yeast Nitrogen Base + dextrose + histidine +
leucine + 1mM ethanolamine) (A) with no chelator or (C) + 1mM of the iron chelator, BPS or
(B) with 1mM of the iron chelator BPS and 100 µM Iron(II) sulfate. Toxicity to iron was assayed
in minimal media with the addition of 100 µM of Iron (II) Sulfate to the medium (Panel D). Cells
were grown with shaking at 37°C and optical density was measured after 48 hours. (* indicates
a p-value < .05 ** indicates a p-valuue < .001)
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The cho1∆/∆ mutant showed greater attenuation compared to psd1∆/∆ psd2∆/∆, and this might
be because it had more iron utilization genes down-regulated (Table 2-7). A comparison of the
50 genes that are more down-regulated in the cho1∆/∆ mutant than the psd1∆/∆ psd2∆/∆
mutant by ≥2 fold, revealed that 20% of them are involved in iron utilization (Table 2-7,
Appendix Table A-4). This would help explain why cho1∆/∆ is more sensitive to iron depletion.
These results are limited to liquid aerated culture and were not observed in the same media on
agar plates (Fig: 2-6). On plates containing BPS with iron added back, the growth between the
strains was similar (Fig: 2-6).
In contrast to down-regulating genes involved in iron uptake and utilization, both the cho1∆/∆
and psd1∆/∆psd2∆/∆ strains up-regulated genes known to be involved in response to hypoxia
(low oxygen) (Table 2-9). A number of these genes are known to be induced under hypoxic
conditions (Synnott et al., 2010) in Candida albicans. We observed a more robust (higher fold)
up-regulation of some of these genes in the cho1∆/∆ strain compared to the psd1∆/∆psd2∆/∆
strain. This data suggests that while both strains exhibit a transcriptional response similar to a
response to hypoxia, the cho1∆/∆ mutant response is indicative of a greater hypoxic response
compared to the psd1∆/∆psd2∆/∆ strain.
In addition, genes involved in oxidative stress response are up-regulated in the cho1∆/∆
mutant compared to the psd1∆/∆ psd2∆/∆ strain (Table 2-8). These genes include the
alternative oxidase (AOX2), which may help shunt electrons away from the classical electron
transport chain to avoid oxidative damage. In addition, genes that neutralize reactive oxygen
and nitrogen species were also up-regulated like SOD5 and YHB1. Several alcohol
dehydrogenases including IFE2 and ADH5 were up-regulated which may help to metabolize
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increased alcohol production if fermentation is increased to compensate for decreased
respiration (data not shown).
Reactive oxygen species (ROS) have been shown to be generated in the mitochondrial
inner membrane under hypoxic conditions (Murphy et al., 2009; Cap et al. 2012). Consistent
with the cho1∆/∆ mutants’ observed mitochondrial defects (Chen et al., 2010), ROS may be
produced in the mitochondria under hypoxic conditions in the PS lacking cho1∆/∆ strain
resulting in more defective mitochondria than the de novo PE lacking psd1∆/∆psd2∆/∆ strain.
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Figure 2-6: Growth on solid minimal media under iron limited conditions. The cho1∆/∆,
and psd1∆/∆psd2∆/∆, and cho1∆/∆:CHO1 strains exhibit no differences in growth under iron
limited conditions on solid minimal media compared to the WT (SC5314) strain (Panel C).
Serial dilutions of 5 µl of 1 O.D./ml of overnight cultured cells were spot inoculated on solid
media (Yeast Nitrogen Base + 1mM ethanolamine + uracil + histidine + Leucine + glucose) on
minimal media plates (A) without chelator or iron or (B) + 1 mM of the iron chelator,
Bathophenanthrolinedisulfonic acid (BPS) or (C) + 1mM BPS + 100 µM Iron (II) Sulfate. The
plates were incubated at 37°C and images were taken at 48 hours.
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Saccharomyces cerevisiae cho1∆ mutant has less severe cell wall defects compared to
the Candida albicans cho1∆/∆ mutant
S. cerevisiae has served as a template for studying phospholipid biosynthetic pathways in C.
albicans (Kent et al 1995).To compare the cell wall phenotypes between the C. albicans
cho1∆/∆ mutant and S. cerevisiae cho1∆ mutant, the susceptibility of the S. cerevisiae cho1∆
mutant to cell wall perturbing drugs was tested. It was observed that like the C. albicans
cho1∆/∆ mutant, the S. cerevisiae cho1∆ mutant is sensitive to congo red (Fig: 2-7), however,
unlike the pathogen, it is not sensitive to calcofluor white.
The cho1∆/∆ mutant in C. albicans has higher chitin content in the cell wall. The loss of
PS in S. cerevisiae does lead to increased chitin content as evidenced by calcofluor white
(CFW) staining (Fig: 2-8). However, the increase in chitin is about two- fold in the S.cerevisiae
cho1∆ mutant, whereas in C. albicans the cho1∆/∆ mutant has a ten-fold higher chitin content
compared to the wild-type strain (Chen et al., 2010). Therefore, the effect of loss of PS on the
cell wall is less severe in S. cerevisiae compared to C. albicans.
Phenotypic differences in response to a loss of PS between C. albicans and S. cerevisiae are
further highlighted by the fact that the ultrastructure of the cell wall differs between the two
mutant strains of different species. Transmission electron microscopy (TEM) was performed to
examine the ultra-structure of the cell wall and quantify its thickness. As we previously reported,
the C.albicans cho1∆/∆ mutant displays a thick, irregular cell wall compared to the wild-type
strain (Chen et al, 2010). However, unlike in C. albicans, the S. cerevisiae cho1∆ mutant does
not display a disordered or thick cell wall. The cell wall appears to be identical to the wild type
strain in both thickness and observable structure (Fig: 2-9).
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Figure 2-7: Sensitivity of the Saccharyomyces cerevisiae cho1∆ mutant to the cell wall
perturbing drugs Calcofluor White and Congo Red. Serial dilutions of 5 µl of 1 O.D./ml of
overnight cultured cells were spot-inoculated on minimal media containing (A) no Drug or (B) 20
µg/ml Calcofluor White, a chitin synthesis inhibitor or (C) 40 µg/ml Congo Red, a β-1-3 glucan
synthesis inhibitor. Images were taken after 48 hours of growth at 30°C. The cho1∆ mutant is
hypersensitive to the cell wall perturbing agent Congo Red compared to WT (Panel C) but is
not hypersensitive to Calcofluor white (Panel B). The plates were incubated at 30°C and images
were taken at 24 hours.
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Figure 2-8: Chitin content of the Saccharomyces cerevisiae cho1∆ strain. The
Saccharomyces cerevisiae cho1∆ mutant has a higher chitin content compared to the wild type
strain. However, unlike the ten-fold increase in chitin observed in C. albicans (Chen et al.,
2010), the increase is only two-fold in S. cerevisiae. Cells were grown overnight in 2% Yeast
extract 2% Peptone 2% Dextrose (YPD) at 30°C and 1ml of 1 O.D./ml of cells were stained with
calcofluor white (1mg/ml) for 5 mins, washed with 1 ml H20, and visualized under a light
microscope equipped with a fluorescent DAPI filter. Percentage fluorescence at low exposure is
expressed as a percentage of total cells. ~400 cells were examined per strain. (** p value <
0.001)
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Figure 2-9: Transmission Electron Microscopy of the Saccharomyces cerevisiae cho1∆
strain. TEM images reveal that the cho1∆ strain (Panel B) shows no observable differences in
cell wall ultrastructure compared to the WT strain (Panel A). Arrows indicate the outer surface of
the cell call. Note that the cell wall thickness and order is not changed, unlike that observed in
the Candida albicans cho1∆/∆ strain (Chen et al., 2010). Overnight cultures were growing at log
phase were harvested using a modiﬁcation of a protocol by Wright (2000). Cells were
resuspended in a ﬁxative consisting of 3% glutaraldehyde and 3% paraformaldehyde in 0.1 M
phosphate buffer, washed in 1% KMnO4 and then en-bloc stained in 1% aqueous uranyl
acetate for1 hour. Cells were inﬁltrated with gradually increasing ratios of Spurr resin/ethanol
over a 24 h period. The ﬁnal 4 h of incubation were in 100% Spurr resin. Image is representative
of the ~150 cells examined by transmission electron microscopy. Scale Bar= 1 µm (panel A)
and 0.8 µm (Panel B).
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Discussion
C. albicans is an important fungal pathogen and accounts for a majority of the cases of invasive
candidiasis. Phospholipid biosynthesis enzymes, in particular the PS synthase Cho1p, have
recently been shown to be required for virulence in a mouse model of systemic candidiasis
(Chen et al., 2010). The mechanism underlying the avirulence of the cho1∆/∆ mutant remains
unknown. However, we have found that this mutant, along with the psd1∆/∆ psd2∆/∆ mutant,
has a defective cell wall as demonstrated by increased chitin content and disordered
ultrastructure using transmission electron microscopy (Chen et al., 2010). An enormous amount
of scientific effort has been spent in understanding the fungal cell wall as a plausible and
effective antifungal drug target and to elucidate the biogenesis of this durable and complex
structure (Blankenship et al, 2010, Plaine et al., 2008; Mora-Montes et al., 2012). In fact, the cell
wall has often been referred to an organelle because of its dynamic structure as well as its
essential role in survival (Chaffin et al., 1998; Nobel et al., 2000; Bussey et al., 2004). In C.
albicans, the cell wall plays a crucial role in maintaining cell structure and regulates
morphogenesis (Gelis et al., 2012; Cabib et al., 1997; Martinez-Lopez et al., 2004; Kelly et al.,
2004). It is crucial to environmental sensing and dictates interactions with the host by facilitating
adhesion, evading immune recognition (McKenzie et al., 2010; Lewis et al., 2012; Mora-Montes
et al., 2012), and activating signaling cascades allowing the fungus to respond to its
environment (Birkaya et al., 2009; Blankenship et a., 2010; LaFayette et al., 2010; Rauceo et
al., 2008). Therefore, a better understanding of how phospholipids influence the cell wall and its
maintenance is necessary for a more complete view of how phospholipids mediate cellular
processes in Candida albicans.
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The cho1∆/∆ mutant has stronger effects on cell wall genes than the psd1∆/∆ psd2∆/∆
mutant
Despite their strong effect on the cell wall, there is currently a lack of information on why losses
of certain phospholipids, in particular PS and de novo PE, affect the cell wall in C. albicans. To
better understand the roles of PS and PE biosynthesis in maintaining the integrity of the cell
wall, we examined whether specific lipid species were affected and what transcriptional changes
occur upon loss of these species of PS and/or PE. RNA sequencing was used to measure
changes in transcripts associated with blocking PS and de novo PE synthesis (cho1∆/∆) or de
novo PE synthesis alone ( psd1∆/∆ psd2∆/∆). Three fold up- and down-regulated genes were
then annotated by Gene Ontology (GO) using GO Slim Mapper tool on the Candida Genome
Database (CGD) website http://www.candidagenome.org/ based on gene component (Figure 21). Both mutants were compared to the wild type strain, and we found that the cho1∆/∆ mutant
up-regulated a greater percentage of genes related to cell wall maintenance than the psd1∆/∆
psd2∆/∆ mutant (Figure 2-1).
While several cell wall proteins (GlycosylPhosphatidyinositol (GPI)-anchored) were up-regulated
in both the cho1∆/∆ and psd1∆/∆ psd2∆/∆ mutants (Tables 2-3 and 2-4), the up-regulation of
ALS1 in both was confirmed using monoclonal antibodies, but Als3p was up-regulated only in
the cho1∆/∆ mutant (Fig:2-2). This may have been due to the fact that many ALS genes are
very similar in sequence. In fact, BLAST searches using ALS1 reveal large regions with very
strong homology to ALS3, ALS2, ALS5, ALS 4, and ALS9,( in that order), where ALS3 and
ALS2 are the strongest. Since RNAseq works by BLASTing the results of the sequenced library
against the database, and ALS1 is strongly expressed in psd1∆/∆ psd2∆/∆, this may have
caused an artifact that suggested increased expression of ALS3, as it is the closest ALS gene in
homology.
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In contrast, expression of the HWP1 gene was reflected very accurately by the RNAseq
data (Table 2-3), as the cho1∆/∆ mutant clearly overexpressed it, but the psd1∆/∆ psd2∆/∆ had
wild-type levels, based on immunofluorescence (Fig 2-2). This is supported by the fact that
HWP1 has little homology to the ALS genes.
Immunofluorescence staining revealed that the cho1∆/∆ mutant, despite having
problems filamenting at 37˚C in response to some of the canonical stimuli such as neutral pH or
nitrogen starvation (Chen et al, 2010), has a population of hyperfilamentous cells at 30˚C (Fig 22). This is clearly a consequence of the loss of PS since the psd1∆/∆ psd2∆/∆ mutant, with a
similar loss of de novo PE, does not share this phenotype. The pathways affected by the loss of
PS that lead to his phenotype, however, remain to be discovered.
There are a number of cell wall genes (GPI-anchor) up-regulated in the cho1∆/∆ mutant,
but not in the psd1∆/∆ psd2∆/∆ strain (Tables 2-3 and 2-4), and several are involved in cell wall
repair including IFF11, PGA13, and PGA31 (Richard et al.,2007). GPI-anchored proteins
regulate cell wall integrity and cell-cell interactions in C.albicans (Richard et al., 2007; Plaine et
al., 2008). Two recently published studies reported that phospholipid levels play an important
role in cell wall biogenesis and that mitochondrial defects may lead to cell wall defects in C.
albicans (Qu et al., 2012, Dagley et al., 2010). Down-regulation of cell wall genes may help
explain why the cho1∆/∆ mutant is more sensitive to cell wall insults like calcofluor white and
Congo red than the psd1∆/∆ psd2∆/∆ mutant (Fig: 2-3), and has a more disordered cell wall and
greater levels of chitin (Chen et al., 2010).

Disruption of phospholipids biosynthesis results in defects in iron utilization
We examined genes that were down-regulated in the mutants compared to the wild-type, we
found that there was enrichment for genes that are involved in iron uptake or utilization (Tables
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2-6 and 2-7). This result led to the hypothesis that our phospholipid biosynthesis mutants would
be defective for growth in iron-limiting conditions. Therefore, we assayed growth of the mutants
under iron-limiting conditions by addition of the iron chelator, bathophenanthroline
disulfonate (BPS), to deplete the media of iron, and amendment of the media with a low
concentration (100 µM or 300 µM) of iron sulfate. Both mutants exhibit defective growth in
response to iron limitation compared to the wild type strain (Fig: 2-5). However, the cho1∆/∆
mutant showed a more severe defect in response to to iron limitation than the psd1∆/∆psd2∆/∆
strain, as addition of 100 µM iron did not rescue growth of cho1∆/∆ to the extent it did for the
psd1∆/∆psd2∆/∆ mutant (Fig: 2-5). Surprisingly, the phenotypic difference in iron response was
limited to liquid culture, as we saw no observable difference on solid media (Fig: 2-6).
The cho1∆/∆ mutant actually exhibits a greater decrease in iron responsive genes than
the psd1∆/∆ psd2∆/∆ strain (Table 2-7), which probably explains the greater growth defect in
iron limiting media for the cho1∆/∆ mutant than the psd1∆/∆ psd2∆/∆ mutant. In addition, the
psd1∆/∆psd2∆/∆ strain exhibited better growth under iron limited conditions compared to the
cho1∆/∆ strain. In correlation to this, we observed that the psd1∆/∆psd2∆/∆ mutant up-regulates
a subset of genes involved in iron uptake response that were not up-regulated in the cho1∆/∆
strain (Table 2-10). These genes include SEF1, SEF2, and HAP2, CCC2 and orf19.2863.1.
SEF1 is a transcriptional activator of iron-uptake genes that include SEF2, CCC2, and the ironutilization gene HAP2 (Chen et al., 2011). This may be an attempt to abrogate effects of iron
limitation due to a loss of PS. The host bloodstream is an iron-limited environment, and it may
be that the poor growth in iron-limiting conditions prevents the mutants from being able to grow
in these conditions.
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The cho1∆/∆ and psd1∆/∆psd2∆/∆ strains exhibit a hypoxic response
We examined genes known to be differentially regulated under hypoxic conditions in Candida
albicans. We found that both the cho1∆/∆ and psd1∆/∆psd2∆/∆ showed an up-regulation of
genes associated with a hypoxic response compared to the wild type strain (Table 2-9).
Specifically, both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains up-regulated ECM331, a GPI
anchored protein gene induced under low oxygen conditions, however the cho1∆/∆ strain upregulates this gene nine-fold whereas the psd1∆/∆psd2∆/∆ strain only induces a five-fold upregulation. In addition, WH11, a phenotypic switching gene, strongly induced under hypoxia is
also more highly up-regulated in the cho1∆/∆ (6-fold) versus the psd1∆/∆psd2∆/∆ strain (2-fold).
In addition, we did find that both ERG11 and ERG3, both involved in the biosynthesis of
ergosterol, were up-regulated in both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains. It is also known
that these genes are induced under hypoxic conditions (Synnott et al., 2010). Taken together,
this data suggests that both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains exhibit a hypoxic
response but that the cho1∆/∆ strains response is stronger and is indicative of a more hypoxic
environment or a response that mimics this hypoxic state.
In contrast to the results above with ERG11 and ERG3 upregulation, it was observed that the
sensitivity of both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strain to the antifungal drug fluconazole
were increased (Fig: 2-10). Fluconazole inhibits the function of ERG11 (lanesterol -14demethylase), and therefore blocks ergosterol biosynthesis. The sensitivity to fluconazole in the
cho1∆/∆ and psd1∆/∆psd2∆/∆ strains in spite of their upregulation of ERG11 may be due to an
overall defect in ergosterol biosynthesis, which can lead to increased sensitivity to fluconazole
(Flowers et al. 2012).
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A

B

psd1∆/∆/
psd2∆/∆
psd1∆/∆
cho1∆/∆
WT
Figure 2-10: Sensitivity to the antifungal drug Fluconazole.The cho1∆/∆, psd1∆/∆, and
psd1∆/∆psd2∆/∆ strains are hypersensitive to the antifungal drug fluconazole, which targets
lanosterol-4-demethylase, an enzyme involved in the biosynthesis of the fungal sterol;
ergosterol. Serial dilutions of 5 µl of 1 O.D./ml of overnight cultured cells were spot inoculated
on solid media containing either (A) no Drug or (B) 5 µg/ml drug of Fluconazole. Images were
taken after 48 hours of growth at 37°C.
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Role of specific lipids in affecting the cell wall, iron-limitation, and other phenotypes
Lipidomics analysis revealed that in addition to the loss of PS, specific species of PE, 16:n/18:n
species were depleted. This is consistent with the fact that these species are most likely
derived from PS, which itself is composed of 16:n/18:n species. We suspect that the defects
seen in the psd1∆/∆ psd2∆/∆ mutant are due to specific loss of this species of PE, and not just
general decreases in PE, as the Kennedy pathway can make more PE to compensate for loss
of the de novo pathway, but its species are generally larger (18:n/18:n and 18:n/20:n). However,
this remains to be tested experimentally.
Since PS is converted to PE in the mitochondria and endosome/Golgi by Psd1p and
Psd2p, respectively, the observed phenotypes may be partly due to mitochondrial defects
because of specific loss of 16:n/18:n PE or even endosomal sorting defects. Defects in
mitochondrial function affect the cell wall in C. albicans (Dagley et al., 2011), and endosomal
defects affect signaling pathways that regulate the cell wall, like the Rim101p pathway. Again,
this remains to be explored.
Finally, the cho1∆/∆ mutant has added defects, as it is missing de novo PE (16:n/18:n)
and PS. PS has been shown to be enriched in the endosomal and plasma membranes, and
could affect a number of signaling proteins that affect the cell wall such as the Rim101p
pathway, which depends on the endosomal components for proper processing (Davis et al,
2010). Pkc1p has not been implicated and our lab has demonstrated that it is likely not
significantly involved in these events (data not shown: Sarah Davis personal communication)
Finally, PS is required for calcineurin to associate with membranes (Kennedy et al., 1997), in
vitro, so this cell wall pathway could be affected as well. We also noted an increase in
phosphatidylglycerol (PG) and phosphatidylinositol (PI) upon blocking de novo PE biosynthesis,
suggesting a possible shuttling of CDP-DAG into PG and PI biosynthesis to prevent a build-up
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of CDP-DAG in the cell (Blankenship et al. 2005). We observed differences in sensitivities to low
pH that may be due to the cell wall defects (Figure 2-11).
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Figure 2-11: Sensitivity of C.albicans strains to low pH. Overnight cultures of C.albicans
were inoculated into 5 ml of minimal media at the indicated pH (Panel A ) pH 4.0 and (Panel B)
pH 2.7 . The pH was adjusted by phosphate citrate buffer. The strains were grown at 37°C with
shaking and the optical density was measured after 48 hours of growth.
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Proposed model for the phenotypic effects observed upon a loss of de novo PS and PE
in Candida albicans
We propose that the loss of phosphatidylserine (PS) in the fungal membrane leads to
pleiotropic effects in C. albicans. These include, a defective cell wall as determined by
sensitivity to the cell wall perturbing drugs, calcofluor white and congo red (Fig: 2-3) , differential
expression of cell wall or glycosylphosphatidylinositol (GPI) anchored proteins (Tables 2-3 and
2-4), a defective response to iron limited conditions (Fig:2-5) and sensitivity to low pH (pH<4)
(Fig:2-11). We hypothesize that the differences observed between the cho1∆/∆ and
psd1∆/∆psd2∆/∆ mutants may be due to dysfunctional mitochondria as the cho1∆/∆ strain
shows a lowered expression of mitochondrial related genes as well as an up-regulation of genes
involved in the neutralization of reactive oxygen species (ROS) generated within the
mitochondria compared to the psd1∆/∆psd2∆/∆ strain. These differences may be caused by
changes in membrane fluidity due to a disruption of de novo aminophospholipid biosynthesis in
the cho1∆/∆ mutant or by a direct chaperone activity of PS, but the exact mechanism remains to
be explored. We examined the phospholipidome of the mutants to determine what species of
lipids were changed upon disrupting the de novo synthesis pathway. We discovered that the
major lipid species absent in the cho1∆/∆ mutant was PS 16:n/18:2 (Table 2-2) and noted a
subsequent decrease in similiar species of downstream de novo synthesized PE and PC. We
also observed an increase in longer acyl chained 18:n/18:n PE species suggesting that the
Kennedy pathway up-regulates synthesis of this PE species upon disruption of the de novo
pathway. It is possible that loss of the anionic PS and a shift toward longer acyl chained
Kennedy pathway derived PE and PC may result in a more rigid membrane structure and this
could lead to improper protein localization inside the mitochondrial membrane, however, more
experiments are necessary to directly test this hypothesis. We show that the cho1∆/∆ strain has
much more severe cell wall and mitochondria defects compared to the psd1∆/∆psd2∆/∆ and
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wild type strains. Our data suggest that mitochondrial dysfunction and generation of reactive
oxygen species, in part, may account for the observed phenotypes in the cho1∆/∆ strain and we
demonstrate a novel role for PS in mitochondrial function. Firstly, transcriptional data is
consistent with a hypoxic stress response in both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains
(Table 2-9). Also, in support of this idea, the PS deficient cho1∆/∆ strain up-regulates genes
involved in neutralization of reactive oxygen species (ROS) (Table 2-8). ROS are generated
within defective mitochondria and can lead to cell damage and/or death (Murphy et al., 2009).
We observed an up-regulation of genes involved in breaking down the reactive oxygen species
such as nitric oxide (NO) and hydrogen peroxide (H202) in the cho1∆/∆ mutant but did not see
these genes up-regulated in the psd1∆/∆psd2∆/∆ strain. Previously published data
demonstrated the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains have defects in mitochondrial function
but the full implications and differences between the strains remained unknown (Chen et al.,
2010). Our transcriptional data indicates that cho1∆/∆ has much more severe mitochondrial
defects than psd1∆/∆psd2∆/∆ which implicates PS in a previously unknown role in mitochondrial
function. It is known that nitric oxide is generated when iron bound by a porphyrin (heme) fails to
receive electrons from cytochrome c (Nicholls et al., 1998; Yi et al., 2012), and instead reacts to
produce damaging nitric oxide in the mitochondrial inner membrane. It will be of interest to
investigate if PS itself, through its anionic headgroup mediates this interaction either directly or
indirectly, and how a loss of PS could affect electron transport and generation of ROS. We also
demonstrate that, in support of this model, the cho1∆/∆ strain represses iron-uptake genes and
unlike the psd1∆/∆psd2∆/∆ mutant does not up-regulate genes involved in iron uptake such as
the canonical iron response regulator SEF1. This may be due to a shift toward glycolysis and a
shut-down of aerobic respiration that mitigates production of oxygen radicals in the mitochondria
in an effort to protect itself from generating damaging intracellular free radicals. The effect of
this damage on cell signaling such as activation of ion or osmotic stress pathways like Hog1 and
Rim101 remains to be explored. We did not see any transcriptional changes in Rim101 or Hog1,
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but that does not necessarily mean that these pathways are not being activated as
transcriptional activation is only a small part of mediating activation of signaling pathways as
proteolytic cleavage and phosophorylation are more common ways to initiate a quick response
to cell damage. It is possible that a combination of the cellular energy and metabolic state, the
generation of reactive oxygen species, and defects in signaling pathways, all related to PS
and/or PE deficiencies, lead to defects in cell wall protein gene expression and thereby lead to
defects in the structure of the wall.
Losses of PS and PE have different consequences for S. cerevisiae and C. albicans
Phospholipid biosynthesis pathways are practically identical between S. cerevisiae and C.
albicans (Chen et al., 2010). However, we wanted to determine if the phenotypes that result
from altered aminophospholipids between the S. cerevisiae cho1∆ mutant and that of C.
albicans cho1∆/∆ are conserved. It was demonstrated that the S. cerevisiae cho1∆ mutant does
not have a disordered and thick cell wall (Fig: 2-9). The chitin content, while increased, was only
two-fold (Fig:2-8) compared to a ten-fold increase in the C. albicans cho1∆/∆ mutant (Chen et
al., 2010). Therefore, there exist differences in the phenotypic response to loss of PS between
S. cerevisiae and C. albicans. It may be that the ability of S. cerevisiae to tolerate mitochondrial
dysfunction compared to C. albicans (which unlike S. cerevisiae cannot survive a loss of the
mitochondrial genome) may contribute to these cell wall phenotypes as cell wall and
mitochondrial function have been linked by the cell signaling pathway Hog-1. This may indicate
a fundamental difference between these two fungi, whereby in C. albicans cell wall maintenance
and mitochondrial function may be more strongly linked compared to S. cerevisiae. However,
the mechanism behind this difference remains to be tested. It may also be related to
differences in conserved, but distinct, cell wall signaling pathways that exist in both microbes,
such as calcineurin and/or Rim101p.
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Conclusions
We show that a loss of de novo PS and PE biosynthesis has pleiotropic effects on the Candida
albicans cell, including cell wall defects, defects in growth under iron limited conditions,
sensitivity to low pH, sensitivity to the membrane-targeting drug fluconazole and differential
expression of hypoxic, cell wall, and mitochondrial related genes. We also show that changes in
the phospholipidome indicate that PS 16:0/18:2 is the main lipid species trafficked through the
de novo pathway in Candida albicans and that there is a subsequent increase in long acyl side
chain 18:n18n PE species , presumably, from increased Kennedy pathway PE and PC
synthesis. The differential effects observed between the cho1∆/∆ and psd1∆/∆psd2∆/∆ strain
implicate PS as having a direct role in the observed phenotypes. Therefore, we suggest a novel
role for PS in Candida albicans, whereby, PS itself is required for cell wall maintenance and
loss of PS leads to both an altered cell wall and dysfunctional mitochondria. This is evidenced
by the increased defects observed upon loss of PS compared to the defects observed upon a
loss of PE alone. We also demonstrate that C. albicans and S. cerevisiae have different PSdeficient cell wall phenotypes and this highlights a major difference between the response of
these fungi to changes in phospholipid composition. Therefore S. cerevisiae cannot be used as
a model to fully extrapolate phospholipid-related phenotypes or responses in C. albicans. It will
be of interest to further explore how these interactions are mediated and, in particular, to
elucidate a direct mechanism for PS in cell wall maintenance and mitochondrial function.
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APPENDIX B: TABLES
Table 2-1: Candida albicans (Ca) and S. cerevisiae (Sc) strains used in this study

Strain

Genotype

Reference

SC5314

Ca. wild-type

Gillum et al. 1984

YLC 337

Ca.cho1∆/∆

Y.Chen et al. 2010

YLC 344

Ca.cho1∆/∆::CHO1-SAT1

Y.Chen et al. 2010

YLC 345

Ca.cho1∆/∆::CHO1-SAT1

Y.Chen et al. 2010

YLC 280

Ca.psd1∆/∆

Y.Chen et al. 2010

YLC 294

Ca.psd1∆/∆::PSD1-SAT1

Y.Chen et al. 2010

YLC 375

Ca.psd1∆/∆psd2∆/∆

Y.Chen et al. 2010

TRY 153

Sc.ura3∆,his3∆

This study

TRY 155

Sc.ura3∆,his3∆,cho1::KanMX6

This study
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Table 2-2: Differences in phospholipids species of the cho1∆/∆ and psd1∆/∆psd2∆/∆
strains compared to the wild type strain. Values are relative amounts(ug) of each
phospholipid species that were normalized to PE (phosphatidylethanolamine), PS
(phosphatidylserine), and PC (phosphatidylcholine) standards in their own classes.The
standarsd used were PE 28:0, PS30:0,and PC 28:0.

Strains
Species m/z

Lipid

WT

psd1∆/∆psd2∆/∆

16:1/18:3
16:1/18:2
16:0/18:2
16:0/18:1
18:2/18:3
18:2/18:2
18:2/18:1
18:0/18:2
18:0/18:1
18:0/18:0
18:2/20:4
18:1/20:4
18:0/20:4
18:1/20:2
18:0/20:2
18:0/20:1

8
35
134
37
64
75
70
29
17
15
17
41
47
23
16
15
643

6
8
18
5
51
57
63
79
18
17
11
38
57
41
14
14
496

WT
5
51
23

psd1∆/∆psd2∆/∆
12
127
46

79

185

WT
10
12
18
9
62
107

psd1∆/∆psd2∆/∆
10
12
18
9
15
22

cho1∆/∆

PE
710.4
712.4
714.4
716.4
736.4
738.4
740.4
742.4
744.5
746.5
762.5
764.5
766.4
768.4
770.4
772.4
Total
amount

PS
760.7
756.7
758.7

16:0/18:1
16:1/18:2
16:0/18:2

Total
amount

PC
730.4
732.5
734.4
752.4
754.4
756.5

16:0/16:2
16:0/16:1
16:0/16:0
14:0/20:5
16:2/18:2
16:1/18:2

6
14
22
13
59
79
89
31
36
5
14
51
57
33
9
13
529
cho1∆/∆
n.d.
n.d.
n.d.
0

cho1∆/∆
9
10
16
9
12
20
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Table
m/z
760.5
762.6
778.4
780.4
782.5
784.5
786.5
788.5
808.5
810.5
812.5
814.5
816.5
Total
amount

2-2 continued.
lipid
16:0/18:1
16:0/18:0
16:2/20:4
16:1/20:4
18:2/18:2
18:1/18:2
18:1/18:1
18:0/18:1
18:1/20:4
18:0/20:4
18:1/20:2
18:0/20:2
18:0/20:1

WT
137
112
78
106
66
49
35
24
6
8
12
14
7
1025

psd1∆/∆psd2∆/∆

cho1∆/∆

34
24
112
147
108
84
44
29
13
24
33
26
10
811

33
21
121
157
132
91
52
26
10
24
13
14
8
814

Table 2-2. n.d.= not detected. m/z= charge to mass ratio of species.
Lipid component is described as number of carbon atoms: saturation number/ number of carbon atoms: saturation
number.
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Table 2-3: Cell Wall related genes up-regulated in the cho1∆/∆ mutant compared to wild
type
Gene
PGA31

Fold upregulated
84

PGA23

Function

p- value

Cell wall protein

1.0E-300

32

GPI-anchored protein transcription is
negatively regulated by Rim101p

1.0E-300

RBR1

31

GPI-anchored cell wall protein
required for filamentous growth at
acidic pH

4.6E-70

PGA58

13

Putative GPI-anchored protein

1.9E-158

PGA13

6

cell wall regeneration and core
caspofungin response

1.0E-300

IFF11

5

7.1E-46

AMS1

4

Secreted protein required for normal
cell wall structure and for virulence
Adhesin-like cell wall protein

HWP1

3

1.0E-300

SAP9

3

N-linked mannoprotein of cell wall
and membrane
Secreted aspartyl protease; roles in
adhesion

orf19.2076

3

N-linked mannoprotein of cell wall
and membrane

4.2E-54

PGA44

3

GPI-anchored protein

6.5E-12

SAP10

2

Secreted aspartyl protease

1.6E-12

IFF6

2

Putative GPI-anchored adhesin-like
protein

2.6E-20

orf19.12206

2

Cell wall adhesin

5.4E-50

7.0E-180

1.0E-300
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Table 2-4: Cell wall-related genes up-regulated in the psd1∆/∆ psd2∆/∆ mutant compared
to wild type.
Gene

psd1∆/∆
psd2∆/∆> WT

Function

p value

(fold upregulated)
RBT5

4

GPI-anchored cell wall protein involved in
hemoglobin utilization

7.08E-55

PGA54

3

Putative GPI-anchored protein

3.47E-149

PGA18

3

GPI-anchored protein

7.99E-51

PGA27

3

GPI-anchored
protein

3.40E-15

PGA55

3

GPI-anchored protein; adhesin-like protein; filament
induced

7.66E-23

PLB5

2

GPI-linked phospholipase B

6.87E-27

PGA1

2

induced during cell wall regeneration; required for
normal adhesion

1.76E-19

CHT2

2

GPI-linked chitinase required for normal filamentous
growth

1E-300

HYR4

2

GPI-anchored adhesin-like protein

1E-16

orf19.2677

2

Putative GPI transamidase component

2.9E-48

PGA25

2

GPI-anchored adhesin-like protein

4.5E-24
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Table 2-5: Cell wall genes up-regulated in both cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants
compared to the wild-type

Gene

cho1∆/∆

psd1∆/∆psd2∆/∆

Function

p value
psd1∆/∆psd2∆/
∆ vs wt

p value
cho1∆/∆

2.4E-17

7.8E-98

1.2E-62

1.5E-200

PGA10

9

4

ECM331

9

5

Plasma membrane
protein of heme-iron
utilization
GPI-anchored protein

ALS2

8

4

Cell wall adhesion

1.1E-65

1.0E-300

ALS3

5

5

Cell wall adhesin

3.1E-177

1.0E-300

HYR1

4

3

2.6E-30

1.4E-50

ALS4

4

3

Hyphal-induced GPIanchored cell wall
protein; macrophageinduced
Cell Wall adhesin

1.3E-77

1.0E-300

GPI1

4

4

Protein GPI synthesis

1.1E-48

3.5E-48

ALS1

3

5

Adhesin

1.0E-300

1.0E-300

PGA6

3

6

cell wall adhesion

1.0E-300

1.0E-300

HYR3

3

2

adhesin-like protein

7.1E-99

1.1E-174

IFF5

2

2

9.6E-23

1.35E-35

ALS9

2

3

GPI-anchored protein;
adhesin-like protein
Cell wall adhesin

7.3E-32

2.7E-34

PGA45

2

2

GPI-anchored protein

4.5E-194

9.4E-211
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Table 2-6: Iron response genes down-regulated ≥ 3 fold in the cho1∆/∆ and
psd1∆/∆psd2∆/∆ mutants compared to wild-type
Gene
name

WT>psd1∆/∆psd2∆/∆
WT > cho1∆/∆
(fold
(fold downregulated)
downregulated)

Cellular function

P-value

CFL2

-11.3

-10

Putative
oxidoreductase, ron
utilization

1E-300, 1E-300

FRE10

-5.0

-4

Ferric reductase

1E-300, 1E-294

FTR1

-4.3

no change

High affinity iron
permease

4.2E-171

CHA1

-3.4

no change

Regulated by
Rim101p and iron

3.0E-67

no change

-3

orf19.2067

7.4E-284
Putative protein
with a predicted
role in
mitochondrial iron
metabolism
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Table 2-7: Iron response genes down-regulated ≥2fold in the cho1∆/∆ mutant compared
to psd1∆/∆ psd2∆/∆ mutant

Gene name

cho1∆/∆>

Cellular function

p-value

psd1∆/∆ psd2∆/∆
RBT5

-5

Cell wall-Hemoglobin utilization

2.2E-88

orf19.4459

-3

Heme binding

2.2E-90

HAP3

-3

Iron regulation gene

8.0E-18

orf19.6976

-3

Heme carrier protein

3.1E-49

CCC2

-2

Iron assimilation

2.3E-61

PGA32

-2

Cell wall-regulated by iron

4.8E-16

FTR1

-2

High affinity iron permease

7.0E-47
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Table 2-8: The cho1∆/∆ strain up-regulates genes associated with neutralization of
reactive oxygen species (ROS).
Gene

Fold up-regulated in
cho1∆/∆ vs
psd1∆/∆psd2∆/∆

P-value
cho1∆/∆ vs
psd1∆/∆psd2∆/∆

Function

orf19.10993

112

H2O2 stress

1.0E-300

AOX2

63

Alternative oxidase

1.0E-300

SOD5

15

superoxidedismutase;

1.0E-300

oxidative stress
YHB1

7

Nitric oxide dioxygenase

1.0E-300

orf19.711

7

Uncharacterized

1.0E-34

ORF

induced by nitric oxide
PCK1

5

Phosphoenolpyruvate
carboxykinase;H202
stress

1.0E-300

72

Table 2-9: Hypoxic genes up-regulated in the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains
compared to WT.

cho1∆/∆

psd1∆/∆psd2∆/∆

ECM331

9

5

WH11

6

2

orf19.1691
ERG3

3
3

3
3

ERG11

3

3

SLD1

3

3

no change
2

2
no change

CSH1

3

2

PNG2

6

3

GDH3

8

11

Gene

RBE1
orf19.6117

Function

GPI-anchor protein;
hypoxia induced
cytoplasmic protein;
hypoxia induced
uncharacterized
C-5 sterol
desaturase;
Lanosterol 14-alphademethylase
Sphingolipid delta-8
desaturase
Cell wall protein
uncharacterized;
hypoxia induced
Aldo-keto reductase
family member
Putative peptide:Nglycanase
NADP-glutamate
dehydrogenase

p value
cho1∆/∆ vs
WT

p-value
psd1∆/∆psd2∆/∆
vs WT

1.5E200
6.0E-146

1.2E-62

1.0E-300
1.0E-300

1.6E-200
3.3E-168

1.0E-300

1.0E-300

1.7E-148

5.5E-82

6.1E-31
1.3E-97

3.4E-64
1.9E-72

3.1E-245

2.5E-78

1.0E-300

1.8E-160

1.0E-300

1.0E-300

2.1E-10
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Table 2-10: Iron uptake genes up-regulated in psd1∆/∆psd2∆/∆ mutant compared to the
wild type
Gene

psd1∆/∆psd2∆/∆
(fold up-regulated)

Function

p-value

orf19.1195

5

Cellular iron ion homeostasis

1.0E-300

RNR3

5

Ribonucleotide reductase

1.7E-82

PGA10

4

Protein of heme-iron utilization

2.4E-17

ALS2

4

Adhesin

1.1E-65

SFU1

4

Transcriptional regulator of iron

8.0E-149

SEF2

3

Putative zinc cluster protein

8.0E-95

FTR2

3

High-affinity iron permease

1.0E-300

SEF1

3

Regulates iron uptake

1.5E-64

orf19.2863.1

3

Cellular iron ion homeostasis

2.1E-74

FTH2

2

Putative iron transporter

4.5E-52

HAP2

2

CCAAT-binding factor

2.0E-21

MNT4

2

Mannosyltransferase

2.5E-11

CCC2

2

Copper-transporting ATPase

2.3E-24

MNN2

2

Alpha-1,2-mannosyltransferase

5.1E-75
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CHAPTER THREE

Conclusions and future directions
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Abstract
In this study, we examine specific changes to the phospholipidome that may help explain some
of the observed phenotypic differences for the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains.
Phospholipid profiling revealed that PS 16:018:2 is the major PS species absent in the cho1∆/∆
strain and this is likely the major lipid species trafficked through the de novo pathway in Candida
albicans. We also noted a shift toward longer acyl chained PE species in the cho1∆/∆ and
psd1∆/∆psd2∆/∆ strains suggesting that these species are synthesized via the Kennedy
pathway in C. albicans. Defects in mitochondrial function are a consequence of
phosphatidylethanolamine (PE) deficiency, and loss of PS causes a loss of de novo synthesized
PE (Kent et al., 1995; Chen et al., 2010). However, a comparison between mutants lacking just
de novo PE (psd1∆/∆ psd2∆/∆) and both PS and de novo PE (cho1∆/∆) reveals that
mitochondrial and cell wall defects are more severe in the cho1∆/∆ mutant, suggesting a direct
role for PS in both of these functions.
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Introduction
The aim of our study is to elucidate the functions of de novo phospholipid biosynthesis in
Candida albicans. We found that disruption of de novo phospholipid biosynthesis leads to both a
defective cell wall and dysfunctional mitochondria. Our data suggests that loss of
phosphatidylserine (PS) itself specifically affects mitochondrial function and leads to the downregulation of iron uptake genes and up-regulation of hypoxia induced genes as well as genes
involved in cell wall repair, and generation of a transcriptional response to neutralize
intracellular reactive oxygen species (ROS) in the fungal pathogen Candida albicans. Defects
in mitochondrial function are a well-known consequence of phosphatidylethanolamine (PE)
deficiency, and loss of PS causes a loss of de novo synthesized PE (Kent et al., 1995; Chen et
al., 2010). However, a comparison between mutants lacking just de novo PE (psd1∆/∆
psd2∆/∆) and both PS and de novo PE (cho1∆/∆) reveals that mitochondrial and cell wall
defects are more severe in the cho1∆/∆ mutant, suggesting a direct role for PS in both of these
functions.
The defects in the cell wall in the cho1∆/∆ mutant may be partially or completely
attributable to mitochondrial defects as recent studies link cell wall defects to mitochondrial
dysfunction (Dagley et al. 2011, Qu et al., 2012). The role of PS in mediating mitochondrial
function has not been well described. We propose a model wherein PS loss leads to
dysfunctional mitochondria, which in turn regulates the pathogen’s response to hypoxia and iron
limitation. In response to a loss of PS, we propose that cho1∆/∆ activates compensatory
pathways involved in cell wall integrity and neutralization of damaging oxygen species. We also
report that PS plays divergent roles in Saccharomyces cerevisiae as we do not see similar cell
wall defects in the S. cerevisiae cho1∆ strain. This demonstrates a fundamental difference in
phospholipid roles between Candida albicans and Saccharomyces cerevisiae and suggests that
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this model organism should be used only with caution in elucidating the roles of these
phospholipids in Candida albicans.

Summary of Results
In this study, we examine specific changes to the phospholipidome that may help explain some
of the observed phenotypic differences for the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains.
Phospholipid profiling revealed that PS 16:018:2 is the major PS species absent in the cho1∆/∆
strain and this is likely the major lipid species trafficked through the de novo pathway in Candida
albicans. We also noted a shift toward longer acyl chained PE species in the cho1∆/∆ and
psd1∆/∆psd2∆/∆ strains suggesting that these species are synthesized via the Kennedy
pathway in C. albicans.
Linking cell wall defects and mitochondrial dysfunction in the C. albicans cho1∆/∆ strain
A comparison of the transcriptional profiles of the cho1∆/∆ strain to the psd1∆/∆psd2∆/∆ strain
indicates that the cho1∆/∆ strain has more defective mitochondria as it up-regulates genes
involved in neutralization of mitochondrial-generated reactive oxygen species (ROS). Recent
advances in the study of mitochondrial and ER-localized protein complexes provide a direct link
between mitochondrial dysfunction and cell wall defects in Candida albicans (Qu et al., 2012,
Alonso-Monge et al., 2009). For example, the SAM (Sorting and Assembly Machine) complex
localized within the mitochondria has been shown to be important for maintaining mitochondrial
function and its deletion (sam37∆/∆) leads to cell wall defects in Candida albicans (Qu et
al.,2012). In addition, this complex has been hypothesized to be involved in the transfer of
phospholipids to and from the mitochondria as it shares Mdm10, a key component of the ERMitochondrial Encounter Structure (ERMES) which aides in tethering mitochondria to the ER to
facilitate phospholipid transfer (Dagley at al., 2011 Osman et al., 2012). The sam37∆/∆ mutant,
like the cho1∆/∆ mutant, exhibits increased chitin content and sensitivity to the cell wall
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perturbing drugs calcofluor white and congo red (Qu et al., 2012). Interestingly, Qu et al.
demonstrate that the sam37∆/∆ mutant showed a loss of mitochondrial DNA (mtDNA) indicating
that the mitochondrial genome is partially lost upon disruption of this SAM37 complex. This data
correlates with the defects in the cell wall observed in the sam37∆/∆ mutant, including the
observation that, like the cho1∆/∆ strain, sam37∆/∆ has a thickened cell wall by transmission
electron microscopy, suggesting that a deletion of SAM37 leads to cell wall defects and an
inability of Candida albicans to maintain the mitochondrial genome by an as yet unidentified
signaling pathway (Qu et al., 2012). It therefore may be possible that loss of PS affects this
complex, directly or indirectly and that some of the shared phenotypes may be due to a
conserved mechanism linking mitochondrial dysfunction to cell wall defects.
We speculate that the phospholipid environment of the mitochondria, in particular the loss of
PS, may lead to a loss of either the mitochondrial genome or transcription of many of its genes.
We also identified nuclear gene products localized to the mitochondria that were downregulated in the cho1∆/∆ verses psd1∆/∆psd2∆/∆ strain including MCD1, SEN2, orf19.2090 and
orf19.4273. MCD1 acts to regulate mitochondrial membrane potential upon oxidative stress in
S. cerevisiae (Yang et al., 2008) but has not been studied in Candida species, SEN2 is a
mitochondrial localized endonuclease and orf19.2090, orf19.4273 are found in the
mitochondria but are of unknown functions (Candida genome database). In addition, we have
identified several genes such as COX2, COX3A, COX3B, NAD1, NAD3, and NAD6, which are
all encoded by the mitochondrial genome and directly involved in the electron transport chain,
that are down-regulated in the cho1∆/∆ mutant compared to the psd1∆/∆ psd2∆/∆ mutant
suggesting a difference in mitochondrial genome stability. However, these genes need to be
independently verified by other means such as qPCR as in our study they were not significantly
different despite their two fold down-regulation. Taken together, this data suggests an inhibition
of the electron transport chain, which may result in respiratory deficiency and the production of
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reactive oxygen species (ROS). In addition, the observed loss of mitochondrial function and the
hypothesized electron transport dysfunction may explain the link between cell wall defects as
these genes are down-regulated in both the cho1∆/∆ and sam37∆/∆ strains (Qu et al.,2012).
It may be that mitochondrial dysfunction in both the cho1∆/∆ and sam37∆/∆ mutants may lead to
activation of cellular mechanisms normally expressed in response to changing metabolic and
oxygen conditions in Candida albicans, which can be induced upon mitochondrial-generated
ROS (Synnott et al., 2010). It is known that hypoxic conditions can cause changes in expression
of iron uptake genes and lower sterol levels in the Candida albicans membrane (Dhamgaye et
al. 2010; Sosinska et al. 2008; Mungai et al., 2011). It may also be that loss of PS causes
defects in respiration that lead to the observed increase in ROS-related genes which may also
be tied to the down-regulation of iron transport genes (the products of which are integral to the
electron transport chain via heme interactions with cyotochrome c) and an increase in hypoxia
induced genes. It is also possible that the Hog1 signaling pathway may be activated upon loss
of PS due to a more fluid membrane as it is known to be activated by changes in membrane
fluidity (Hickman et al., 2011). Therefore, C. albicans may have evolved a mechanism where
mitochondrial dysfunction leads to production of ROS which initiates a response that alters cell
wall structure, regulates iron uptake, neutralizes damaging free radicals, and thus allows the
fungus to thrive in diverse environmental niches of varying carbon sources and environmental
stresses . In addition, it is known that respiratory deficiency in S. cerevisiae leads to increased
mRNA stability of the cho1∆ transcript which also supports the idea that PS has some function
in mitochondrial maintenance (Carmen et al., 2007). Our work examines some of these
connections and presents a model where PS is critical for normal cell wall structure and
mitochondrial function C. albicans.
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A proposed role for phosphatidylserine in hypoxic response and iron uptake
We found that both the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains are sensitive to the anti-fungal
drug fluconazole, although cho1∆/∆ was much more sensitive than psd1∆/∆psd2∆/∆.
Fluconazole targets the Erg11 (lanosterol-14α-demethylase) enzyme that is involved in the
biosynthesis of the major fungal sterol, ergosterol. It is known that ERG11 is up-regulated under
hypoxic conditions (low oxygen, ~1% O2) and, sterols are important markers of hypoxic
response (as molecular oxygen is required for ergosterol biosynthesis) in several fungi including
Candida albicans , Saccharomyces cerevisiae, Schizosaccaharomyces pombe and Aspergillus
fumigatus (Hughes et al., 2006; Blatzer et al., 2011; Synnott et al., 2010; Hickman et al., 2011;
Blosser et al., 2012). The decreased expression of mitochondria related genes and the
production of ROS in C. albicans may mimic hypoxia. In Candida albicans and
Saccharoymyces cerevisiae, heme biosynthesis is also central in mediating the response to
hypoxia (Lai et al., 2008; Mcdonagh et al., 2011; Sosinska et al. 2008). In Candida albicans, the
transcription factor UPC2 directly activates hypoxic response upon lowered sterol levels
(Synnott et al., 2010). In parallel, the heme binding transcription factor HAP1 acts to reduce
aerobic respiration and activates expression of hypoxic genes in low oxygen environments
(Synnott et al.,2010; Sing et al. 2011). In S. cerevisiae, under normoxic conditions HAP1 binds
directly to heme and activates the transcriptional repressor ROX1, but upon loss of molecular
oxygen, heme biosynthesis ceases, as oxygen is required for the biosynthesis of heme, and
HAP1 can no longer bind to heme, thereby causing the loss of the repressor and activation of
hypoxia induced genes (Synnott et al., 2010). The ortholog to ROX1 in C. albicans , RFG1,
does not mediate hypoxic response but rather activates cell wall enzymes required for
filamentation (Synnott et al., 2010). This may, in part, explain how cho1∆/∆ exhibits changes in
cell wall structure, increased filamentation (Fig 2-2) (Chen et al. 2010), and the repression of
iron uptake genes. In C. albicans, an increase in ROS by decreased expression of the
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alternative oxidase (AOX1) has been shown to induce hypersensitivity to fluconazole (Yan et al.,
2009). Thus, increased ROS due to a loss of PS may be responsible for the observed
phenotypes in the cho1∆/∆ mutant. This is consistent with our proposed model of mitochondrial
dysfunction leading to these phenotypes as decreased oxygen levels have been linked to
generation of ROS (Mungai et al., 2011) and a reduction in heme biosynthesis.
In psd1∆/∆psd2∆/∆ increased ROS may be mitigated by activation of the iron uptake
transcriptional activator SEF1 and this may explain why growth under iron limited conditions,
while defective, is not as deficient as that observed in the cho1∆/∆ strain. SEF1 acts to upregulate heme biosynthesis genes and iron utilization genes (Chen et al., 2011). This may aide
in stabilizing the slight defects in the mitochondria observed in the psd1∆/∆psd2∆/∆ strain by
increasing heme biosynthesis and thereby reducing generation of ROS.
In addition to less of a defect with regards to iron assimilation genes, the
psd1∆/∆psd2∆/∆ strain grew better than the cho1∆/∆ strain under iron limited conditions. This
indicates a role for PS in iron response in Candida albicans. It could be that loss of PS
inherently alters iron uptake and this causes defects in iron related processes such as heme
biosynthesis and uptake. Alternatively, the observed hypoxic-like response causes decreased
expression of iron uptake genes as oxygen and iron sensing are tightly linked (Sosinska et al.,
2008, Dhamgaye et al., 2012, Chen et al., 2011). This suggests that cho1∆/∆ may shift away
from aerobic respiration possibly to mitigate damaging effects of ROS due to dysfunctional
mitochondria. The observed up-regulation of AOX2 (Alternative Oxidase 2) in cho1∆/∆
compared to the psd1∆/∆psd2 ∆/∆ supports this idea, as AOX2 is an electron acceptor which
has recently been shown to be involved in the neutralization of reactive oxygen species
generated from leaky electron transport chains (Cvetkovska et al., 2012).
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We found that the cho1∆/∆ mutant up-regulated genes involved in hypoxic response and
neutralization of H2O2 (hydrogen peroxide) and NO (Nitric oxide) compared to the wild type
strain. These reactive oxygen species can be generated by dysfunctional mitochondrial electron
transport chains, NO is produced upon failure of cytochrome c to transfer electrons to heme
during aerobic respiration (Bourens et al., 2012). It is also known that reactive oxygen species
(ROS) can inhibit mitochondrial function and biogenesis in S. cerevisiae but little is known of
their effect in C. albicans (Chevtzoff et al., 2010).
Taken together our data indicate a novel function for phosphatidylserine (PS) in maintaining
mitochondrial function and cell wall structure. We propose a model whereby loss of PS leads to
a hypoxic type response that shuts down iron uptake and heme biosynthesis, and generation of
reactive oxygen species that activate cell wall integrity stress pathways and leads to differential
cell wall protein expression. This could be due to changes in membrane fluidity caused by the
loss of PS but more experiments are necessary to confirm the role of membrane fluidity in these
processes. It may also be that PS acts directly as a molecular chaperone either through
interaction with Sam37p or with components of the electron transport chain such as
cyotochromes. As PE has been shown to act as a molecular chaperone in E. coli, through
interaction with the membrane protein lactose permease (Xie et al., 2006), a chaperone function
has not yet been described for PE or PS in yeast. The pathways most likely to be activated
upon loss of PS are the Rim101 pathway, shown to be linked to hypoxia and ion stress, or the
Hog1 pathway which has been linked both to mitochondrial defects and changes in membrane
fluidity in S. cerevisiae (Hickman et al., 2011; Ikeda et al., 2008).
The defects observed in psd1∆/∆psd2∆/∆ are not as severe as in the cho1∆/∆ and they can
possibly be explained by the observed shift in acyl length of the phosphatidylethanolamine (PE)
species leading to less severe changes in mitochondrial function when compared to cho1∆/∆
mutant, as it still has PS present in the membrane. It may also be that greater changes in
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membrane fluidity due to a loss of phosphatidylserine (PS) cause these differential wall and
mitochondrial phenotypes in cho1∆/∆ and psd1∆/∆psd2∆/∆ strains. In S. cerevisiae, hypoxic
response has been directly linked to changes in membrane fluidity via the transcription factors
MGA2 and SPT23 (Jiang et al., 2001, Kelley et al., 2009) but this remains to be tested in
Candida species.
Our study also demonstrates that C. albicans and S. cerevisiae do not conserve cell wall
phenotypes associated with disruption of de novo phospholipid biosynthesis, suggesting they
have evolved different mechanisms to respond to stresses associated with disruption of
phospholipid biosynthesis. In support of this, it has been shown that the hypoxic response and
iron sensing pathways are not identical between S. cerevisiae and C. albicans. This may be due
to the fact that C. albicans is not viable upon loss of its mitochondrial genome (a petite negative
yeast) whereas S. cerevisiae (a petitie positive yeast) is better able to overcome mitochondrial
genome loss and the problems associated with loss of PS. In S. cerevisiae psd1∆ psd2∆ and
cho1∆ strains require PE for growth on non-fermentable carbon sources and this growth is
correlated to an increase in mitochondrial PE content (Birner et al. 2001). PE depletion also
causes increased respiratory deficiency suggesting that PE itself may play a more direct role in
S. cerevisiae mitochondrial dysfunction and cell wall phenotypes. This is in contrast to C.
albicans where a loss of PE alone does not explain the observed cell wall and mitochondrial
defects suggesting that PS has an independent function in this petite negative yeast.

Future Directions
To test the hypothesis that the cho1∆/∆ strain produces more reactive oxygen species (ROS)
compared to the psd1∆/∆psd2∆/∆ and wild type (SC5314) strains, the dye Lucigenen
(Invitrogen™) that specifically binds to reactive oxygen species and produces a quantifiable
colorimetric signal can be used to measure differences in ROS between cho1∆/∆,
psd1∆/∆psd2∆/∆, and wild type (SC5314) strains. Also, it will be of interest to delete AOX2 in
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the cho1∆/∆ strain, since it may be involved in preventing electron leakage from the electron
transport chain and thereby compensate for generation of ROS in the cho1∆/∆ strain. A
aox2∆/∆ cho1∆/∆ double mutant could be used to test if this can further increase damage
caused by ROS generation compared to wild-type, cho1∆/∆, and aox2∆/∆ single mutants.
Alternatively, the AOX inhibitor, salicylhydroxamic acid (SHAM) can be added to the media to
test if blocking Aox1p and Aox2p function enhances the mitochondrial and cell wall defects
observed in the cho1∆/∆ strain. Specific dyes that bind to nitric oxide, hydrogen peroxide and
O2 – species, such as MitoSOX red (Mukhopadhyay et al., 2007, Cvetkovska et al., 2012), or
DAF-FM (which measures NO production) can also be utilized in our mutant strains. These
experiments will provide a method to directly test our hypothesis that the cho1∆/∆ strain
produces reactive oxygen species (ROS) due to dysfunctional mitochondria.
Transcriptional profiling revealed a possible down-regulation of mitochondrial-encoded genes
such as COX1 and COX2. This can be directly tested by qPCR of DNA. It is speculated that
down-regulation of mitochondrial genes reflects a partial loss of mitochondrial genome in
cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants, and this can be assayed by staining the cells with 4',6diamidino-2-phenylindole (DAPI) to visualize for punctate spots that are indicative of a loss of
the mitochondrial genome. Alternatively, mitochondrial morphology changes can be examined
using Mitotracker® Red (a dye that stains mitochondria) and transmission electron microscopy
(TEM) for more detailed analysis.
Since there are many similarities between the sam37∆/∆ and the cho1∆/∆ mutants, it might also
be relevant to delete the SAM37 complex component, Mdm10, to test if this complex is
responsible for any of the phenotypes seen in the cho1∆/∆ strain. Since mislocalization of
Mdm10 causes mitochondrial and cell wall defects (Qu et al., 2012), examining the localization
of a C-terminally GFP-tagged Mdm10p or Sam37p may be useful to determine if this key protein
is mislocalized due to loss of PS in the cho1∆/∆ mutant. This can be accomplished by
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flouresecnt microscopy. Conversely, it will be of interest to also measure the phospholipid
composition of the mitochondria in both the sam37∆/∆ and cho1∆/∆ strains to directly measure
differences in phospholipids and how this may directly affect mitochondrial function by coupling
it with morphological studies and oxygen consumption assays to measure electron transport
chain activity.
The cell wall phenotypes will also be tested under low and high oxygen conditions (using an
anaerobic chamber to control oxygen levels) to assay if hypoxic conditions exacerbate these
cell wall defects in the cho1∆/∆ , psd1∆/∆psd2∆/∆ and wild type (SC5314) strains; we expect a
large decrease in available oxygen would limit free radical production. Strains grown under
anoxic conditions and normoxic conditions could be subjected to TEM to determine if the
cho1∆/∆ mutants’ cell wall defects are present even under limited oxygen conditions. It is
expected that the further reducing oxygen levels in the environment may mitigate wall defects
by reducing electron transport activity and thereby reducing reactive oxygen species. If our
model is valid and the wall defects are due to activation of cell wall repair pathways induced by
ROS, we would expect to see no differences in sensitivities to cell wall perturbing drugs
calcofluor white and congo red between the cho1∆/∆, psd1∆/∆ psd2∆/∆ ,and wild type strain
upon neutralization of ROS in the presence of the scavengers 6-Hydroxy-2,5,7,8tetramethylchroman-2-carboxylic acid or terbinafine.
The role of iron in mediating these processes remains to be tested. For example, does
exogenous heme addition abrogate the cell wall defects in the mutant and what effect would
addition of heme have on the cell wall phenotypes, response to hypoxia, or Als adhesin and
other cell wall protein expression? It will be of interest to determine the role of SEF1 in these
processes by knocking out SEF1 in psd1∆/∆psd2∆/∆ and assaying if it has more severely
altered cell walls like those observed in the cho1∆/∆ strain
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It would also be of interest to determine if deletion of ERG11 may change the fluidity of
the membrane and transcriptionally effect hypoxic response gene expression in C. albicans.
Gene expression can be quantified and measured by RNA sequencing or qRT PCR. A more
direct approach to measure membrane fluidity in the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains
would also be extremely valuable as inherent lipid polymorphisms (see chapter 1) most likely
influence biochemical interactions between proteins and lipids and/or lipid-lipid interactions in
membranes. This assay may be accomplished by generating protoplasts and using the dye 1,6diphenyl-1,3,- hexatriene that intercalates within the membrane and then measuring its change
in optical absorbance (which is directly dependent on membrane fluidity). As we hypothesized
that the cho1∆/∆ strain has a less fluid membrane, we predict an increase in fluorescence of this
dye in cho1∆/∆ mutant compared to the wild type or psd1∆/∆psd2∆/∆ strains.
In vitro phosphatidylserine (PS)/phosphatidylethanolamine (PE) liposome complexes
may also be a valuable tool to test the hypothesis that phosphatidylserine (PS) directly interacts
with components of the electron transport chain. Assays to determine the effects of phospholipid
structural changes, including acyl chain length and saturation on the interactions of components
of the electron transport chain such as the interaction of cytochrome c with heme in the
mitochondrial inner membrane may indicate a previously unknown role for phosphatidylserine
(PS) in facilitating correct orientation and proper protein-protein and/or protein- lipid interactions
within these membranes.
The identity of the specific signaling pathway activated by loss of phosphatidylserine (PS) and
/or de novo phosphatidylethanolamine (PE) may provide a direct mechanism for how these
specific phospholipid changes cause defects in the Candida albicans cell wall. The role of the
signaling pathways - Rim101, the major ion stress response pathway and Hog-1, an osmosensing mitochondrial activated pathway should be investigated(Davis et al., 2011, Alonso
Monge et al., 2008). Western blotting can help elucidate if these pathways are activated and if
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they are involved in the cell wall phenotypes in the cho1∆/∆ strain. It would be of interest to test
the effect of cell wall glycosylphosphatidylionositol (GPI) anchor proteins that are highly
differentially expressed between the strains on the cell wall phenotypes by deleting genes such
as PGA31 and ECM331 and assaying the effect these deletions have on cell wall ultrastructure
and biochemical make up.
Conclusions
Taken together, these experiments should provide a better understanding of the role of PS in
maintaining the cell wall and mitochondria in C. albicans. The diverse cellular process that are
influenced by phospholipids are just being uncovered and the ability to use phospholipid
biosynthesis as a tool for elucidating drug targets and chemotherapies against the fungal
pathogen Candida albicans is a promising area for future research.
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Abstract
The cho1 ∆/∆ mutant is effectively cleared five days post-infection and therefore it may serve as
an ideal live vaccine strain. The cho1∆/∆ strain is however not viable as an anti-candidal
vaccine strain against systematic candidiasis despite its lack of virulence and ability to initially
colonize and grow in the mouse host. We also characterize the cell wall glycomic composition of
the different strains and determine that unmasking of β-1,3-glucans may be responsible for the
avirulence of the cho1∆/∆ mutant.
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Introduction
Vaccines against Candida albicans have been proposed to protect against both systemic and
vulvovaginal candidiasis (Filler et al., 2010; Antonio C., 2000). We therefore hypothesized that
since the cho1∆/∆ mutant is able to grow in the host, but is avirulent in a murine model of
disseminated candidiasis, it may be an ideal candidate for a live vaccine against C. albicans.
The mutant is however effectively cleared five days post-infection and therefore it may serve as
an ideal live vaccine strain. Cell surface components or wall proteins have been proposed as
vaccine candidates (Bundle et al. 2012; Luo et al., 2012; Paulovicova et al. 2012; Filler et al.,
2010). The cell wall changes observed in the cho1∆/∆ mutant as well as the transcriptional
increase in cell wall gene expression coupled with its hyper-filamentation suggested that the
cho1∆/∆ strain may present to the host an altered cell wall structure (Chapter 2 and Chen et al.,
2010). We hypothesize that its unique cell wall phenotype via differential expression of Als
proteins and Hwp1 may lead to enhanced recognition by host immune cells and effective
clearance from host tissue. Thus this strain could confer resistance to re-infection by a virulent
wild-type strain of C. albicans and represents a candidate for an experimental live, attenuated
vaccine against systemic candidiasis and can be used as a tool to further decipher mechanisms
of protective immunity during candidiasis. This section demonstrates that the cho1∆/∆ mutant is
not a viable vaccine candidate despite its lack of virulence and ability to initially colonize and
grow in the mouse host.
As another analysis, we also analyzed the glycomic composition of these phospholipid
mutants and delineated if the avirulence of the mutant is due to an auxotrophic growth defect.
In Chapter 2, we showed that the phospholipid biosynthesis mutants have a defective cell wall.
However, the biochemical make-up of the cell wall in these mutants has not been analyzed.
Furthermore, the failure of the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants to cause virulence in the
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host is not fully understood. We hypothesized that the lack of virulence may be due to an
auxotrophic growth defect as the mutant may fail to grow by not acquiring essential phospholipid
precursors, such as ethanolamine and choline, in the host environment. The resulting loss of
virulence could be due to an inability to grow or due to a more effective clearance and response
by the host immune system.

Materials and Methods
Strains and Growth conditions
All strains used in this study are listed in Table 2-1. Unless otherwise mentioned, the strains
were grown in 2% yeast-extract 2 % peptone 2% dextrose (YPD) medium for 24 hrs at 30ºC
with shaking.
Growth in the mouse host
To examine growth in the host, the cells were stained with Alexa fluor 647 label. Cells were
grown at 37°C overnight in YPD and were washed three times in phosphate buffered saline
(PBS) and resuspended in PBS at a concentration of 1x10 9/ml. Alexa fluor 647 (Molecular
Probes) was dissolved and stored in DMSO at a concentration of 10 mg/ml. Prior to labeling, 11
µL of 1 M NaCO3 pH 10 was added to the Candida cells and then 2 µL of Alexa fluor 647 was
added and mixed briefly by vortexing. Cells were labeled for 1 hour at room temp, then washed
five times with PBS, counted by hemacytometer, and used for infection ( as described in the
mice virulence section below). Viability of the cells used for injection was determined by plating
the suspension on 2% yeast extract 2 % peptone 2% dextrose (YPD) agar plates. 6 h postinfection, mice kidneys were collected and homogenized in PBS, and suspensions were
observed by fluorescence microscopy using Alex fluor and GFP specific filters. Images were
taken with a MagnaFire Olympus digital camera and Olympus BX50 microscope (Olympus
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America, Melville, NY,USA). Images were superimposed with PictureFrame software
(Optronics, Goleta,CA).
β-Glucan exposure and Dectin-1 binding
The strains were sent to Dr.Robert Wheeler (University of Maine, Dept. of Molecular and
Biomedical Sciences) to determine the unmasking of β-1,3-glucan and dectin-1 binding. Briefly,
cells were grown overnight in YPD, washed, collected by centrifugation, resuspended in saline
and then stained with anti-β-glucan antibody, specific for β1,3-glucan (Biosupplies, Inc.,
Australia), diluted 1:200 in 2%BSA /PBS overnight at 4°C on a rotator and washed three times
with PBS. Then homogenates were stained for 1 hour at room temp with goat anti-mouse Cy3
antibody (Jackson Immunoresearch) diluted 1:100 into 2%BSA/PBS with or without Alexa647labeled Dectin-CRD (diluted 1:40 in 2%BSA/PBS). After three washes, cells were visualized by
fluorescence microscopy. Live cells were identified based on GFP fluorescence.
Extraction of Cell Wall Polysaccharides and Glycosyl Composition Analysis
Glycosyl composition analysis was performed by combined gas chromatography/mass
spectrometry (GC/MS) at the Complex Carbohydrate Research Center by Dr.Parastoo Azadi.
The per-O-trimethylsilyl (TMS) derivatives of the monosaccharide methyl glycosides produced
from the sample by acidic methanolysis. Between 100 and 400ug of sample was used for the
analysis. 20ug of inositol was added to the samples. The samples were initially hydrolyzed
using 4M HCL at 100 degrees for 2 hours. Methyl glycosides were then prepared from the
samples by methanolysis in 1 M HCl in methanol at 80C (18 hours), followed by re-Nacetylation with pyridine and acetic anhydride in methanol (for detection of amino sugars). The
samples were then per-O-trimethylsilylated by treatment with Tri-Sil (Pierce) at 80C (0.5 hours).
These procedures were carried out as previously described in Merkle and Poppe (1994).
GC/MS analysis of the TMS methyl glycosides was performed on an Agilent 6890N GC
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interfaced to a 5975B MSD, using a Supelco EC-1 fused silica capillary column (30m  0.25 mm
ID).
Mouse virulence studies
For the infection studies, 5- to 6-week old male ICR mice from Harlan Laboratories were used.
Five mice were housed per cage. C.albicans strains were grown overnight in 2% Yeast 2%
Peptone 2% Dextrose (YPD) at 37ºC with shaking and were washed three times in phosphate
buffered saline. Cell numbers were determined by a haemocytometer and adjusted to a final
concentration of 107 cells/ml in phosphate buffered saline. 100µL of the cell suspension (10^6
total cells) were injected into the tail veins of mice. Mice were monitored for three weeks for
signs of infection. Moribund mice were euthanized. Each experiment was done in triplicate with
five mice in each group. All experimental procedures were carried out in accordance with the
NIH guidelines for the ethical treatment of animals. CFU numbers were determined from the
weighed kidneys 3 and 5 days after infection by plating tissue homogenates on YPD agar. For
the vaccine study, mice were first pre-inoculated with the cho1∆/∆ or control strain using the
same procedure and monitored for two weeks, after which the mice were challenged with 1x10 6
Candida albicans wild-type(SC5314) cells and monitored as described above.
Statistical Analysis
Prism 4.0 software (GraphPad) was used to determine the significance of differences for the
mouse virulence studies. Statistically significant differences were determined using the Kaplan
Meir survival curve test. Statistical significance was set at a P value of <0.05.

Results and Discussion
Lack of virulence of the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains are not due to auxotrophic
growth defects
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We tested the hypothesis that the lack of virulence of the cho1∆/∆ and psd1∆/∆psd2∆/∆ mutants
is due to auxotrophic growth defects. In order to test if the strains could grow in vivo we injected
Alexa fluor stained yeast form C. albicans cells expressing GFP and examined if they were able
to form hyphae upon infection of the host by microscopy (see methods). We show that in the
systemic model of infection that all the C.albicans strains are able to grow and form hyphae in
mice kidneys 6 hours post infection (Fig:A-1). We also found that there are no differences in
growth in mouse serum for all the strains tested (data not shown). This suggests that these
strains are capable of obtaining ethanolamine or choline from the host and the avirulence of the
mutants is not due to nutritional auxotrophies leading to starvation and death in the host.
Increased β-glucan exposure on cho1∆/∆ mutant may enhance host immune recognition
β-1-3 glucan “unmasking” is the uncovering of inner cell wall layer, namely β-13-glucan, that is
normally covered by mannoproteins. Masking of β-glucan avoids immune recognition through
the Dectin-1 receptor on phagocytes (Brown et al., 2002; Gow et al., 2007; Netea et al., 2008).
Recognition by Dectin-1 has been shown to activate defense mechanisms for the stimulation of
pro-inflammatory cytokines (Le et al., 2012, Wheeler et al., 2008). In addition, Candida infection
have been shown to be mitigated by IL-33 pretreatment; IL-33 mediates neutrophil recruitment
to Candida infection sites via activation of Dectin-1 on host macrophages (Le et al., 2012). We
propose that the cell wall defects of the cho1∆/∆ mutant may cause an increase in immunemediated clearance by increased immune recognition. This hypothesis is supported by an
increased exposure of β-1-3 glucan on the fungal cell surface (Fig: A-2A) and increased binding
of the soluble binding domain of Dectin-1 receptor on macrophages to the less virulent cho1∆/∆
and psd1∆/∆psd2∆/∆ mutants (Fig:A-2B). This is also consistent with the finding that the cho1
∆/∆ mutant has increased sensitivity to caspofungin (Chen et al., 2010), a strong inhibitor of β-1
3 glucan synthesis. Thus, increased exposure of β-1 -3 glucans may be responsible for
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increased host recognition and at least partially explain the lack of virulence observed in the
cho1∆/∆ strain.
Cell wall carbohydrate analysis reveals no differences in amounts of glucose or mannose
residues between strains
We next analyzed the cell wall glycosyl composition by combined gas chromatography/mass
spectrometry (GC/MS) of the per-O-trimethylsilyl (TMS) derivatives of the monosaccharide
methyl glycosides collected from each strain by acid methanolysis. We observed no difference
in wall carbohydrates suggesting that the total amount of β-1-3 glucans in the cell is not
changed in the cho1∆/∆ or psd1∆/∆psd2∆/∆ mutant (Table A-1).This is similar to the observed
cell wall polysaccharide structure in the mitochondria-defective sam37∆/∆ strain that
interestingly has similar phenotypes to cho1∆/∆ (Qu et al., 2012, Chapter 2). We were unable to
quantify chitin content in these strains but we did note an increase in Nacetyl glucosamine (a
break down product of chitin) in the cho1∆/∆ strain compared to the wild type. This is consistent
with our fluorescent calcofluor white staining data that indicates much higher chitin content in
the cho1∆/∆ strain.
Pre-inoculation with cho1∆/∆ mutant provides no protective effect against systemic
candidiasis in mice.
The avirulence of the cho1∆/∆ mutant and its clearance by the immune system after infection
enabled us to examine its possible use as a live vaccine to prevent Candida infections. Isolated
peptides against cell wall components and cell wall proteins have been utilized to show
protective effects in Candida albicans systemic mouse infections such as the β-(Man)3-Fba
glycopeptide, mannosides, Hyr-1 recombinant vaccines (Cutler et al., 2011; Bar et al., 2012,
Pietrella et al., 2012; Paulovicova et al., 2012; Luo et al., 2012). Anti-β-glucan antibodies have
also shown to confer protective properties against vaginal candidiasis (Pietrella et al., 2010;
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Torosantucci et al., 2009). In addition Filler et al. (2010), have found a vaccine to Als3p to be
protective in mice, and we found Als3p be highly up-regulated in the cho1∆/∆ strain in YPD (see
Chapter 2). Since Als3 is highly expressed at the surface of the cho1∆/∆ strain and β-1-3 glucan
is highly exposed in this mutant, we hypothesized that the cho1∆/∆ strain may be a good
vaccine strain. To test our hypothesis, we performed in vivo infection assays to determine if
pretreatment with cho1∆/∆ cells leads to prolonged survival upon subsequent infection with wild
type Candida albicans cells in a mouse model. We found that there was no protective effect in
mice using this method suggesting that cho1∆/∆ is not a viable vaccine candidate for the
preventive treatment of invasive candidiasis despite its initial colonization of the host kidneys
and its subsequent clearance from the host (Fig:A-3)(Chen et al., 2010).
No difference in virulence between the psd2∆/∆ strain and the wild type strain in a mouse
model of systemic infection.
The avirulence of the cho1∆/∆ mutant and the severely reduced virulence of the
psd1∆/∆psd2∆/∆ mutant also led us to assay the virulence of the psd2∆/∆ mutant alone.We had
initially found that the psd2∆/∆ strain may be hypervirulent in a mouse model of systemic
infection as it had a higher fungal burden and more virulent survival curve data. We therefore
tested the strain repeatedly to verify if our previous results were valid, and found that there is
no difference in virulence between the wild type strain and the psd2∆/∆ strain (Fig: A-4).

Summary
The data presented in this section suggests that although the cho1∆/∆ strain is able to grow in
the host kidney and form hyphae initially upon systemic infection, the cho1∆/∆ strain is not an
ideal vaccine candidate to prevent systemic infection as it did not provide any protection in our
mouse model. We also propose that differences in virulence may be due to unmasking of β-1,3
glucans as we show that the cho1∆/∆ strain has much more unmasking β-1,3 glucan and higher
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Dectin-1 binding. Therefore, it is likely that alterations in the cell wall and immune recognition
attenuates the virulence of the mutant and may modulate its response to hypoxia or iron
limitation in the host. Recently it has been demonstrated that disruption of MAP kinase
pathways in C.albicans causes enhanced β-glucan exposure, triggering more efficient immune
responses (Galan-Diez et al., 2010). Thus, enhanced β-glucan exposure and altered cell wall
organization (reflected in the transcriptional profile) in the cho1∆/∆ mutant may trigger activation
of signaling pathways. Similar to the cho1∆/∆ mutant, these mutants that are defective in
phosphorylation are hypersensitive to the cell wall perturbing drugs congo red and calcofluor
white (Galan-Diez et al., 2010), suggesting that similar signaling pathways may be affected in
the cho1∆/∆ mutant leading to unmasking of β-glucan and enhanced immune recognition in
these strains.
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Supplementary Figures

Figure A-1: Growth of the cho1∆/∆ and psd1∆/∆psd2∆/∆ strains in mice kidneys in vivo.
The cho1∆/∆ and psd1∆/∆psd2∆/∆ showed no defects in hyphal formation and growth 6 hours
post infection. 1 x 106 Alexa fluor-labeled (RED) yeast cells were injected in the tail vein of
mice, 6 h post-infection kidneys were harvested homogenized and viewed under a fluorescent
microscope. Green fluorescence is indicative of new hyphal growth in vivo. Image is
representative of 40 cells per strain.Sarah Davis collaborated on this figure and experiment.
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Figure A-2: Increased β-glucan exposure on the cho1∆/∆ strain. (A) Cells were grown in
YPD, washed, diluted and stained with anti-β-glucan antibody and Cy2-labeled secondary
antibody. Images are representative of three independent experiments. Scale bar is 20µm. This
experiment was done in colloboration with Robert Wheeler at the University of Maine.
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Untreated
cho1∆/∆ pre-treated
mice

Figure A-3: Survival curves of the cho1∆/∆ pre-treated and untreated mice challenged
with the wild type strain. For the pre-treated group, mice were inoculated with1x106 Candida
albicans cho1∆/∆ cells by tail vein injection. For the untreated group, saline was injected as a
control. After two weeks, mice in both groups were challenged with 1x10 5 wild-type (SC5314)
cells. Survival was monitored for four weeks. No difference in survival was observed between
the two treatment groups. Number of mice used is indicated in parentheses. P value cho1 ∆/∆treated v/s untreated mice = 0.059 (no difference).
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B

Figure A-4: (A)Survival curve of the psd2∆/∆ strain in a mouse model of systemic
infection. Mice were infected with 1x106 Candida albicans cells by tail vein injection and mice
were monitored for 21 days. Survival curves for the wild type (SC5314), psd2∆/∆ and
psd2∆/∆:PSD2 were examined. The number of mice used is indicated in parentheses. P value
of wild type verses psd2∆/∆ = 0.186 (no statistical difference).(B) Fungal burden in the kidney of
the psd2∆/∆ strain compared to the wild type (SC5314) strain. 1x106 Candida albicans cells
were injected by tail vein injection. After five days post infection, kidneys were harvested,
homogenized, and the fungal burden was measured by counting CFUs on YPD agar plates.

102

Table A-1: Glycosyl Composition analysis of C.albicans strains by GC/MS.

Glycosyl

Mol %

Mol%

Mol%

Mol%

Mol%

redidue

Wild-type

cho1∆/∆

psd1∆/∆

psd1∆/∆psd2∆/∆ cho1∆/∆::CHO1

Ribose

-

-

-

-

-

Arabinose

-

-

-

-

-

Rhamnose

-

-

-

-

-

Fucose

-

-

-

-

-

Xylose

-

2.0

10.6

2.6

-

Glucuronic acid

-

-

-

-

-

Galacturonic

-

-

-

-

-

Mannose

48.1

40.6

24.6

43.3

39.0

Galactose

-

0.2

0.5

0.4

-

Glucose

51.9

53.8

63.5

52.0

60.2

N-acetyl

-

-

-

-

-

3.3

0.8

1.7

-

-

-

-

acid

-

galactosamine
N-acetyl

0.9

glucosamine
N-acetyl

-

mannosamine
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Table A-2: Expression of glucan and chitin synthases genes

Gene
Name
GLS1
GLS2
CHS1
CHS2
CHS3
CHS4
CHS5
CHS6
CHS7
CHS8

CGD Function
Glucan Synthase 1
Glucan Synthase 2
Chitin Synthase 1
Chitin Synthase 2
Chitin Synthase 3
Chitin Synthase 4
Chitin Synthase 5
Chitin Synthase 6
Chitin Synthase 7
Chitin synthase 8

cho1∆/∆
1.39
2.14
1.35
2.83
1.52
1.23
1.40
1.41
1.44
2.00

psd1∆/∆psd2∆/∆
1.41
2.83
2.82
2.46
1.83
2.22
1.14
1.35
1.74
1.74
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Table A-3: List of all the genes up-regulated in the cho1∆/∆ mutant compared to the wildtype strain.

Gene ID
CAL0005124

Fold upregulated
125

CAL0004244

86.6

CGD annotated Function

P-value

Secreted Protein

1.00E-300
1.00E-300
1.00E-300
1.00E-300
4.64E-70

Uncharacterized ORF

CAL0000215

50.1

Inositol-1-phosphate synthase

CAL0001195

33.16

Putative GPI-anchored protein

CAL0000162

31.48

CAL0004933

30.16

GPI-anchored cell wall protein required
for filamentous growth at acidic pH
Immunogenic stress-associated protein

CAL0003753

19.11

CAL0002828

15.10

Putative transcription factor; required for
wild-type resistance to cell wall
perturbation
Uncharacterized ORF

CAL0000413

14.78

General amino acid permease

CAL0000986

13.30

Putative GPI-anchored protein

CAL0001735

10.76

CAL0001866

10.69

CAL0002992

10.40

Putative ribonucleoside diphosphate
reductase
Member of the secreted aspartyl
proteinase family
Basic amino acid permease

CAL0000567

9.77

CAL0001974

9.63

CAL0000715

9.48

CL0000259

9.01

CAL0004374

8.34

CAL0000188

8.34

CAL0001283

8.10

Uncharacterized ORF; Ortholog(s) have
tubulin binding activity, role in microtubule
cytoskeleton organization, mitochondrion
inheritance
Plasma-membrane-localized protein;
filament induced; Hog1p-, and hypoxiainduced
ALS family protein

CAL0120975

7.94

Uncharacterized ORF

CAL0120924

7.39

Putative adhesin-like protein

CAL0001538

6.70

CAL0000427

6.68

CAL0004799

6.43

CAF0006989

6.25

CAL0002282

6.24

Putative peroxisomal copper amine
oxidase
Protein similar to plant pathogenesisrelated proteins; required for virulence in
mouse systemic and rabbit corneal
infections
Uncharacterized ORF; Hap43p-repressed
gene
Cytoplasmic protein expressed
specifically in white phase yeast cells
Unchara Putative ceramide hydroxylase;
predicted enzyme of sphingolipid Tsa1Bp

Verified ORF; Protein required for
cohesion, adhesion, and biofilm formation
Urea amidolyase
Plasma membrane protein of heme-iron
utilization upregulated by Rim101p
GPI-anchored protein

1.00E-300
1.00E-300
1.09E-76
4.54E-166
1.19E-158
1.00E-300
1.59E-225
1.00E-300
1.14E-39
1.00E-300
7.82E-98
1.50E-200
1.00E-300

1.00E-300
1.00E-300
1.00E-300
2.99E-05
1.08E-189
1.00E-300

6.26E-56
6.03E-146
1.00E-300
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Table A-3 continued
Gene ID
CAL0000377

Fold upregulated
6.15

CGD annotated Function

P-value

CAL0001605

5.98

Uncharacterized ORF; Planktonic growthinduced gene
ALS family cell wall adhesin

5.38E-14

CAL0001407

5.91

Putative DNA-binding transcription factor

CAL0003337

5.75

Putative ARP2/3 complex subunit

CAL0002165

5.71

GPI-anchored protein

CAL0005195

5.64

Predicted ORF in retrotransposon Tca8

CAL0000023

5.61

Uncharacterized ORF

CAL0006337

5.60

Ammonium permease

CAL0005305

5.55

Uncharacterized ORF

CAL0001738

5.36

Uncharacterized ORF

CAF0007042

5.32

Uncharacterized ORF

CAL0004418

5.29

CAL0000494

5.24

Putative protein of unknown function;
Hap43p-repressed gene
Essential protein involved in cytokinesis

CAL0000285

5.20

Uncharacterized ORF

CAL0004349

5.15

Putative DNA cross-link repair protein

CAL0000177

5.05

Putative aminopeptidase

CAL0004191

4.99

Uncharacterized ORF

CAL0003075

4.94

Uncharacterized ORF

CAL0003484

4.94

CAL0002632

4.92

Uncharacterized ORF; Hap43p-induced
gene
G1 cyclin

CAL0003166

4.70

Uncharacterized ORF

CAL0005585

4.68

CAL0004553

4.63

Uncharacterized ORF; Biofilm-induced
gene
Essential transcription factor

CAL0006272

4.60

Acyl CoA:sterol acyltransferase

CAL0000709

4.59

Basic amino acid permease

CAL0003763

4.57

Uncharacterized ORF

CAL0004442

4.55

Uncharacterized ORF

CAL0005876

4.51

Putative peptide:N-glycanase

CAL0000443

4.45

Cell wall acid trehalase

CAL0000739

4.43

Uncharacterized ORF

CAL0003828

4.42

Secreted lipase

CAL0004833

4.40

Uncharacterized ORF

CAL0000503

4.39

Uncharacterized ORF

CAL0004522

4.36

Predicted membrane transporter

CAL0000209

4.32

Putative transcription factor

CAL0002724

4.26

CAL0002389

4.25

Member of a family encoded by FGR6related genes
Uncharacterized ORF

CAL0005923

4.24

Uncharacterized ORF

CAL0001357

4.19

Uncharacterized ORF;role in
mitochondrial genome maintenance

1.00E-300
1.01E-53
4.63E-42
1.00E-300
1.45E-113
5.67E-222
1.00E-300
1.00E-300
4.52E-39
2.29E-15
1.00E-300
4.62E-50
5.88E-88
4.11E-124
6.07E-183
1.86E-55
5.56E-09
6.46E-75
3.45E-144
1.00E-300
9.17E-40
1.00E-300
3.27E-220
1.45E-90
1.00E-300
7.80E-46
1.00E-300
1.41E-176
3.41E-70
1.00E-300
2.40E-258
1.68E-11
2.54E-12
1.00E-300
2.35E-32
3.99E-45
2.79E-44
2.33E-191
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Table A-3 continued
Gene ID
CAL0004258

Fold upregulated
4.16

CGD annotated Function

P-value

Putative GPI-anchor

7.02E-180

CAL0002907

4.12

Putative phosphomethylpyrimidine kinase

CAL0001619

4.11

CAL0003020

4.02

CAL0006302

4.00

Uncharacterized ORF; ATP sulfurlyase of
sulfate assimilation
Zinc finger transcriptional regulator of
nitrogen utilization
Mannose-1-phosphate guanyltransferase

1.92E-53
5.84E-80

CAL0000359

3.97

Uncharacterized ORF

CAL0005075

3.97

Hypha-specific G1 cyclin-related protein

CAL0005323

3.96

Secreted lipase

CAL0006398

3.94

CAL0002156

3.94

Hyphal-induced GPI-anchored cell wall
protein
Uncharacterized ORF

CAL0001358

3.93

CAL0120845

3.90

CAL0002630

3.90

CAL0001625

3.87

CAL0002161

3.87

CAL0002939

3.86

CAL0002789

3.85

UDP-glucose:ceramide
glucosyltransferase
ALS family protein

CAL0005541

3.84

Squalene epoxidase

CAL0002798

3.82

Uncharacterized ORF

CAL0006312

3.82

Putative DNA mismatch repair factor

CAL0003055

3.80

Phosphofructokinase alpha subunit

CAL0002550

3.80

Predicted zinc-finger protein

CAL0000318

3.74

CAL0001295

3.73

CAL0004519

3.71

Uncharacterized ORF; Hap43p-induced
gene
Uncharacterized ORF; Hap43p-repressed
gene
Putative mitochondrial biogenesis protein

CAL0006341

3.71

CAL0003546

3.70

CAL0001212

3.68

CAL0002964

3.66

CAF0007422

3.65

CAL0001762

3.60

CAL0005303

3.60

Uncharacterized ORF; Ortholog(s) have
role in mitochondrial genome
maintenance and integral to mitochondrial
inner membrane localization
Putative transporter of ATP-binding
cassette (ABC) superfamily
Uncharacterized ORF

CAL0000374

3.59

Putative protein of GPI synthesis

Putative mitochondrial leucyl-tRNA
synthetase
Uncharacterized ORF
Putative mitochondrial translation
initiation factor
Zinc cluster DNA-binding transcription
factor
Uncharacterized ORF

Biofilm- and planktonic growth-induced
gene
Uncharacterized ORF; Ortholog(s) have
role in mitochondrial genome
maintenance
DNA binding protein with Cys2-His2 zincfinger
Uncharacterized ORF

2.61E-105
1.13E-132
1.51E-113
1.91E-37
2.14E-28
1.36E-50
3.89E-74
1.00E-300
0.0013996
1.00E-300
1.69E-30
1.00E-300
9.80E-36
1.00E-300
1.00E-300
5.03E-15
1.57E-92
1.00E-300
1.00E-300
8.91E-177
1.18E-35
1.00E-300
3.14E-72
1.56E-22
1.00E-300
2.68E-06
4.17E-267

1.00E-300
2.97E-71
3.26E-48
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Table A-3 continued

Gene ID

CGD annotated Function

P-value

CAL0000998

Fold upregulated
3.56

Uncharacterized ORF

CAL0003593

3.55

Uncharacterized ORF

CAL0002878

3.54

CAL0000151

3.54

Member of a family encoded by FGR6related genes
Predicted zinc-finger protein

1.31E-183
8.47E-37
1.57E-62

CAL0001515

3.52

Uncharacterized ORF

CAL0004602

3.52

CAL0002404

3.47

CAL0002930

3.44

Uncharacterized ORF; Ortholog(s) have
cytosol localization
Uncharacterized ORF; Protein related to
arginases
Uncharacterized OR; induced by hypoxia

CAL0006342

3.44

Verified ORF; Hap43p-repressed gene

CAL0001440

3.43

ALS family of cell-surface glycoproteins

CAL0005593

3.41

CAL0000040

3.41

CAL0000601

3.38

Verified ORF; Putative mitochondrial
protein with a predicted role in respiratory
growth; mutants display a strong defect in
biofilm formation; fluconazole-induced;
ketoconazole-repressed
Uncharacterized ORF; Putative acyl-CoA
oxidase
Uncharacterized ORF

CAL0003697

3.35

CAL0003797

3.33

Uncharacterized ORF; Hap43p-induced
gene
Uncharacterized ORF

CAL0003896

3.33

Uncharacterized ORF

CAL0005961

3.32

Putative glucokinase

CAL0004071

3.32

Uncharacterized ORF

CAL0002158

3.32

Uncharacterized ORF

CAL0001776

3.31

Uncharacterized ORF

CAL0000212

3.31

Secreted aspartyl protease

CAL0005531

3.31

CAL0002488

3.31

CAL0004528

3.30

Predicted extracellular or membraneassociated glucoamylase
Uncharacterized ORF;gene induced by
hypoxia
Inositol phosphoryl transferase

CAL0006186

3.30

Mannosyltransferase

CAL0004027

3.30

Chitin synthase

CAL0002852

3.29

Uncharacterized ORF

CAL0004944

3.29

CAL0003435

3.28

CAL0005027

3.25

Zn2-Cys6 transcriptional regulator of
ergosterol biosynthetic genes and sterol
uptake
Plasma membrane-localized protein;
repressed by nitric oxide; Hap43prepressed gene
Coproporphyrinogen III oxidase

CAL0000800

3.23

Putative GPI-anchored protein

CAL0002549

3.23

Uncharacterized ORF

CAL0003463

3.22

Putative transcription factor with zinc
cluster DNA-binding motif

1.22E-16
1.56E-32
1.15E-39
1.63E-14
4.42E-209
1.20E-216
1.00E-300
1.00E-300

2.83E-22
1.00E-300
1.00E-300
1.13E-192
6.32E-130
1.00E-300
4.55E-142
6.76E-14
2.28E-33
1.00E-300
9.16E-31
1.79E-44
1.04E-41
5.73E-27
1.73E-148
1.86E-19
1.00E-300
1.13E-11
1.00E-300
9.83E-07
0.000571786
2.45E-25
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Table A-3 continued
Gene ID

Fold upregulated

CGD annotated Function

P-value

2.25E-20
1.00E-300
6.94E-14
1.75E-06
1.00E-300
1.00E-300

CAL0003217

3.21

Putative stretch-activated Ca2+ channel

CAL0001985

3.21

Putative ceramide hydroxylase

CAL0003499

3.21

Uncharacterized ORF

CAL0004275

3.20

Uncharacterized ORF

CAL0003180

3.18

Uncharacterized ORF

CAL0004436

3.16

CAL0001911

3.16

Uncharacterized ORF; role in endosome
transport
Putative adhesin-like protein

CAL0003637

3.15

Uncharacterized ORF

CAL0001478

3.15

CAL0001393

3.13

CAL0004601

3.12

Uncharacterized ORF; Ortholog(s) have
role in mitochondrial translation and
mitochondrion localization
Trehalose-6-phosphate (Tre6P)
phosphatase
Uncharacterized ORF

CAL0004745

3.12

CAL0004169

3.12

Purine-cytosine permease of pyrimidine
salvage;
Uncharacterized ORF

CAL0005203

3.11

Putative GPI-anchored protein

CAL0003532

3.11

Uncharacterized ORF

CAL0000344

3.10

Uncharacterized ORF

CAL0005136

3.09

Putative transcription factor

CAL0005640

3.07

Predicted membrane transporter

CAL0004499

3.07

CAL0004417

3.06

CAL0001962

3.06

N-linked mannoprotein of cell wall and
membrane
Putative peroxisomal 3-ketoacyl CoA
thiolase
Aldo-keto reductase family member

CAL0002117

3.06

CAL0003915

3.03

CAL0005752

3.02

CAL0005674

3.01

Putative nicotinic acid mononucleotide
adenylyltransferase
Neutral trehalase

CAL0005400

3.01

Uncharacterized ORF

CAL0004456

3.00

Uncharacterized ORF

CAL0000422

2.99

Cytochrome oxidase assembly protein

CAL0004319

2.96

Putative choline/ethanolamine transporter

CAL0004678

2.96

Uncharacterized ORF

CAL0004368

2.96

Uncharacterized ORF

CAL0000899

2.94

Uncharacterized ORF

CAL0001558

2.94

DNA ligase

CAL0000390

2.94

Uncharacterized ORF;

CAL0000808

2.93

CAL0000041

2.93

CAL0002752

2.93

Uncharacterized ORF; Protein similar to
isoleucyl-tRNA synthetase
Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF

Transcriptional regulator of the CTR1
copper transporter
Translation factor eRF3

3.68E-22
1.00E-300
2.10E-216
1.00E-300
4.22E-09
2.62E-179
1.00E-300
6.42E-09
1.41E-172
3.76E-95
2.03E-112
1.38E-26
4.19E-54
6.86E-106
3.01E-245
1.28E-81
1.00E-300
7.81E-284
2.74E-173
1.31E-16
1.00E-300
1.00E-300
1.00E-300
5.97E-232
8.43E-27
3.19E-11
2.62E-86
8.20E-131
1.00E-300
2.92E-42
6.25E-285
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Table A-3 continued
Gene ID
CAL0004026

Fold upregulated
2.92

CGD annotated Function

P-value

Putative cystathionine gamma-synthase

CAL0004624

2.92

CAL0001294

2.91

Uncharacterized ORF; Putative actin
interacting protein;
Uncharacterized ORF

6.41E-165
4.86E-58

CAL0003069

2.91

Uncharacterized ORF

CAL0005571

2.91

CAL0001564

2.90

CAL0000820

2.90

CAL0004892

2.90

CAL0000430

2.89

CAL0000779

2.88

Uncharacterized ORF; Protein similar to
GTPase regulators
Uncharacterized ORF; Hap43p-repressed
gene
Putative cytochrome c lysine
methyltransferase
Uncharacterized ORF; Hap43p-repressed
gene
Putative mitochondrial translation
elongation factor
Putative GPI-anchored protein

CAL0002436

2.88

Putative prolyl-tRNA synthetase

CAL0003968

2.87

Phosphomannose isomerase

CAL0004017

2.87

Uncharacterized ORF

CAL0001729

2.86

CAL0004146

2.86

Uncharacterized ORF; Possible stress
protein
Putative RNA polymerase II subunit B150

CAF0007014

2.85

Uncharacterized ORF

CAL0002758

2.85

Uncharacterized ORF

CAL0003714

2.85

Uncharacterized ORF

CAL0005643

2.84

Putative zinc transporter

CAL0005848

2.82

Uncharacterized ORF

CAL0005127

2.82

CAL0003889

2.81

CAL0000588

2.81

Uncharacterized ORF; role in oxidationreduction process
Uncharacterized ORF; Biofilm-induced
gene
Uncharacterized ORF

CAL0003612

2.81

CAL0000782

2.81

CAL0005050

2.80

CAL0004394

2.80

CAL0002471

2.79

CAL0005937

2.79

Uncharacterized ORF; Putative lowaffinity copper transporter
Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF

CAF0006940

2.79

Uncharacterized ORF

CAL0006344

2.79

Glucosamine-6-phosphate synthase

CAL0002198

2.79

CAL0004847

2.77

Uncharacterized ORF; Ortholog(s) have
fungal-type vacuole membrane,
mitochondrion localization
Protein similar to S. cerevisiae Ybr075wp

CAL0004976

2.76

Uncharacterized ORF

Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF; Putative Pol
Protein
Putative amino acid permease

3.68E-17
2.02E-11
8.13E-177
1.02E-109
1.00E-300
3.45E-13
2.76E-260
6.45E-12
2.94E-156
1.25E-15
5.14E-92
1.61E-75
6.71E-56
9.28E-85
7.38E-96
4.35E-252
1.00E-300
1.30E-262
2.25E-58
2.86E-42
1.71E-09
7.81E-15
1.44E-224
2.38E-13
8.35E-193
1.79E-233
5.76E-09
4.10E-05
1.00E-300
1.75E-89
0.000482213
1.00E-73
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Table A-3 continued

Gene ID

CGD annotated Function

P-value

CAL0005306

Fold upregulated
2.76

Uncharacterized ORF

CAL0004351

2.76

Uncharacterized ORF

CAL0003611

2.75

Uncharacterized ORF

CAL0000416

2.75

CAL0001905

2.74

Uncharacterized ORF; Putative
transmembrane protein
C-5 sterol desaturase

3.12E-58
1.00E-300
1.12E-07
6.05E-11

CAL0002781

2.74

Predicted membrane transporter

CAL0001123

2.72

Uncharacterized ORF

CAF0006926

2.72

Uncharacterized ORF

CAL0004652

2.72

CAL0004120

2.72

CAL0001720

2.71

CAL0005236

2.71

Putative glutamine-dependent NAD
synthetase
Uncharacterized ORF; Predicted
ribosomal protein
Ribosomal protein of the large subunit,
mitochondrial;
Glycerol 3-phosphatase

CAL0005673

2.70

CAL0002049

2.70

Uncharacterized ORF; Putative
carboxypeptidase
Putative mitochondrial carrier protein

CAL0001970

2.70

Putative glycogen phosphorylase

CAL0000985

2.69

Putative D-xylulose reductase

CAL0005762

2.69

Isocitrate lyase

CAL0001734

2.69

Putative malate permease

CAL0001803

2.69

Putative glucokinase

CAL0001919

2.69

Uncharacterized ORF

CAL0004952

2.69

Uncharacterized ORF

CAL0002546

2.68

CAL0003251

2.68

Uncharacterized ORF; Putative
transporter
Uncharacterized ORF

CAL0000727

2.68

Cysteine transporter

CAL0003477

2.68

Dynein heavy chain

CAL0003007

2.68

CAL0002531

2.67

CAL0001380

2.67

Mitochondrial methionyl-tRNA synthetase
(MetRS
Uncharacterized ORF; Putative adhesinlike protein
Uncharacterized ORF

CAL0001310

2.67

Putative zinc-finger transcription factor

CAL0001963

2.67

CAL0003709

2.66

CAL0004444

2.66

CAL0003627

2.66

CAL0004521

2.65

CAL0005579

2.65

Uncharacterized ORF; role in
mitochondrial aspartyl-tRNA
aminoacylation and mitochondrion
localization
Putative transcription factor with zinc
cluster DNA-binding motif
Uncharacterized ORF; role in
mitochondrial inner boundary membrane
Protein required for normal filamentous
growth
Putative transcription factor with zinc
cluster DNA-binding motif
Uncharacterized ORF

CAL0005583

2.66

Uncharacterized ORF

1.00E-300
7.72E-72
4.60E-195
9.51E-08
7.08E-44
1.45E-08
1.00E-300
1.00E-300
1.43E-18
1.10E-117
1.00E-300
1.00E-300
5.19E-47
9.88E-12
1.00E-300
2.95E-89
2.35E-33
6.08E-14
8.28E-112
5.35E-150
3.08E-14
6.10E-113
1.28E-170
1.71E-30
2.33E-35
5.43E-201

1.12E-21
1.44E-31
1.00E-300
4.88E-22
1.68E-19
8.95E-31
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Table A-3 continued
Gene ID

CGD annotated Function

P-value

CAL0004434

Fold upregulated
2.66

Uncharacterized ORF

CAL0004938

2.65

Uncharacterized ORF

CAL0003100

2.64

Uncharacterized ORF

CAL0001160

2.64

Putative phospholipase B

CAL0005805

2.63

CAL0005121

2.63

Uncharacterized ORF; Hap43p-repressed
gene
Cirt family transposase

9.18E-87
5.96E-15
3.14E-245
7.55E-17
6.39E-17

CAL0004496

2.63

Predicted exocyst subunit

CAL0003364

2.63

Putative alcohol dehydrogenase

CAL0001987

2.63

Uncharacterized ORF

CAL0004048

2.62

CAL0000475

2.61

Putative transcription factor with zinc
cluster DNA-binding motif
Predicted serine/threonine protein kinase

CAL0002874

2.61

CAL0002448

2.61

Uncharacterized ORF; Early-stage
biofilm-induced gene
Amino acid permeases

CAL0002772

2.61

Uncharacterized ORF

CAL0005944

2.60

Dubious ORF

CAL0005550

2.60

Uncharacterized ORF

CAL0001861

2.60

Uncharacterized ORF

CAL0005146

2.60

Uncharacterized ORF

CAL0001663

2.60

CAL0002008

2.59

Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF

CAL0001534

2.59

CAL0004987

2.59

CAL0000884

2.58

Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF

CAL0006085

2.58

Uncharacterized ORF

CAL0006226

2.58

Uncharacterized ORF

CAL0004509

2.57

Uncharacterized ORF

CAL0004476

2.57

Uncharacterized ORF

CAL0001907

2.56

Uncharacterized ORF

CAL0002764

2.56

Putative ion transporter

CAL0005175

2.56

Uncharacterized ORF

CAL0004219

2.56

Putative 2-deoxyglucose-6-phosphatase

CAL0000304

2.56

Putative GPI-anchored protein

CAL0006161

2.56

Uncharacterized ORF

CAL0006370

2.55

CAL0000780

2.55

Putative transcription factor with zinc
cluster DNA-binding motif
Uncharacterized ORF

CAL0001309

2.55

Uncharacterized ORF

CAL0001898

2.55

Uncharacterized ORF

CAL0003133

2.55

B-type mitotic cyclin

CAL0001047

2.55

Uncharacterized ORF

7.84E-62
0.00768509
7.94E-07
7.74E-244
6.20E-91
1.51E-246
7.50E-98
7.77E-152
1.14E-26
2.54E-05
3.88E-120
1.67E-21
1.43E-135
1.22E-150
0.000145466
6.00E-31
3.28E-123
2.44E-11
3.19E-118
1.60E-71
1.23E-75
6.52E-109
3.73E-120
1.35E-113
1.49E-116
1.87E-197
1.13E-174
2.55E-107
2.39E-34
2.59E-261
8.30E-27
6.33E-31
1.00E-300
2.11E-55
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Table A-3 continued

Gene ID
CAL0003604

Fold upregulated
2.55

CGD annotated Function

P-value

CAL0004443

2.55

CAL0004447

2.55

Uncharacterized ORF; Hap43p-induced
gene
Secreted protein required for normal cell
wall structure
Uncharacterized ORF

1.91E-41

CAL0005563

2.54

Uncharacterized ORF

CAL0005693

2.54

Uncharacterized ORF

CAL0003608

2.54

Uncharacterized ORF

CAL0006262

2.54

Uncharacterized ORF

CAL0005544

2.54

Uncharacterized ORF

CAL0005574

2.53

Uncharacterized ORF

CAL0000712

2.53

CAL0001981

2.53

Ammonium permease and regulator of
nitrogen starvation
Uncharacterized ORF

CAL0004473

2.53

Uncharacterized ORF

CAL0005031

2.53

Uncharacterized ORF

CAL0005771

2.52

Uncharacterized ORF

CAL0003522

2.52

Dubious ORF

CAL0001415

2.52

Uncharacterized ORF

CAL0004802

2.51

CAL0002799

2.51

CAL0001431

2.51

Potential role in beta-1,6 glucan
biosynthesis
Putative vacuolar transporter of large
neutral amino acids
Putative patatin-like phospholipase

CAL0004432

2.51

Uncharacterized ORF

CAL0002507

2.51

Uncharacterized ORF

CAL0001591

2.50

Protein similar to S. cerevisiae Kar9p

CAL0006406

2.50

Uncharacterized ORF

CAL0004429

2.50

CAL0002996

2.49

N-acetylglucosamine (GlcNAc)-specific
transporter
Uncharacterized ORF

CAL0004609

2.49

CAL0000703

2.49

CAL0000402

2.49

Putative glucanase; induced during cell
wall regeneration
Uncharacterized ORF; Hap43p-repressed
gene
Putative dynamin-related GTPase

CAL0004733

2.49

Uncharacterized ORF

CAL0005604

2.49

Uncharacterized ORF

CAL0006261

2.48

Secreted aspartyl proteinase

CAL0003232

2.48

Protein kinase C

CAL0005369

2.48

Transcriptional activator

CAF0006954

2.48

Uncharacterized ORF

CAL0001744

2.48

Heat shock protein

CAL0003154

2.48

Regulator of nitrogen utilization

CAL0006027

2.48

Putative ferric reductase

CAL0000707

2.47

Uncharacterized ORF

CAL0004107

2.47

Uncharacterized ORF

1.00E-300
3.03E-08
2.35E-45
0.000497533
3.41E-215
9.63E-121
1.68E-45
1.19E-110
3.77E-30
3.94E-74
4.04E-298
7.26E-35
5.31E-45
1.33E-111
1.53E-32
7.01E-19
3.27E-61
1.00E-300
1.00E-300
6.47E-60
6.16E-34
2.61E-12
1.37E-190
5.72E-05
5.54E-24
2.80E-58
1.52E-296
5.71E-74
1.87E-44
2.56E-06
4.23E-09
2.16E-11
1.79E-30
1.00E-300
8.25E-44
4.58E-11
1.31E-18
1.00E-300
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Table A-3 continued
Gene ID
CAL0003873

Fold upregulated
2.47

CGD annotated Function

P-value

Putative adhesin-like protein

CAL0003395

2.47

CAL0004704

2.46

CAL0005204

2.45

Putative UDP glucose/starch
glucosyltransferase
Uncharacterized ORF; Hap43p-repressed
gene
Putative GPI-anchored protein

6.55E-144
3.80E-45

CAL0001161

2.45

Putative glycerol 3-P dehydrogenases)

CAL0002626

2.45

Uncharacterized ORF

CAF0006965

2.45

CAL0002283

2.45

CAL0000393

2.45

CAL0003208

2.44

Flavin-linked sulfhydryl oxidase activity
and role in cellular iron ion homeostasis
NAD(P)H oxidoreductase family protein;
induced by nitric oxide
Ortholog(s) have mitochondrion
localization
Ortholog(s) have thiol oxidase activity

CAL0004615

2.44

Srb9p transcription mediator

CAL0003229

2.44

CAL0003874

2.44

Uncharacterized ORF; Similar to Rab
GTPase
Uncharacterized ORF

CAL0001980

2.44

Uncharacterized ORF

CAL0003844

2.44

Putative RNA-binding protein

CAL0003011

2.44

CAL0005953

2.43

Uncharacterized ORF; Ortholog(s) have
phosphatidylserine decarboxylase
activity,
Putative class III aminotransferase

CAL0003062

2.43

Plasma membrane-localized protein

CAL0001158

2.43

Aldo-keto reductase family member

CAL0000894

2.42

Probable protein kinase

CAL0003267

2.42

Uncharacterized ORF

CAL0002010

2.42

Putative mitochondrial respiratory protein

CAL0000008

2.42

Uncharacterized ORF

CAL0002917

2.41

Uncharacterized ORF

CAL0000997

2.41

Uncharacterized ORF

CAL0005126

2.41

Putative mitochondrial RNA polymerase

CAL0006340

2.41

CAL0004070

2.40

CAL0002453

2.40

Putative transcription factor with a role in
colony morphology
Putative thiamin-phosphate
pyrophosphorylase
Putative phosphatidylinositol kinase

CAL0002529

2.40

CAL0005002

2.40

CAL0002087

2.40

CAL0005933

2.39

CAL0000530

2.39

structural constituent of ribosome and
localizes to mitochondrial small ribosomal
subunit
Putative beta-mannosyltransferase,

CAL0005365

2.39

Putative RNA-binding protein

CAL0004261

2.38

Uncharacterized ORF

Cell wall adhesin-like protein;repressed
by Rim101p
Sef1p-, Sfu1p-, and Hap43p regulated
gene
Uncharacterized ORF

1.60E-07
1.35E-35
1.00E-300
0.000985931
6.24E-111
3.37E-41
8.65E-38
4.77E-124
1.43E-18
3.84E-32
1.51E-23
3.86E-88
9.35E-124
1.24E-108
7.43E-07
5.53E-84
1.57E-36
6.32E-176
2.20E-48
8.89E-50
1.58E-64
1.66E-235
7.80E-22
1.00E-300
1.64E-52
2.74E-29
7.28E-111
3.68E-36
1.67E-05
7.42E-10
1.00E-300
5.53E-124
3.78E-128
3.31E-29
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Table A-3 continued

Gene ID
CAL0005727

Fold upregulated
2.38

CGD annotated Function

P-value

Regulated by Sef1p-, Sfu1p-, and
Hap43p
Putative translation initiation factor

2.17E-124

CAL0003673

2.38

CAL0003274

2.38

CAL0005434

2.38

CAL0003363

2.37

CAL0005212

2.37

Putative Rho1p GTPase activating
protein
Ortholog(s) have phosphatidylinositol-4phosphate phosphatase activity
Uncharacterized ORF; Putative fungalspecific transmembrane protein
Putative patatin-like phospholipase

CAL0005009

2.37

Uncharacterized ORF

CAL0002807

2.36

Uncharacterized ORF

CAL0004422

2.36

Uncharacterized ORF

CAL0003054

2.36

CAL0005800

2.36

Putative cell wall protein, member of the
CRH family
Uncharacterized ORF

CAL0005015

2.36

CAL0000621

2.35

Putative serine/threonine/tyrosine (dualspecificity) kinase
Putative processing peptidase

CAL0005588

2.35

Uncharacterized ORF

CAL0003243

2.35

CAL0004910

2.35

CAL0002160

2.35

CAL0004555

2.35

CAL0005224

2.34

Imidazoleglycerol-phosphate
dehydratase
Protein involved in sphingolipid
biosynthesis
Protein similar to asparagine and
glutamine permease
Putative transcription factor with zinc
cluster DNA-binding motif
ERK-family protein kinase

CAL0002154

2.34

Uncharacterized ORF

CAL0120529

2.34

Uncharacterized ORF

CAL0005343

2.34

CAF0007423

2.34

involved in ubiquitin-mediated protein
degradation
Rho GTPase activator activity

CAL0005683

2.34

CAL0005653

2.34

CAL0004518

2.34

CAL0002941

2.33

CAL0003907

2.33

CAL0006309

2.33

CAL0004511

2.33

Uncharacterized ORF;regulated upon
white-opaque switching
Protein with a Gal4p-like DNA-binding
domain
Putative oxidoreductas

CAL0003712

2.33

Uncharacterized ORF

CAL0002210

2.33

Uncharacterized ORF

CAL0001069

2.33

CAL0001600

2.32

Putative membrane protein with a
predicted role in membrane fusion during
mating
Protein involved in heme uptake

Verified ORF;mutation affects filamentous
growth
Protein mannosyltransferase
Ortholog(s) have poly(A)-specific
ribonuclease activity
Uncharacterized ORF

1.61E-49
9.53E-133
1.48E-157
1.00E-300
1.45E-19
1.19E-33
8.61E-52
1.00E-300
5.91E-52
6.64E-06
2.13E-111
7.39E-147
3.04E-50
2.81E-33
4.97E-111
1.00E-300
1.34E-42
3.82E-89
2.07E-15
0.285184
3.73E-263
1.00E-300
1.53E-14
1.00E-300
3.47E-198
5.21E-34
2.41E-65
3.88E-139
1.00E-300
2.61E-294
1.91E-13
3.61E-20
2.22E-134
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Table A-3 continued

Gene ID
CAL0001725

Fold upregulated
2.32

CGD annotated Function

P-value

CAL0004577

2.32

CAL0005580

2.31

CAL0001210

2.31

Putative protein kinase with a role in cell
wall regulation
Protein involved in synthesis of the
thiamine precursor
hydroxymethylpyrimidine
Role in manganese ion transport and
mitochondrion localization
Putative phosphoglycerate mutas

1.45E-82

CAL0002602

2.31

Uncharacterized ORF

CAL0002765

2.31

CAL0000064

2.31

CAL0005516

2.30

Protein with a predicted role in docking
and fusion of post-Golgi vesicles with the
plasma membrane
Required for homologous DNA
recombination
Possible regulatory protein

CAL0000818

2.30

Uncharacterized ORF

CAL0003539

2.30

Dubious ORF

CAL0000429

2.30

Uncharacterized ORF

CAL0003065

2.30

3-hydroxyacyl-CoA epimerase

CAL0001565

2.30

Putative cytochrome b2 precursor protein

CAL0006330

2.30

Uncharacterized ORF

CAL0005320

2.29

Uncharacterized ORF

CAL0006120

2.29

Uncharacterized ORF

CAL0000099

2.29

Protein similar to Yta6p ATPase

CAL0002790

2.29

Uncharacterized ORF

CAL0005497

2.29

Uncharacterized ORF

CAL0002655

2.29

Uncharacterized ORF

CAL0005239

2.29

Uncharacterized ORF

CAL0000417

2.29

CAL0000807

2.29

CAL0000816

2.29

Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF; Putative adhesinlike protein
Putative tRNA-Pro synthetase

CAL0004665

2.28

Uncharacterized ORF

CAL0001498

2.28

CAL0000139

2.28

Putative glucose transporter of the major
facilitator superfamily
Uncharacterized ORF

CAL0003557

2.28

CAL0002003

2.28

CAL0001629

2.27

Putative enzyme with predicted indole-3glycerol-phosphate synthase
Putative vacuolar transporter of large
neutral amino acids
Uncharacterized ORF

CAL0005560

2.27

Protein mannosyltransferase

CAL0006399

2.27

Uncharacterized ORF

CAL0001441

2.27

ALS family cell-surface glycoprotein

CAL0004068

2.27

CAL0001828

2.26

Uncharacterized ORF; mitochondrion
localization
Heat shock protein

CAF0006969

2.26

Gene induced by hypoxia

1.00E-300
2.69E-72
3.16E-222
1.00E-300
8.20E-174
1.54E-62
1.29E-89
1.00E-300
1.07E-93
2.80E-37
3.11E-113
4.50E-37
2.44E-07
4.00E-16
1.44E-70
3.99E-76
1.16E-269
1.96E-51
0.000290448
2.46E-46
9.40E-69
1.53E-27
2.46E-235
1.00E-300
1.19E-22
7.93E-42
8.74E-61
1.08E-47
1.05E-20
1.00E-300
2.06E-39
2.72E-34
4.63E-142
1.00E-300
5.23E-55
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Table A-3 continued
Gene ID
CAL0006390

Fold upregulated
2.26

CGD annotated Functon

P-value

CAL0001098

2.26

Uncharacterized ORF; Hap43p-induced
gene
Uncharacterized ORF

7.66E-59

CAL0000244

2.25

Putative oligopeptide transporter

CAL0003239

2.25

CAL0005620

2.25

Uncharacterized ORF; Hap43p-induced
gene; induced upon biofilm formation
Uncharacterized ORF

CAL0003766

2.25

Uncharacterized ORF

CAL0005021

2.25

CAL0003571

2.25

Putative glucose transporter of the major
facilitator superfamily;
Putative sphingosine kinase

CAL0001179

2.25

CAL0001213

2.25

CAL0000075

2.25

CAL0005852

2.25

Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF; Putative
serine/threonine protein kinase
Similar to S. cerevisiae Afg3p, a subunit
of the mitochondrial inner membrane mAAA protease
Uncharacterized ORF

CAL0001131

2.24

Uncharacterized ORF

CAL0005119

2.24

Late-stage biofilm-induced gene

CAL0002530

2.24

Uncharacterized ORF

CAL0002548

2.24

CAL0005698

2.24

Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF

CAL0005471

2.24

Uncharacterized ORF

CAL0004790

2.24

Uncharacterized ORF

CAL0002761

2.24

Uncharacterized ORF

CAL0003737

2.24

Uncharacterized ORF

CAL0001944

2.24

Uncharacterized ORF

CAL0006276

2.23

CAL0003151

2.23

CAL0002954

2.23

role in mitochondrial translation and
mitochondrion localization
Putative oxidized purine base lesion DNA
N-glycosylase activity
Putative GTPase-activating protein

CAL0005141

2.23

CAL0004072

2.23

CAF0006932

2.22

CAL0004575

2.22

Putative copper metallochaperone;
Hap43p-repressed gene
Uncharacterized ORF

CAL0004606

2.22

Predicted membrane transporter

CAL0000789

2.22

Uncharacterized ORF

CAL0004832

2.22

CAL0004600

2.22

CAL0004042

2.21

Ortholog(s) have ATP-dependent RNA
helicase activity
Uncharacterized ORF; Adenine
phosphoribosyltransferase; flucytosine
induced; repressed by nitric oxide; protein
level decreased in stationary phase yeast
cultures
Putative type-1 protein phosphatase
targeting subunit

Ortholog(s) have protein kinase regulator
activity
Uncharacterized ORF

3.11E-17
1.00E-300
5.71E-114
1.76E-06
3.24E-92
7.93E-28
6.49E-19
1.64E-112
4.63E-78
1.00E-300
4.23E-88
8.23E-47
8.70E-19
7.17E-22
9.91E-111
9.99E-29
1.49E-41
1.35E-09
4.01E-156
1.00E-300
5.76E-24
1.00E-300
0.00207077
1.00E-300
6.25E-37
2.24E-07
3.27E-44
1.40E-253
3.65E-30
4.27E-07
8.53E-141
1.46E-43

2.98E-57
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Table A-3 continued
Gene ID

CGD annotated Function

P-value

CAL0006244

Fold upregulated
2.21

Uncharacterized ORF

CAL0003485

2.21

Uncharacterized ORF

CAL0005202

2.21

Putative pyruvate decarboxylase

CAL0006036

2.20

CAL0002245

2.20

Putative dicarboxylic amino acid
permease
Ribonucleoside-diphosphate reductase

4.31E-26
2.11E-45
1.00E-300
1.00E-300

CAL0004789

2.20

Uncharacterized ORF

CAL0000249

2.20

CAL0005453

2.20

CAL0003949

2.20

Uncharacterized ORF; Predicted zincfinger protein
Ortholog(s) have metalloendopeptidase
activity
Uncharacterized ORF

CAL0004457

2.20

CAL0004587

2.20

CAL0002979

2.20

CAL0003016

2.20

CAL0003838

2.19

CAL0003199

2.19

CAL0005655

2.19

CAL0003178

2.19

Uncharacterized ORF; Hap43p-induced
gene
Uncharacterized ORF

CAL0006182

2.19

Uncharacterized ORF

CAL0002565

2.19

Putative biotin synthase

CAL0005976

2.19

CAL0002649

2.19

Uncharacterized ORF; Protein similar to
DNA helicase
Uncharacterized ORF

CAL0005517

2.19

CAL0001427

2.19

Uncharacterized ORF; Hap43p-repressed
gene
Putative Arf3p GTPase activating protein

CAL0002041

2.18

Secreted aspartyl protease

CAL0002725

2.18

Uncharacterized ORF

CAL0003641

2.18

Uncharacterized ORF

CAL0005854

2.18

CAL0001120

2.18

CAL0002025

2.18

CAL0004709

2.18

CAL0005745

2.18

Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF; Hap43p-repressed
gene
Protein involved in proteolytic activation
of Rim101p
Protein with predicted role in beta-1,6glucan synthesis
Putative PDR-subfamily ABC transporter

CAL0001297

2.18

Uncharacterized ORF

CAL0001575

2.18

CAL0001136

2.18

Putative termination and polyadenylation
protein
Putative mitochondrial carrier protein

CAL0005112

2.18

CAL0003852

2.18

Copper- and zinc-containing superoxide
dismutase
Uncharacterized ORF
Protein involved in the negative control of
pseudohyphal growth
Protein with role in resistance to host
antimicrobial peptides
Putative RSC chromatin remodeling
complex component
Cytosolic chaperonin Cct ring complex

Member of a family encoded by FGR6related genes
Uncharacterized ORF

1.00E-300
1.04E-18
1.99E-07
1.43E-159
1.56E-161
1.62E-146
1.00E-300
2.05E-139
1.00E-300
5.64E-65
4.33E-32
6.02E-13
3.17E-17
1.96E-58
1.03E-14
1.03E-36
1.52E-22
1.46E-112
6.30E-71
1.61E-12
3.33E-17
1.00E-300
3.99E-210
3.22E-53
4.85E-38
4.43E-63
4.63E-95
0.00081435
1.01E-158
1.00E-300
8.41E-13
3.17E-13
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Table A-3 continued
Gene ID
CAL0000385

Fold upregulated
2.18

CGD annotated Function

P-value

oxidoreductase activity, role in
cytochrome c-heme linkage,
mitochondrial membrane organization
and extrinsic to mitochondrial inner
membrane localization
Verified ORF; Putative RNA helicase

6.79E-92

CAL0006152

2.17

CAL0004999

2.17

CAL0120801

2.17

CAL0004816

2.17

CAL0002229

2.16

Ortholog(s) have DNA-directed DNA
polymerase activity mitochondrion,
nuclear chromatin localization
Uncharacterized ORF

CAL0005461

2.16

Uncharacterized ORF

CAL0005737

2.16

CAL0002777

2.16

Ortholog(s) have ubiquitin-specific
protease activity
Putative secreted aspartyl protease

CAL0003073

2.16

CAL0002942

2.16

CAL0004311

2.15

Uncharacterized ORF; induced by nitric
oxide
Putative GTPase-activating protein (GAP)
for Rho-type GTPase Cdc42p
Predicted ribosomal protein

CAL0000861

2.15

Putative GINS complex subunit

CAL0003131

2.15

Uncharacterized ORF

CAL0000137

2.15

Uncharacterized ORF

CAL0000012

2.14

Uncharacterized ORF

CAL0000489

2.14

Uncharacterized ORF

CAL0003370

2.14

Cell wall protein

CAL0003919

2.14

CAF0007419

2.14

Ortholog(s) have role in ubiquinone
biosynthetic process, aerobic respiration
and mitochondrial inner membrane
Putative adhesin-like protein

CAL0000184

2.14

CAL0001237

2.14

Protein lacking an ortholog in S.
cerevisiae; transposon mutation affects
filamentous growth
Uncharacterized ORF

CAL0005436

2.14

VH1 family MAPK phosphatase

CAL0004905

2.13

CAL0000235

2.13

Putative GPI-anchored adhesin-like
protein
Monooxygenase of the cytochrome P450

CAL0000885

2.13

Uncharacterized ORF

CAL0000116

2.13

Uncharacterized ORF

CAL0003638

2.13

Uncharacterized ORF

CAL0001553

2.13

Cell wall protein; putative GPI-anchor

CAL0004810

2.13

Uncharacterized ORF

CAL0005353

2.13

CAL0005948

2.12

Malate synthase; glyoxylate cycle
enzyme
Uncharacterized ORF

CAL0120947

2.12

Uncharacterized ORF

mRNA binding activity, role in
mitochondrion organization
Uncharacterized ORF

9.78E-45
8.60E-12
8.90E-114
3.39E-29
2.29E-11
1.00E-300
9.93E-127
0.000631581
5.01E-06
1.03E-132
2.58E-35
7.61E-10
1.14E-142
1.28E-64
2.54E-05
1.83E-31
7.77E-39
6.49E-170
5.21E-33
3.69E-106
1.75E-11
8.33E-39
2.55E-20
6.85E-09
2.79E-22
1.00E-300
7.40E-116
9.41E-211
1.49E-217
3.47E-144
1.00E-11
0.130919
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Table A-3 continued
Gene ID
CAL0001758

Fold upregulated
2.12

CGD annotated Function

P-value

Putative methionyl-tRNA transformylase

CAL0001396

2.12

Predicted acyl-CoA oxidase

1.49E-39
9.03E-36
6.11E-11
4.89E-236

CAL0003804

2.12

Uncharacterized ORF

CAL0002434

2.12

CAL0005443

2.12

Plasma membrane, hyphal cell wall
protein
Uncharacterized ORF

CAL0001496

2.12

Uncharacterized ORF

CAL0000122

2.12

Uncharacterized ORF

CAL0000180

2.11

CAL0005908

2.11

CAL0002933

2.11

Uncharacterized ORF; Putative mRNA
maturation factor
Uncharacterized ORF; Hap43p-repressed
gene
Transcriptional repressor

CAL0001799

2.11

Putative Rho GTPase activating protein

CAL0005187

2.11

Heme oxygenase

CAL0006202

2.11

CAL0004874

2.11

CAL0005238

2.11

Uncharacterized ORF; Putative MFS
transporter
Uncharacterized ORF; Hap43p-repressed
gene
Uncharacterized ORF

CAL0000305

2.11

Putative allantoate permease

CAL0003619

2.11

Uncharacterized ORF

CAL0005019

2.11

Uncharacterized ORF

CAL0003351

2.11

Uncharacterized ORF

CAL0002509

2.11

Alcohol dehydrogenase

CAL0003264

2.10

CAL0003448

2.10

CAL0006303

2.10

Putative histone acetyltransferase
complex subunit
Voltage-gated Ca2+ channel of the
calcium uptake system;
Uncharacterized ORF

CAL0004451

2.10

CAL0001139

2.10

CAL0002621

2.105

Cell wall adhesin required for cell-cell
adhesion, GPI anchored
Uncharacterized ORF
Protein similar to S. cerevisiae Bck1p
MAP kinase kinase kinase of cell integrity
pathway
Subunit of beta-1,3-glucan synthase

CAL0005999

2.10

CAL0005832

2.103

Uncharacterized ORF

CAL0003148

2.10

Uncharacterized ORF

CAL0001560

2.10

Uncharacterized ORF

CAL0000729

2.10

Uncharacterized ORF

CAL0001943

2.10

Uncharacterized ORF

CAL0005421

2.10

ALS family protein

CAL0000198

2.09

Uncharacterized ORF; Hexokinase II

CAL0004675

2.09

Uncharacterized ORF

CAL0002088

2.09

Uncharacterized ORF

CAL0004157

2.09

Uncharacterized ORF

CAL0000038

2.09

Uncharacterized ORF

1.72E-152
1.05E-52
1.48E-128
8.06E-242
2.41E-46
2.00E-19
1.52E-202
3.10E-129
6.17E-15
2.14E-24
2.71E-20
2.42E-17
1.00E-300
1.82E-23
1.00E-300
7.64E-267
1.00E-300
9.05E-43
1.64E-21
5.41E-50
1.11E-28
6.08E-40
1.00E-300
6.30E-05
3.07E-83
8.95E-101
5.16E-61
4.02E-31
1.29E-24
1.00E-300
2.44E-26
4.58E-15
1.55E-73
2.01E-72
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Table A-3 continued

Gene ID
CAL0005977

Fold upregulated
2.09

CGD annotated Function

P-value

Pyruvate kinase

CAL0000651

2.09

Uncharacterized ORF; Hap43p-repressed

1.00E-300
1.02E-170
1.50E-19

CAL0003413

2.08

CAL0002370

2.08

CAL0005685

2.08

Uncharacterized ORF; histone
demethylase activity
Role in heme a biosynthetic process and
mitochondrion localization
C-14 sterol reductase

CAL0003516

2.08

Uncharacterized ORF

CAL0000518

2.08

Uncharacterized ORF

CAL0003880

2.08

CAL0003394

2.08

Transcription factor involved in alkaline
pH response
Dubious ORF

CAL0003139

2.08

Uncharacterized ORF

CAL0000858

2.07

Uncharacterized ORF

CAL0000614

2.07

Ferric reductase

CAL0001626

2.07

Uncharacterized ORF

CAL0006048

2.07

Uncharacterized ORF

CAL0003728

2.07

Uncharacterized ORF

CAL0000438

2.07

Uncharacterized ORF

CAL0005901

2.07

CAL0005404

2.07

CAL0001834

2.07

Glucosaminyl-phosphotidylinositol Oacyltransferase activity
Phosphatidylinositol 3-phosphate 5kinase
Uncharacterized ORF

CAL0004653

2.07

Uncharacterized ORF

CAL0002276

2.07

CAL0004490

2.07

CAL0002184

2.07

CAL0004695

2.07

Uncharacterized ORF; Putative glycerol3-phosphate acyltransferase; fungalspecific (no human or murine homolog)
Uncharacterized ORF; Hap43p-repressed
gene
Putative glucose-6-phosphate isomerase,
enzyme of glycolysis;
Uncharacterized ORF

CAL0000445

2.07

Uncharacterized ORF

CAL0005341

2.06

CAL0001865

2.06

CAL0005273

2.06

Uncharacterized ORF; Hap43p-repressed
gene
Putative mitochondrial large subunit
ribosomal protein
Uncharacterized ORF

CAL0001902

2.06

CAL0004450

2.06

Putative Golgi alpha-1,2mannosyltransferase
Uncharacterized ORF

CAL0004425

2.06

Uncharacterized ORF

CAL0003326

2.06

Uncharacterized ORF

CAL0003492

2.06

Uncharacterized ORF

CAL0000052

2.06

Uncharacterized ORF

CAL0003572

2.06

CAL0006266

2.06

Uncharacterized ORF;induced by nitric
oxide
Uncharacterized ORF; oxidoreductase

CAL0002993

2.06

Possible oxidoreductase

6.82E-199
6.75E-140
1.12E-82
1.36E-261
8.70E-12
1.00E-300
4.73E-58
1.11E-05
2.43E-05
5.49E-31
1.90E-64
8.55E-87
4.57E-18
9.11E-65
1.79E-64
3.43E-91
3.25E-192
1.77E-70
1.01E-149
1.00E-300
3.71E-52
4.65E-49
3.07E-110
6.62E-93
2.78E-38
7.80E-141
2.18E-38
7.10E-51
1.08E-37
4.56E-47
1.86E-211
1.64E-15
1.82E-39
1.51E-05
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Table A-3 continued
Gene ID
CAL0001941

Fold upregulated
2.05

CGD annotated Function

P-value

CAL0003528

2.05

Uncharacterized ORF; Putative golgi
GTPase-activating protein
Uncharacterized ORF

1.49E-108

CAL0006090

2.05

Uncharacterized ORF

CAL0002950

2.05

CAL0004580

2.05

Uncharacterized ORF; Ortholog(s) have
peptidase activity
Protein with a role in phosphate transport

CAL0004949

2.05

Protein similar to S. cerevisiae Ecm29p

CAF0006924

2.05

Uncharacterized ORF

CAL0005656

2.05

CAL0001630

2.05

CAL0004808

2.05

CAL0002479

2.05

Uncharacterized ORF; Putative
proteinase
Putative transcription factor with zinc
finger DNA-binding motif
protein involved in regulation of SCF
complex
Uncharacterized ORF

CAL0005679

2.05

CAL0004963

2.04

Uncharacterized ORF; Ortholog of <i>C.
glabrata CBS138</i> : CAGL0L12628g
Uncharacterized ORF

CAL0000444

2.04

Uncharacterized ORF

CAL0002334

2.04

Putative RNA binding protein

CAL0006143

2.04

Predicted membrane transporter,

CAL0001524

2.04

Ribonucleotide reductase large subunit;

CAL0005233

2.04

CAL0005308

2.04

CAL0001752

2.04

Protein involved in the pH response
pathway;
Scaffold protein for the mitogen-activated
protein (MAP) kinase
Uncharacterized ORF

CAL0004037

2.04

Protein with putative zinc finger

CAL0006311

2.04

Uncharacterized ORF

CAL0000549

2.04

Uncharacterized ORF

CAL0002936

2.040

CAL0005024

2.03

CAL0005328

2.03

Major carnitine acetyl transferase
localized in peroxisomes and
mitochondria
Lysine histone methyltransferase;
methylates K4 of histone H3
Uncharacterized ORF

CAL0005010

2.03

Hyphal growth regulator

CAL0004775

2.03

Adhesin-like protein;Rim101p-repressed

CAL0003640

2.03

CAL0000583

2.03

Putative high affinity methionine
permease; upregulated by Rim101p
Putative 1,4-glucan branching enzyme

CAL0002321

2.03

Uncharacterized ORF

CAL0000547

2.029

Uncharacterized ORF

CAF0006896

2.028

Ribosomal protein S27

CAL0003161

2.028

CAL0000141

2.025

Uncharacterized ORF; Hap43p-induced
gene
Predicted zinc-finger protein

CAL0005260

2.023

Putative kynurenine 3-monooxygenase

2.80E-127
2.07E-18
1.00E-300
1.00E-300
2.72E-153
2.38E-33
1.00E-300
4.07E-34
9.38E-104
0.00195682
5.77E-37
3.51E-05
1.00E-300
4.85E-28
8.71E-25
1.00E-300
2.73E-34
1.88E-16
1.28E-12
1.09E-10
6.91E-48
3.21E-223
3.79E-151
1.06E-42
2.32E-56
1.00E-300
3.27E-142
5.61E-242
2.71E-240
1.47E-29
1.68E-10
4.73E-14
3.42E-34
5.33E-61
3.36E-206
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Table A-3 continued
Gene ID
CAL0005696

Fold upregulated
2.022

CGD annotated Function

P-value

Uncharacterized ORF

CAL0004102

2.021

Uncharacterized ORF

6.75E-137
9.82E-89
1.57E-28

CAL0004468

2.021

CAL0002900

2.020

CAL0001871

2.020

Uncharacterized ORF; Putative
transcription factor with zinc finger DNAbinding motif
Essential protein involved in endocytosis
and polarized growth;
Uncharacterized ORF

CAL0004405

2.019

Uncharacterized ORF

CAL0003306

2.018

Putative ribosomal protein;

CAL0000720

2.018

Uncharacterized ORF

CAL0004028

2.017

Sphingolipid delta-8 desaturase

CAL0003072

2.017

CAL0003196

2.017

Predicted subunit of the exocyst
complex,
Uncharacterized ORF

CAL0003800

2.016

Carboxypeptidase Y

CAL0002787

2.015

Uncharacterized ORF

CAL0003545

2.015

Uncharacterized ORF

CAL0001802

2.014

Uncharacterized ORF

CAL0003613

2.014

Uncharacterized ORF

CAL0002988

2.014

Uncharacterized ORF

CAL0002002

2.011

Glycosidase of cell surface

CAL0002890

2.010

Uncharacterized ORF

CAL0002238

2.010

Uncharacterized ORF

CAL0000516

2.009

Putative glutamate synthase

CAF0006928

2.009

Uncharacterized ORF

CAL0005962

2.009

Uncharacterized ORF; hypoxia induced

CAL0003703

2.008

CAL0120967

2.008

Uncharacterized ORF; role in
mitochondrial translational termination
and mitochondrion localization
Uncharacterized ORF

CAL0003185

2.006

CAL0000015

2.005

Master regulator (activator) of a-type
mating
Uncharacterized ORF

CAL0004900

2.004

Uncharacterized ORF

CAL0000796

2.004

Uncharacterized ORF t

CAL0000004

2.004

Uncharacterized ORF

CAL0003029

2.000

Protein similar to S. cerevisiae Cdc20p

1.00E-300
1.00E-300
6.18E-173
2.59E-83
1.50E-270
4.87E-184
1.01E-44
8.16E-177
4.03E-110
1.71E-53
2.43E-87
6.95E-24
1.03E-25
4.25E-63
1.00E-300
4.98E-24
5.74E-08
1.00E-300
3.06E-12
1.29E-97
0.0019543
0.000246561
1.45E-42
7.82E-115
3.35E-09
1.72E-65
1.66E-80
1.09E-52

123

Table A-4: List of all the genes down-regulated in the cho1∆/∆ mutant compared to the
wild-type strain

CAL0003238

Fold
downregulated
2.01

CAL0003246

2.02

CAL0004170

2.02

Ortholog(s) have role in protein import into mitochondrial outer
membrane,phospholipid transport, mitochondrial outer membrane
translocase complex assembly
GPI-anchored cell wall transglycosylase

CAL0001598

2.02

Uncharacterized ORF

CAL0005139

2.02

Uncharacterized ORF; Hap43p-repressed gene

CAL0001250

2.05

Uncharacterized ORF

CAL0000435

2.08

Putative 30 kda heat shock protein

CAL0000520

2.08

CAL0001881

2.08

Protein with homology to peroxisomal membrane proteins; Sef1p-,
Sfu1p-, and Hap43p-regulated gene
Putative heme-binding stress-related protein

CAL0005617

2.09

Uncharacterized ORF

CAL0004738

2.11

Uncharacterized ORF; regulated by Sef1p-, Sfu1p-, and Hap43p

CAL0005454

2.12

Putative mitochondrial inner membrane transporter

CAL0000815

2.14

Uncharacterized ORF

CAL0003028

2.17

Uncharacterized ORF

CAL0003510

2.17

Putative 3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity

CAL0001041

2.17

Uncharacterized ORF

CAL0004846

2.18

Uncharacterized ORF; Hap43p-induced gene

CAL0005956

2.18

Dubious ORF

CAL0004997

2.19

Uncharacterized ORF

CAL0000267

2.23

Putative nucleolar protein

CAL0002986

2.23

Ferric reductase

CAL0004548

2.24

Uncharacterized ORF

CAL0004552

2.25

Alternative oxidase

CAL0002995

2.25

Transcriptional repressor

CAF0006908

2.26

Hap43p-repressed gene; hypoxia downregulated

CAL0000921

2.26

Putative RNase MRP and nuclear RNase P component

CAL0004612

2.28

Uncharacterized ORF

CAL0004328

2.28

Uncharacterized ORF; Protein not essential for viability

CAL0005065

2.28

Putative nucleolar protein with role in ribosomal assembly

CAL0003742

2.29

a ubiquitin hydrolase

CAL0002023

2.31

Ortholog(s) have telomerase inhibitor activity

CAL0001782

2.32

Putative inducible acid phosphatase

CAL0001718

2.34

Secreted protein

CAL0002504

2.38

Uncharacterized ORF

Gene ID

Function

Putative dihydrolipoamide acetyltransferase

P-value
7.16E-70
1.25E-36
6.84E-50
5.01E-142
1.00E-300
1.34E-110
1.16E-69
2.47E-18
4.04E-190
1.00E-300
1.27E-63
2.20E-92
2.36E-46
0.0472951
0.000408543
4.30E-185
7.94E-147
2.72E-36
4.67E-247
1.37E-61
1.96E-11
1.00E-300
3.08E-22
6.36E-288
1.50E-57
5.43E-83
0.0411878
2.06E-55
6.46E-49
1.97E-07
4.97E-130
1.00E-300
6.49E-176
4.78E-108
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Table A-4 continued

CAL0003860

Fold
downregulated
2.38

CAL0001507

2.46

Putative transcription factor with bZIP DNA-binding motif

CAL0001053

2.47

Putative nucleolar protein

CAL0005460

2.48

Putative ATP-dependent DEAD-box RNA helicase

CAL0003683

2.50

CAL0000014

2.52

Ortholog(s) have phosphatidylinositol-3-phosphate binding,
phosphatidylinositol-5-phosphate binding activity
Uncharacterized ORF; Hap43p-induced gene

CAL0000479

2.56

Uncharacterized ORF; Ortholog(s) have rRNA binding activity

CAL0006057

2.57

Putative constituent of 66S pre-ribosomal particles

CAL0004872

2.58

Uncharacterized ORF

CAL0000754

2.65

Putative zinc finger transcription factor

CAL0002350

2.68

Response regulator of a two-component system involved in stress

CAL0001258

2.69

Uncharacterized ORF; Hap43p-induced gene

CAL0002743

2.74

Similar to catabolic serine/threonine dehydratases;

CAL0003582

2.78

CAL0002189

2.89

Putative RNA polymerase III transcription initiation factor complex
subunit
Uncharacterized ORF

CAL0001847

2.92

Protein of unknown function; Plc1p-regulated

CAL0006076

2.93

Uncharacterized ORF

CAL0005712

2.96

Uncharacterized ORF

CAL0001467

3.00

Glycerol permease involved in glycerol uptake

CAL0006301

3.05

Dubious ORF

CAF0007089

3.08

Ortholog(s) have electron carrier activity

CAL0001013

3.12

Uncharacterized ORF; Biofilm-induced gene

CAL0120807

3.14

Putative adhesin-like protein

CAL0005860

3.15

Predicted hydrolase activity

CAL0003136

3.35

Ortholog(s) have role in cytoplasmic translation

CAL0003776

3.43

Cell wall protein

CAL0004550

3.87

Alternative oxidase

CAL0000982

3.89

Formate dehydrogenase

CAL0004487

4.02

CAL0000550

5.15

Putative cytosolic iron-sulfur (FeS) protein assembly machinery
protein; induced by nitric oxide
Glycerophosphoinositol permease

CAL0003313

5.23

Putative TFIID and SAGA complex subunit

CAL0005695

5.88

Uncharacterized ORF

CAL0001883

7.40

Uncharacterized ORF

CAL0120803

7.86

Uncharacterized ORF

CAL0000501

8.37

Putative potassium transporter

CAL0005929

8.61

Putative oxidoreductase

CAL0002987

9.03

Putative oxidoreductase, iron utilization

CAL0000931

20.80

Gene ID

Function

Uncharacterized ORF

Uncharacterized ORFe

P-value
2.32E-27
3.74E-196
6.97E-130
4.05E-67
3.75E-14
1.06E-62
8.11E-67
1.08E-144
1.08E-144
2.91E-29
7.32E-220
3.48E-27
2.69E-268
1.84E-38
9.61E-20
1.20E-08
7.76E-81
1.76E-42
3.86E-41
1.01E-163
1.56E-27
2.24E-174
8.61E-11
1.00E-209
4.70E-19
1.66E-113
0.000190087
2.04E-207
8.97E-156
1.03E-78
1.00E-300
1.01E-129
1.00E-300
1.00E-300
3.25E-32
2.22E-62
6.73E-43
4.50E-153
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Table A-5: List of all the genes up-regulated in the psd1∆/∆psd2∆/∆ mutant compared to
the wild-type strain
Gene ID
CAL0002907

Fold upregulated
17.62

Function

CAL0004215

14.21

Putative tRNA splicing endonuclease subunit; Hap43p-induced

CAL0004374

11.99

NADP-glutamate dehydrogenase

CAL0004601

9.51

Uncharacterized ORF; Ortholog(s) have cytosol localization

CAL0001974

9.22

Urea amidolyase

CAL0005400

9.14

Protein similar to S. cerevisiae Hcm1p; Hap43p-induced gene

CAL0002939

8.90

UDP-glucose:ceramide glucosyltransferase

CAL0000318

8.83

Uncharacterized ORF; Hap43p-induced gene

CAL0002632

8.53

Verified ORF; G1 cyclin

CAL0000377

8.33

Uncharacterized ORF; Planktonic growth-induced gene

CAL0004068

8.12

High affinity spermidine transporter

CAL0004528

7.71

Putative transporter

CAL0001357

7.54

Uncharacterized ORF

CAL0003064

7.45

Uncharacterized ORF

CAL0003075

7.42

Dubious ORF

CAL0000215

7.18

Inositol-1-phosphate synthase; inositol biosynthesis

CAL0002798

7.00

Uncharacterized ORF

CAL0004602

6.93

Putative transporter

CAL0000494

6.79

Essential protein involved in cytokinesis

CAL0003463

6.78

Uncharacterized ORF; Cyclin homolog

CAL0003477

6.47

Uncharacterized ORF

CAL0005136

6.34

Putative transcription factor; oxidative stress-induced

CAL0004833

6.31

Uncharacterized ORF; mitochondrion localization

CAL0000998

6.30

Uncharacterized ORF

CAL0001407

6.25

Putative DNA-binding transcription factor

CAF0007042

6.09

Uncharacterized ORF

CAL0004275

6.08

Uncharacterized ORF; Hap43p-repressed gene

CAL0004519

6.06

Putative GPI-anchored cell wall adhesin-like protein

CAL0003555

5.77

Putative ATP-binding protein with a predicted role in DNA replication

CAL0000707

5.77

Uncharacterized ORF; Ortholog of <i>S. cerevisiae</i> : PRM5

CAL0000371

5.74

CAL0002531

5.70

Predicted membrane transporter; member of the proton coupled
folate transporter/heme carrier protein (PCFT/HCP) family
Putative adhesin-like protein

CAL0120975

5.66

Uncharacterized ORF

CAL0005322

5.65

Uncharacterized ORF

CAL0000344

5.54

CAL0004436

5.50

Ortholog(s) have exoribonuclease II activity, role in RNA catabolic
process and mitochondrial matrix localization
Putative DEAD-box protein required for efficient splicing of
mitochondrial Group I and II introns; Hap43p-induced gene

Putative phosphomethylpyrimidine kinase

P-value

1.00E-300
3.01E-261
1.00E-300
1.82E-32
1.00E-300
2.20E-88
4.54E-108
1.00E-300
1.63E-259
2.44E-16
1.00E-300
6.72E-143
1.00E-300
4.01E-127
7.39E-12
8.84E-59
7.71E-30
1.94E-98
1.73E-55
3.41E-73
1.23E-58
1.00E-300
1.00E-300
1.00E-300
3.81E-42
4.64E-14
4.37E-12
1.00E-300
2.47E-89
1.91E-79
1.90E-70
1.00E-300
3.44E-155
8.14E-07
2.00E-218
1.00E-300
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Table A-5 continued

Gene ID
CAL0000259

Fold upregulated
5.40

Function

CAL0005923

5.36

Uncharacterized ORF

CAL0003499

5.30

Uncharacterized ORF; Hap43p-repressed gene

CAL0001605

5.27

ALS family cell wall adhesin

CAL0001358

5.22

Putative mitochondrial leucyl-tRNA synthetase

CAL0004847

5.21

Protein affects filamentous growth

CAL0000413

5.10

General amino acid permease

CAL0002161

5.06

CAL0005574

5.01

CAL0005771

5.01

CAL0006360

4.98

Ortholog(s) have metalloendopeptidase activity, cellular iron ion
homeostasis and mitochondrion localization
Ortholog(s) have structural constituent of ribosome activity and
mitochondrial small ribosomal subunit localization
Ortholog(s) have role in mitochondrial tRNA
threonylcarbamoyladenosine modification and mitochondrion
localization
Uncharacterized ORF

CAL0001415

4.96

Uncharacterized ORF

CAL0005693

4.94

Uncharacterized ORF

CAL0000885

4.91

Uncharacterized ORF

CAL0004840

4.89

Dubious ORF

CAL0000601

4.88

Uncharacterized ORF

CAL0003267

4.86

Nucleoside permease

CAL0004522

4.86

Putative transcription factor with zinc cluster DNA-binding motif

CAL0001440

4.81

Adhesin

CAL0002354

4.81

Putative ribonucleotide reductase large subunit

CAL0001629

4.80

Uncharacterized ORF

CAL0002549

4.75

Uncharacterized ORF

CAL0004976

4.75

CAL0004789

4.69

Ortholog(s) have 1-acylglycerophosphocholine O-acyltransferase
activity
Uncharacterized ORF

CAL0002550

4.67

Predicted zinc-finger protein

CAL0000151

4.66

Predicted zinc-finger protein

CAL0004952

4.66

Uncharacterized ORF

CAL0000028

4.65

Putative RNA-binding protein

CAL0003637

4.62

Uncharacterized ORF

CAL0002630

4.61

Putative mitochondrial translation initiation factor

CAL0005203

4.60

Putative GPI-anchored protein

CAL0001515

4.60

Uncharacterized ORF

CAL0003797

4.55

Amino acid permease

CAL0005710

4.52

Putative transporter

CAL0002049

4.51

Putative mitochondrial carrier protein

CAL0003166

4.40

Putative vacuolar protease

CAL0000858

4.38

Uncharacterized ORF

CAL0003697

4.37

Putative mitochondrial membrane protein

CAL0005633

4.37

Uncharacterized ORF; Putative transcription factor with zinc finger
DNA-binding motif; Hap43p-induced

GPI-anchored protein; hypoxia, Hap43p-induced

P-value

1.22E-62
7.91E-48
1.09E-25
3.09E-177
1.00E-300
5.85E-09
2.53E-24
1.00E-300
1.00E-300
4.33E-146
1.24E-28
1.67E-102
2.68E-10
1.02E-114
4.90E-05
1.00E-300
6.01E-167
7.30E-11
1.00E-300
1.73E-82
2.25E-82
1.38E-05
1.61E-168
3.99E-78
1.00E-300
4.92E-20
1.82E-77
2.42E-126
1.00E-300
1.00E-300
2.05E-13
8.01E-39
1.70E-255
5.69E-29
1.01E-258
1.00E-300
1.99E-22
1.00E-300
4.56E-59
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Table A-5 continued

Gene ID
CAL0000188

Fold upregulated
4.35

CAL0005320

Function

P-value

1.64E-200

4.35

Plasma-membrane-localized protein; filament induced, hypoxiainduced
Uncharacterized ORF

CAL0005583

4.35

Uncharacterized ORF

CAL0000430

4.35

Putative mitochondrial translation elongation factor

CAL0002964

4.34

Protein involved in nuclear membrane fusion during karyogamy

CAL0001309

4.34

Uncharacterized ORF

CAL0000374

4.33

Putative protein of GPI synthesis

CAL0000782

4.31

Uncharacterized ORF; Putative Pol protein of retrotransposon Tca2

CAL0000285

4.29

Uncharacterized ORF

CAL0002139

4.29

Uncharacterized ORF

CAL0002992

4.28

Uncharacterized ORF; Basic amino acid permease

CAL0003611

4.21

Uncharacterized ORF; Hap43p-repressed gene

CAL0001720

4.16

Ribosomal protein of the large subunit, mitochondrial

CAL0000808

4.16

Protein similar to isoleucyl-tRNA synthetase

CAL0000715

4.13

Plasma membrane protein of heme-iron utilization

CAL0001591

4.12

Protein has role in mitotic spindle positioning

CAL0005579

4.10

Uncharacterized ORF

CAL0120984

4.10

Uncharacterized ORF

CAL0000023

4.10

CAL0001478

4.09

Uncharacterized ORF; transcription is induced upon yeast-hyphal
transition
Uncharacterized ORF

5.76E-64
1.00E-300
4.06E-06
3.66E-62
1.09E-48
1.00E-300
1.27E-42
3.58E-47
1.37E-116
6.26E-13
1.00E-300
1.00E-300
2.42E-17
6.88E-75
1.03E-29
2.08E-18
2.58E-84

CAL0000709

4.08

Basic amino acid permease

CAL0001283

4.08

ALS family protein

CAF0007422

4.05

CAF0006931

4.02

Putstive role in mitochondrial genome maintenance and integral to
mitochondrial inner membrane localization
Uncharacterized ORF

CAL0006161

3.99

Protein induced upon induction of hyphal growth

CAL0001294

3.97

Uncharacterized ORF

CAL0004745

3.95

Purine-cytosine permease of pyrimidine salvage

CAL0001919

3.89

Uncharacterized ORF

CAL0003673

3.89

Uncharacterized ORF

CAL0002117

3.88

Transcriptional regulator of the CTR1 copper transporter

CAL0003035

3.86

NADPH oxidoreductase

CAL0004790

3.86

Uncharacterized ORF

CAL0000929

3.86

Uncharacterized ORF

CAL0000209

3.85

Putative transcription factor with zinc cluster DNA-binding motif

CAL0001735

3.84

Putative ribonucleoside diphosphate reductase

CAL0000390

3.82

Protein similar to mitochondrial tryptophanyl-tRNA synthetase

CAL0005937

3.81

Uncharacterized ORF

CAL0005126

3.81

Uncharacterized ORF; Putative mitochondrial RNA polymerase

CAL0003199

3.79

G1 cyclin; required for hyphal growth

CAL0000443

3.78

Cell wall acid trehalase

2.33E-50

1.05E-261
2.18E-49
1.12E-65
2.99E-226
1.10E-15
2.75E-212
5.57E-23
2.08E-205
3.38E-144
1.90E-113
4.59E-94
3.22E-42
6.21E-15
6.30E-135
9.09E-211
6.67E-120
4.81E-161
3.22E-12
1.00E-300
4.01E-89
1.05E-85
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Table A-5 continued

Gene ID
CAL0005563

Fold upregulated
3.77

Function

CAL0004832

3.76

Ortholog(s) have ATP-dependent RNA helicase activity

CAL0005442

3.75

Transcriptional regulator of iron-responsive genes

CAL0002996

3.74

Uncharacterized ORF

CAL0004594

3.74

Protein similar to S. cerevisiae Esc4p, which represses transposition

CAL0002565

3.74

Putative biotin synthase, Hap43p-repressed

CAL0003435

3.73

Uncharacterized ORF

CAL0004394

3.73

Uncharacterized ORF

CAL0003968

3.72

Uncharacterized ORF; Hap43p-repressed gene

CAL0004100

3.71

Uncharacterized ORF

CAL0003188

3.69

Uncharacterized ORF

CAL0001087

3.68

Uncharacterized ORF

CAL0003714

3.66

Uncharacterized ORF; Hap43p-repressed gene

CAL0005306

3.66

Uncharacterized ORF

CAL0001776

3.62

Uncharacterized ORF

CAL0004447

3.60

Uncharacterized ORF; Putative SH3-domain-containing protein

CAL0000618

3.59

GPI-anchored cell wall protein involved in hemoglobin utilization

CAL0003484

3.56

Uncharacterized ORF

CAL0002282

3.55

Putative ceramide hydroxylase

CAL0005948

3.54

Uncharacterized ORF

CAL0002890

3.53

Uncharacterized ORF

CAL0006398

3.52

Hyphal-induced GPI-anchored cell wall protein

CAL0003880

3.50

Uncharacterized ORF

CAL0006303

3.50

Uncharacterized ORF

CAL0003338

3.49

Predicted zinc-finger protein

CAL0003133

3.49

Putative mitochondrial acidic matrix protein;

CAL0003532

3.48

CAL0005195

3.48

Putative GPI-anchored protein; hyphal induced; Hog1pdownregulated
Uncharacterized ORF; Predicted ORF in retrotransposon

CAL0002436

3.47

Putative prolyl-tRNA synthetase

CAL0003149

3.46

Uncharacterized ORF; Hap43p-induced gene

CAL0003984

3.45

Putative DNA damage checkpoint protein

CAL0005876

3.45

Putative peptide:N-glycanase

CAL0001213

3.44

Putative serine/threonine protein kinase

CAL0002156

3.42

Uncharacterized ORF

CAL0000393

3.42

Uncharacterized ORF

CAL0002229

3.40

Uncharacterized ORF

CAL0000351

3.40

Uncharacterized ORF

CAL0002383

3.38

Uncharacterized ORF

CAL0005700

3.38

Putative polysome-associated RNA binding protein

CAL0002283

3.36

NAD(P)H oxidoreductase family protein; induced by nitric oxide

CAL0003705

3.36

Similar to CCAAT-binding transcription factor that regulates
respiration

Uncharacterized ORF

P-value

1.07E-79
1.00E-300
8.04E-149
1.09E-07
4.46E-75
2.68E-38
1.70E-10
4.06E-256
4.49E-19
7.25E-73
3.47E-37
1.23E-24
1.00E-300
1.41E-76
1.80E-27
2.19E-12
7.08E-55
1.16E-26
1.00E-300
1.02E-29
7.30E-78
2.61E-30
1.66E-31
1.58E-56
7.45E-52
1.00E-300
3.57E-149
4.82E-30
2.12E-163
1.33E-26
6.29E-26
1.83E-160
5.97E-162
5.50E-37
3.18E-59
1.17E-24
7.70E-32
2.55E-15
1.08E-32
9.23E-62
4.38E-14

129

Table A-5 continued

Gene ID
CAL0002467

Fold upregulated
3.36

Function

CAL0006315
CAL0000807

3.35
3.33

Uncharacterized ORF
Putative adhesin-like protein

CAL0005323

3.31

Secreted lipase

CAL0002540

3.28

Putative zinc cluster protein

CAL0004624

3.28

Putative GPI-anchored protein

CAL0004933

3.27

CAL0005593

3.27

CAL0005544

3.26

Immunogenic stress-associated protein; regulated by filamentous
growth
Putative mitochondrial protein with a predicted role in respiratory
growth
Uncharacterized ORF

CAL0003073

3.26

Dubious ORF; Protein induced by nitric oxide

CAL0001524

3.24

CAL0002799

3.22

Ribonucleotide reductase large subunit; regulated by Sef1p, Sfu1p,
and Hap43p
Putative vacuolar transporter of large neutral amino acids

CAL0004709

3.22

Protein with predicted role in beta-1,6-glucan synthesis

CAL0000422

3.22

Cytochrome oxidase assembly protein

CAL0003007

3.22

Mitochondrial methionyl-tRNA synthetase

CAL0000621

3.22

Putative processing peptidase

CAL0005145

3.21

Uncharacterized ORF

CAL0005785

3.21

Predicted Zn2-Cys6 zinc-finger protein

CAL0006202

3.21

Putative MFS transporter

CAL0006237

3.20

Uncharacterized ORF

CAL0003627

3.19

Lanosterol 14-alpha-demethylase; hypoxia regulated

CAL0001075

3.17

Uncharacterized ORF

CAL0000906

3.17

CAL0003631

3.17

Transcriptional repressor; required for white-phase cell type; hyphal
growth, metabolism, cell-wall gene regulator
Putative exodeoxyribonuclease

CAL0001968

3.16

Uncharacterized ORF

CAF0006940

3.16

Uncharacterized ORF

CAL0001860

3.16

Uncharacterized ORF

CAL0003614

3.15

Uncharacterized ORF; Hap43p-induced gene

CAL0005303

3.15

Uncharacterized ORF

CAL0001656

3.15

Protein similar to Ste3p, the receptor for a-factor mating pheromone

CAL0004994

3.15

Uncharacterized ORF; Hap43p-induced gene

CAL0006312

3.14

Putative DNA mismatch repair factor

CAL0004031

3.14

Protein similar to S. cerevisiae Smc3p, which is an

CAL0001744

3.13

Heat shock protein

CAL0000721

3.13

Putative urea permease

CAL0003557

3.13

Uncharacterized ORF; Protein of major facilitator superfamily

CAL0003896

3.13

Putative cell wall integrity and stress response subunit 4 precursor

CAL0005933

3.12

Uncharacterized ORF

CAL0000997

3.12

Uncharacterized ORF

CAL0004675

3.11

component of RNA polymerase II holoenzyme

Uncharacterized ORF

P-value

7.50E-48
8.70E-37
4.28E-49
2.06E-13
8.99E-95
7.99E-51
4.09E-59
1.00E-300
6.18E-57
2.14E-11
1.00E-300
1.10E-76
2.49E-123
1.00E-300
2.67E-118
4.83E-224
3.18E-122
1.13E-197
4.08E-31
2.57E-44
1.00E-300
1.75E-91
1.83E-289
7.36E-191
2.18E-197
6.42E-05
0.00063809
1.04E-32
5.27E-35
1.06E-12
1.34E-48
1.30E-39
6.03E-74
1.00E-300
7.34E-22
2.26E-95
1.34E-73
1.00E-300
3.06E-28
1.15E-53
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Table A-5 continued

Gene ID
CAL0004339

Fold upregulated
3.11

Function

CAL0001963

3.10

Uncharacterized ORF

CAL0001123

3.10

Putative integral inner mitochondrial membrane protein

CAL0003443

3.10

Uncharacterized ORF

CAL0001036

3.10

CAL0003069

3.09

Protein involved in regulation of DNA-damage-induced filamentous
growth
Uncharacterized ORF

CAL0003834

3.09

High-affinity iron permease

CAL0004027

3.08

Sphingolipid delta-8 desaturase

CAL0005069

3.08

Uncharacterized ORF

CAL0006272

3.08

Acyl CoA:sterol acyltransferase

CAL0005620

3.07

Uncharacterized ORF

CAL0004064

3.06

Uncharacterized ORF

CAL0002008

3.06

Uncharacterized ORF

CAL0003082

3.06

Uncharacterized ORF

CAL0006390

3.06

Uncharacterized ORF; Hap43p-induced gene

CAL0002724

3.05

Protein member of a family encoded by FGR6-related genes

CAL0005805

3.05

Uncharacterized ORF; Hap43p-repressed gene

CAL0001145

3.05

Uncharacterized ORF

CAL0006305

3.05

Uncharacterized ORF; Protein involved in mismatch repair

CAL0001687

3.04

Uncharacterized ORF

CAL0004368

3.04

Member of a family encoded by FGR6-related genes

CAL0004107

3.04

Uncharacterized ORF; Ortholog(s) have ATPase activator activity

CAL0005580

3.04

Uncharacterized ORF; Ortholog(s) have metallochaperone activity

CAL0002835

3.04

Verified ORF; Putative ammonium transporter

CAL0004999

3.04

Uncharacterized ORF

CAL0001931

3.04

Uncharacterized ORF

CAL0000652

3.03

Uncharacterized ORF; Hap43p-induced gene

CAL0006262

3.03

Uncharacterized ORF

CAL0006204

3.03

Putative Ribonuclease H (RNAse H); hyphal-induced

CAL0005519

3.03

CAL0000884

3.03

Ste20p family Ser/Thr kinase required for wild-type filamentous
growth
Uncharacterized ORF

CAL0000324

3.02

Predicted zinc ion binding activity

CAL0005767

3.01

Dubious ORF

CAL0004443

3.00

Uncharacterized ORF

CAL0003193

3.00

Uncharacterized ORF

CAL0001534

3.00

Uncharacterized ORF;Hap43p-repressed gene

CAL0001655

3.00

Uncharacterized ORF

CAL0002184

2.99

Putative glucose-6-phosphate isomerase

CAL0003671

2.99

Uncharacterized ORF

CAL0005558

2.99

Uncharacterized ORF

CAL0005696

2.98

Uncharacterized ORF

Uncharacterized ORF

P-value

5.06E-16
1.78E-193
2.10E-176
2.35E-264
4.42E-137
5.21E-09
1.00E-300
5.54E-82
3.53E-98
1.05E-60
2.46E-09
7.85E-13
0.000116314
3.06E-13
4.15E-89
5.13E-11
3.63E-16
4.48E-05
5.44E-223
4.88E-10
5.31E-19
1.00E-300
5.44E-100
9.19E-166
2.75E-19
1.91E-06
5.60E-146
1.33E-125
9.71E-123
1.26E-128
2.68E-11
1.15E-119
3.42E-07
1.00E-300
3.39E-28
1.52E-29
1.43E-81
1.00E-300
1.83E-48
2.26E-20
2.70E-292
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Table A-5 continued

Gene ID
CAL0000561

Fold upregulated
2.98

Function

CAL0002790

2.98

CAL0006337

2.97

Uncharacterized ORF; Has domain(s) with predicted structural
molecule activity
Ammonium permease

CAL0003251

2.97

Uncharacterized ORF

CAL0003161

2.97

CAL0005031

2.97

Protein required for virulence in reconstituted human epithelium
(RHE) model of ex vivo infection
Uncharacterized ORF

CAL0004892

2.96

Uncharacterized ORF; Hap43p-repressed gene

CAL0002431

2.96

Putative DNA directed DNA polymerase alpha

CAL0002878

2.96

Member of a family encoded by FGR6-related genes

CAL0001746

2.95

Putative RNA polymerase I subunit

CAL0000369

2.95

Protein involved in telomere maintenance

CAL0004072

2.94

Uncharacterized ORF

CAL0005941

2.94

Putative Argonaute protein involved in RNA silencing

CAL0120845

2.94

Uncharacterized ORF

CAL0001396

2.93

Predicted acyl-CoA oxidase

CAL0001936

2.93

Putative homeodomain-containing transcriptional repressor

CAL0006244

2.93

Uncharacterized ORF

CAL0000499

2.93

Uncharacterized ORF

CAL0003229

2.92

Putative multidrug resistance protein; upregulated by Efg1p

CAL0001481

2.92

CAL0004412

2.92

Protein similar to S. cerevisiae Smc5p, which is involved in DNA
repair
Putative GPI-anchored protein

CAL0001158

2.92

Aldo-keto reductase family member

CAL0006363

2.91

Uncharacterized ORF

CAL0004048

2.91

CAL0003781

2.91

Component of the general transcription factor for RNA polymerase
III
Putative transcription factor

CAL0005187

2.91

Heme oxygenase

CAL0004987

2.91

Uncharacterized ORF; Hap43p-repressed gene

CAL0000244

2.91

Putative oligopeptide transporter

CAL0003239

2.91

Ortholog(s) have rRNA (guanine-N1-)-methyltransferase activity

CAL0001295

2.91

Uncharacterized ORF; Hap43p-repressed gene

CAL0003154

2.91

Verified ORF; Hap43p-repressed gene

CAL0000464

2.91

Uncharacterized ORF

CAL0000614

2.91

Ferric reductase

CAL0003304

2.90

Uncharacterized ORF

CAL0004977

2.90

Uncharacterized ORF

CAL0003638

2.90

Uncharacterized ORF

CAL0003737

2.90

Uncharacterized ORF

CAL0001318

2.89

Uncharacterized ORF

CAL0003641

2.89

Uncharacterized ORF

CAL0000780

2.89

Putative Gag protein of retrotransposon Tca2

Uncharacterized ORF

P-value

8.86E-102
1.00E-300
7.51E-137
1.31E-94
5.59E-70
6.81E-35
1.66E-09
4.78E-224
5.84E-27
1.53E-39
7.87E-09
3.88E-10
6.07E-164
0.0526201
2.03E-59
7.49E-65
1.67E-37
1.26E-113
3.33E-34
6.44E-96
3.40E-15
3.95E-39
6.27E-15
8.26E-78
1.00E-300
9.54E-218
1.74E-108
1.00E-300
1.37E-152
1.46E-13
1.73E-43
2.03E-145
1.38E-08
5.35E-36
2.56E-63
2.96E-185
1.00E-300
0.00284226
1.00E-300
8.01E-234
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Table A-5 continued

Gene ID
CAL0001380

Fold upregulated
2.88

Function

CAL0003370

2.87

Protein similar to beta-1,3-glucan synthase

CAL0000729

2.87

Uncharacterized ORF

CAL0001169

2.86

Uncharacterized ORF

CAL0005779

2.86

Putative mismatch repair protein

CAL0005652

2.86

Uncharacterized ORF

CAL0002712

2.86

Uncharacterized ORF; Major facilitator superfamily protein

CAL0002807

2.85

Uncharacterized ORF

CAL0000075

2.85

A subunit of the mitochondrial inner membrane m-AAA protease

CAL0006245

2.85

Uncharacterized ORF; Hap43p-repressed gene

CAL0005653

2.84

Protein mannosyltransferase with roles in hyphal growth

CAL0001828

2.84

Heat shock protein

CAL0000273

2.83

Uncharacterized ORF

CAL0005752

2.83

Putative nicotinic acid mononucleotide adenylyltransferase

CAL0006182

2.83

Uncharacterized ORF

CAL0003874

2.83

Putative GPI-anchored protein

CAL0000890

2.83

Uncharacterized ORF

CAL0005385

2.82

Uncharacterized ORF

CAL0005976

2.82

Uncharacterized ORF

CAL0003619

2.82

Putative fructose-bisphosphate aldolase, enzyme of glycolysis

CAL0002087

2.81

Uncharacterized ORF

CAL0001215

2.81

Zn2-Cys6 transcription factor; regulates iron uptake

CAL0004463

2.81

Uncharacterized ORF; Hap43p-induced gene

CAL0001117

2.81

Uncharacterized ORF

CAL0000116

2.81

Uncharacterized ORF

CAL0000955

2.80

Uncharacterized ORF

CAL0000429

2.80

Uncharacterized ORF

CAL0001753

2.80

Uncharacterized ORF

CAL0000811

2.80

CAL0005560

2.79

CAL0002663

2.79

Role in mitochondrial translation and mitochondrial inner membrane
localization
Protein mannosyltransferase required for normal cell wall
composition
Protein required for chlamydospore formation

CAL0003196

2.79

Uncharacterized ORF

CAL0005365

2.79

Putative RNA-binding protein

CAL0001139

2.78

Uncharacterized ORF

CAL0002874

2.78

Uncharacterized ORF

CAL0001080

2.77

Uncharacterized ORF

CAL0002245

2.77

Ribonucleoside-diphosphate reductase

CAL0005977

2.77

Pyruvate kinase

CAL0000180

2.77

Uncharacterized ORF; Putative mRNA maturation factor

CAL0002758

2.77

Uncharacterized ORF

CAL0002127

2.76

Uncharacterized ORF

Uncharacterized ORF

P-value

3.33E-24
3.64E-59
2.41E-100
1.84E-105
2.15E-21
8.21E-31
6.86E-53
2.52E-56
1.00E-300
1.38E-11
1.00E-300
1.00E-300
4.35E-62
9.50E-154
1.95E-79
7.66E-23
5.05E-24
2.93E-90
2.14E-49
1.00E-300
6.44E-10
1.52E-64
1.74E-42
1.50E-11
1.00E-300
1.59E-44
7.82E-42
5.80E-46
9.26E-46
1.00E-300
1.07E-133
1.00E-300
2.54E-126
1.95E-42
5.03E-74
2.80E-100
1.00E-300
1.00E-300
1.00E-300
1.62E-56
9.41E-173
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Table A-5 continued

Gene ID
CAL0003243

Fold upregulated
2.76

Function

CAL0000402

2.76

Putative dynamin-related GTPase

CAL0001564

2.76

Uncharacterized ORF; Hap43p-repressed gene

CAL0001595

2.76

Class V myosin

CAL0004060

2.76

Uncharacterized ORF

CAL0006036

2.76

CAL0006143

2.75

Putative dicarboxylic amino acid permease; upregulated by
Rim101p
Predicted membrane transporter

CAL0001981

2.75

Ortholog(s) have role in vacuole organization, endocytosis,

CAL0005901

2.75

CAL0000530

2.75

Glucosaminyl-phosphotidylinositol O-acyltransferase activity, role in
GPI anchor biosynthetic process
Putative beta-mannosyltransferase

CAL0004042

2.74

Protein required for normal filamentous growth

CAL0000873

2.74

Putative transcription factor with zinc finger DNA-binding motif

CAL0004669

2.74

Uncharacterized ORF; tubulin-dependent ATPase activity

CAL0003055

2.74

Phosphofructokinase alpha subunit

CAL0004069

2.74

Putative thiamin-phosphate pyrophosphorylase

CAL0000385

2.73

Uncharacterized ORF; oxidoreductase activity

CAL0000486

2.73

Uncharacterized ORF

CAL0001160

2.73

Putative phospholipase B

CAL0001319

2.73

Putative fatty acid elongase with a predicted role in sphingolipid
biosynthesis

CAL0004557

2.73

Putative dihydroxyacetone kinase

CAL0003940

2.72

Uncharacterized ORF

CAL0001136

2.72

Putative mitochondrial carrier protein

CAL0000969

2.71

Uncharacterized ORF

CAL0001865

2.71

Putative mitochondrial large subunit ribosomal protein

CAL0002507

2.70

Uncharacterized ORF; Role in osmosensory signaling pathway

CAL0002602

2.70

Uncharacterized ORF

CAL0000712

2.70

CAL0000720

2.70

Ammonium permease and regulator of nitrogen starvation-induced
filamentation
Uncharacterized ORF

CAL0000861

2.69

Uncharacterized ORF; Putative GINS complex subunit

CAL0006048

2.69

Uncharacterized ORF

CAL0005024

2.69

Lysine histone methyltransferase

CAL0000842

2.69

Predicted membrane transporter

CAL0005453

2.68

Ortholog(s) have metalloendopeptidase activity

CAL0004828

2.68

Protein involved in regulation of filamentous growth and virulence

CAL0006276

2.68

Ortholog(s) have role in mitochondrial translation and localization

CAL0002488

2.68

CAL0002211

2.68

Uncharacterized ORF; Hap43p-repressed gene; gene induced by
hypoxia
Uncharacterized ORF; Hap43p-induced gene

CAL0005516

2.67

Possible regulatory protein; putative adhesin-like protein;

CAL0004799

2.67

Uncharacterized ORF; Hap43p-repressed gene

Uncharacterized ORF

P-value

1.10E-33
2.76E-251
2.13E-61
1.00E-300
1.01E-99
1.00E-300
2.47E-39
1.73E-59
6.90E-99
5.03E-117
5.78E-69
5.59E-24
1.27E-58
1.00E-300
2.36E-40
3.47E-116
1.93E-64
3.58E-12
1.62E-116
1.00E-300
1.69E-17
1.00E-300
1.51E-80
2.79E-137
9.99E-47
1.00E-300
5.14E-23
1.00E-300
4.92E-12
7.06E-92
1.02E-64
3.45E-40
3.56E-183
3.36E-163
1.00E-300
2.66E-17
1.49E-62
3.46E-87
6.91E-07
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Table A-5 continued

Gene ID
CAL0003178

Fold upregulated
2.67

Function

CAL0003761

2.66

Uncharacterized ORF

CAL0004810

2.66

Uncharacterized ORF

CAL0001202

2.66

Dubious ORF

CAL0006399

2.66

Uncharacterized ORF

CAL0004281

2.66

Putative transcription factor with zinc finger DNA-binding motif

CAL0001498

2.66

Putative glucose transporter of the major facilitator superfamily

CAL0004071

2.66

Uncharacterized ORF; Stationary phase enriched protein

CAL0003878

2.65

Uncharacterized ORF

CAL0005112

2.65

Protein member of a family encoded by FGR6-related genes

CAF0006928

2.64

Uncharacterized ORF

CAL0000249

2.64

Predicted zinc-finger protein

CAL0003703

2.64

CAL0000703

2.64

Protein required for damage to oral epithelial cells and for normal
hyphal growth and stress resistance
Uncharacterized ORF; Hap43p-repressed gene;

CAL0004889

2.64

Uncharacterized ORF

CAL0002334

2.63

Putative RNA binding protein

CAL0003255

2.63

CAL0006010

2.63

Putative structural maintenance of chromosomes protein; Hap43pinduced gene
Uncharacterized ORF

CAL0001166

2.62

Uncharacterized ORF; Protein of RGS superfamily

CAL0005675

2.62

Role in DNA repair, replication fork arrest

CAL0004934

2.62

Dubious ORF

CAL0002933

2.61

Transcriptional repressor; regulator of filamentation

CAL0005764

2.61

Uncharacterized ORF

CAL0004575

2.61

Corticosteroid binding protein

CAL0005537

2.61

Cyclin homolog

CAL0004555

2.61

CAL0005055

2.61

Uncharacterized ORF; Ortholog(s) have protein kinase activator
activity
Putative flavodoxin

CAL0003249

2.60

CAL0001985

2.60

CAL0000894

2.60

CAL0005058

2.60

Probable protein kinase involved in determination of morphology
during the cell cycle of both yeast-form and hyphal cells
Uncharacterized ORF

CAL0000375

2.60

Thioredoxin reductase

CAL0004518

2.59

Putative mitochondrial biogenesis protein

CAL0004521

2.59

Predicted membrane transporter

CAL0000796

2.59

Rab guanyl-nucleotide exchange factor activity

CAL0003227

2.59

Similar to Rab GTPase activators; Hap43p-induced gene

CAL0000134

2.59

Putative high-affinity glutamine permease

CAL0000846

2.58

Uncharacterized ORF

CAL0005338

2.58

Uncharacterized ORF; GTPase activity

CAL0001987

2.58

Uncharacterized ORF

Uncharacterized ORF

Membrane insertase activity and role in protein insertion into
mitochondrial membrane from inner side
Putative ceramide hydroxylas; regulated by iron

P-value

1.78E-19
9.98E-21
6.82E-274
0.00734558
7.21E-40
2.34E-34
2.58E-22
3.43E-51
8.94E-73
1.79E-14
3.49E-18
4.55E-08
0.000649097
2.47E-43
1.37E-48
3.14E-39
5.18E-99
2.51E-55
6.31E-10
3.32E-72
0.0259515
1.63E-23
5.27E-56
3.75E-260
4.73E-32
1.00E-36
3.91E-83
1.00E-300
1.62E-278
4.19E-135
9.22E-60
1.00E-300
4.95E-169
2.20E-13
2.13E-95
1.14E-45
1.32E-24
1.04E-25
9.68E-103
2.25E-144
135

Table A-5 continued

Gene ID
CAL0000863

Fold upregulated
2.58

Function

CAL0000816

2.58

Uncharacterized ORF; Putative tRNA-Pro synthetase

CAL0005944

2.58

Dubious ORF

CAL0004026

2.58

Chitin synthase

CAL0001441

2.58

ALS family cell-surface glycoprotein

CAL0003151

2.57

Dubious ORF

CAL0001245

2.57

Plasma membrane protein; negatively regulated by Rim101p

CAL0002662

2.57

Uncharacterized ORF; ubiquitin-protein ligase activity

CAL0004490

2.57

Cytochrome oxidase assembly protein

CAL0120672

2.56

Uncharacterized ORF

CAL0003502

2.56

Uncharacterized ORF

CAL0003947

2.56

Uncharacterized ORF; Hap43p-induced gene

CAL0005202

2.56

Putative pyruvate decarboxylase

CAL0004148

2.55

Putative mannosyltransferase

CAL0002787

2.55

CAL0001575

2.55

Uncharacterized ORF; L-glutamate transmembrane transporter
activity
Putative termination and polyadenylation protein

CAL0003828

2.55

Secretory protein

CAL0004938

2.55

Uncharacterized ORF

CAL0005685

2.55

C-14 sterol reductase

CAL0001578

2.55

Uncharacterized ORF; mitochondrion localization

CAL0005823

2.55

Uncharacterized ORF

CAL0006186

2.54

Mannosyltransferase

CAL0004577

2.54

Putative copper transporter; Hap43p-repressed gene

CAL0004586

2.54

Uncharacterized ORF

CAL0002917

2.54

Uncharacterized ORF

CAL0000278

2.54

Manganese transporter required for normal filamentous growth

CAL0004816

2.54

Uncharacterized ORF; DNA-directed DNA polymerase activity

CAL0000616

2.54

CAL0005541

2.54

possible GPI-anchor; induced by Rim101p, cell wall regenerationinduced
Squalene epoxidase

CAL0001313

2.53

Uncharacterized ORF

CAL0002789

2.53

ALS family protein

CAL0006287

2.53

CAL0005009

2.53

mRNA-binding protein that localizes specific mRNAs to daughter
yeast-form cells and to hyphal tips
Uncharacterized ORF

CAL0006342

2.53

CAL0000015

2.53

CAL0006191

2.53

CAL0001119

2.53

Protein similar that affects filamentous growth; Hap43p-repressed
gene
Putative role in regulation of mitochondrion organization, signal
peptide processing and mitochondrial inner membrane localization
Putative protein with a predicted role in establishment and
maintenance of sister chromatid condensation and cohesion
Predicted GPI-anchor, role in 1,6-beta-D-glucan biosynthesis

CAL0002448

2.52

Amino acid permease

CAL0003398

2.52

Glucose and galactose sensor

CAL0005819

2.52

Outwardly rectifying, noisily gated potassium channel

Uncharacterized ORF

P-value

1.21E-79
4.84E-212
0.000959105
6.85E-74
7.25E-32
0.0032933
1.28E-81
1.94E-160
3.76E-187
8.49E-08
2.07E-49
3.11E-23
1.00E-300
6.07E-122
1.39E-72
1.06E-161
1.25E-64
7.05E-09
3.54E-166
4.04E-68
2.06E-27
2.31E-09
1.20E-252
3.86E-152
6.40E-171
2.01E-213
9.16E-30
6.51E-06
1.00E-300
4.40E-233
1.27E-77
4.38E-171
9.14E-26
5.08E-62
6.15E-155
1.62E-88
1.68E-06
2.14E-85
3.36E-18
1.67E-33
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Table A-5 continued

Gene ID
CAL0004120

Fold upregulated
2.52

Function

CAL0003218

2.52

Uncharacterized ORF

CAF0006965

2.52

CAL0005524

2.51

flavin-linked sulfhydryl oxidase activity and role in cellular iron ion
homeostasis
Uncharacterized ORF

CAL0005657

2.51

NAD-linked glyceraldehyde-3-phosphate dehydrogenase

CAL0006044

2.51

Uncharacterized ORF

CAL0004468

2.51

Enzyme regulator involved in phospholipid metabolism

CAL0004875

2.51

GABA/polyamine transporter

CAL0000727

2.51

Cysteine transporter

CAL0000173

2.50

Uncharacterized ORF; Hap43p-induced gene

CAL0004672

2.50

Uncharacterized ORF

CAL0001047

2.50

Uncharacterized ORF

CAL0005999

2.50

Subunit of beta-1,3-glucan synthase

CAL0000350

2.50

CAL0000093

2.50

Transcription factor that positively regulates rRNA and ribosomal
protein gene transcription
Dubious ORF

CAL0001239

2.50

Transcriptional activator, required for hyphal growth

CAF0006924

2.49

Uncharacterized ORF

CAL0003261

2.49

Putative endosomal transmembrane protein; Hap43p-induced

CAL0003907

2.49

Uncharacterized ORF

CAL0005775

2.49

Uncharacterized ORF

CAL0006074

2.49

Uncharacterized ORF

CAL0003275

2.49

Putative SH3-domain-containing protein

CAL0005141

2.49

Uncharacterized ORF

CAL0001241

2.49

Putative pre-replication complex helicase subunit

CAL0005040

2.48

Uncharacterized ORF

CAL0003148

2.48

Putative mitochondrial lysine-tRNA synthetase

CAL0003431

2.48

Putative glucose transporter of the major facilitator superfamily

CAL0000304

2.48

Putative GPI-anchored protein

CAL0002655

2.48

Uncharacterized ORF

CAL0003029

2.48

Protein member of conserved Mcm1p regulon

CAL0004231

2.48

CAL0005986

2.47

CAL0005745

2.47

Uncharacterized ORF; Ortholog(s) have role in invasive growth in
response to glucose limitation
Mitochondrial 60S ribosomal protein subunit; Hap43p-repressed
gene
Putative PDR-subfamily ABC transporter

CAL0004733

2.47

Uncharacterized ORF

CAL0005199

2.47

DNA topoisomerase II

CAL0004882

2.47

Uncharacterized ORF

CAL0003260

2.47

Putative iron transporter

CAL0005204

2.47

Putative GPI-anchored protein

CAL0005038

2.47

Uncharacterized ORF

CAL0002525

2.47

Uncharacterized ORF

Uncharacterized ORF; Hap43p-repressed gene

P-value

6.54E-05
8.31E-10
2.11E-74
3.71E-27
1.00E-300
4.04E-47
3.92E-36
1.32E-07
1.10E-76
1.85E-20
1.70E-75
1.10E-32
1.00E-300
4.65E-73
7.39E-07
5.25E-44
2.99E-39
3.25E-65
1.17E-49
4.44E-24
2.33E-13
7.87E-126
3.69E-32
3.04E-61
2.70E-44
1.06E-88
2.73E-15
7.07E-99
0.00136654
3.46E-67
3.51E-155
1.00E-300
2.79E-87
5.08E-45
9.72E-177
0.00010797
4.51E-52
9.63E-23
5.93E-21
9.34E-24
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Table A-5 continued

Gene ID
CAL0002687

Fold upregulated
2.46

Function

CAL0004874

2.46

CAL0001311

2.46

Protein kinase involved in growth control, normal cell size, prevents
hypha formation under hypoxia at high CO2 levels
Putative transcription factor with zinc finger DNA-binding motif;
Hap43p-repressed gene
Putative serine transporter with possible role in assimilation of sulfur

CAL0001054

2.46

Autophosphorylated kinase

CAL0004706

2.46

Uncharacterized ORF

CAL0005239

2.46

Uncharacterized ORF

CAL0002321

2.46

Uncharacterized ORF

CAL0000889

2.46

Amino acid permease

CAL0004778

2.46

Putative subunit of the Nucleotide Excision Repair Factor 4

CAL0001514

2.45

Dubious ORF

CAL0002494

2.45

Putative DNA replication protein

CAL0002812

2.45

Uncharacterized ORF

CAL0006175

2.45

Uncharacterized ORF

CAL0004826

2.45

Uncharacterized ORF

CAL0000957

2.45

Uncharacterized ORF

CAF0006932

2.45

Putative copper metallochaperone

CAL0005042

2.45

Polo-like kinase

CAL0001758

2.45

Putative methionyl-tRNA transformylase

CAL0000546

2.44

Verified ORF; Putative calcium-transporting ATPase

CAL0003256

2.44

CAL0002841

2.44

Putative sensor/transporter protein with a predicted role in cell wall
biogenesis
CCAAT-binding factor regulates low-iron induction of FRP1

CAL0005540

2.44

Uncharacterized ORF

CAL0005874

2.43

Uncharacterized ORF

CAL0006391

2.43

Chitinase

CAL0000087

2.43

Uncharacterized ORF

CAL0003574

2.42

Phosphoglycerate mutase

CAF0006926

2.42

Uncharacterized ORF

CAL0005084

2.42

Putative mitochondrial ATP-dependent RNA helicase

CAL0002487

2.42

Putative GPI-linked phospholipase B

CAL0001448

2.42

Uncharacterized ORF

CAL0004837

2.42

Golgi membrane GDPase, required for wild-type O-mannosylation

CAL0000639

2.42

Uncharacterized ORF

CAL0001553

2.42

Cell wall protein; putative GPI-anchor

CAL0004016

2.41

Monopolar spindle protein, a putative kinase

CAL0001905

2.41

C-5 sterol desaturase

CAL0001962

2.41

Aldo-keto reductase family member

CAL0005794

2.41

Uncharacterized ORF

CAL0005800

2.41

Uncharacterized ORF

CAL0003752

2.41

CAL0004243

2.41

Putative transcription factor; required for resistance to cell wall
perturbation
Uncharacterized ORF

P-value

1.78E-56
6.59E-25
4.74E-21
7.72E-151
3.55E-44
8.80E-36
1.74E-34
5.54E-185
2.23E-46
0.0572537
8.61E-128
1.00E-300
8.12E-168
2.97E-78
3.31E-47
7.48E-37
1.17E-195
1.73E-38
1.00E-300
1.51E-216
2.06E-21
1.20E-10
2.64E-71
4.70E-36
3.27E-14
1.00E-300
0.000470138
1.00E-300
6.87E-27
2.07E-261
1.89E-207
1.61E-10
4.52E-194
8.90E-33
3.35E-168
2.59E-78
1.00E-300
0.000211114
1.17E-38
2.45E-59
138

Table A-5 continued

Gene ID
CAL0002370

Fold upregulated
2.41

Function

CAL0005713

2.40

Putative role in heme a biosynthetic process and mitochondrion
localization
Uncharacterized ORF

CAL0004509

2.40

Aldo-keto reductase family protein

CAL0000363

2.40

CAL0001854

2.40

Putative role in protein N-linked glycosylation and endoplasmic
reticulum membrane localization
Uncharacterized ORF

CAL0006365

2.40

Uncharacterized ORF

CAL0002909

2.40

Uncharacterized ORF

CAL0003716

2.40

Uncharacterized ORF

CAL0000820

2.40

Putative cytochrome c lysine methyltransferase

CAL0002088

2.39

CAL0000642

2.39

Uncharacterized ORF; Has domain(s) with predicted catalytic
activity
Uncharacterized ORF

CAL0000542

2.39

Uncharacterized ORF

CAL0004598

2.39

Uncharacterized ORF

CAL0000099

2.39

Protein similar to S. cerevisiae Yta6p ATPase

CAL0005683

2.39

Verified ORF; Protein that affects filamentous growth

CAL0000378

2.39

Uncharacterized ORF

CAL0000432

2.39

Uncharacterized ORF

CAL0005781

2.38

Uncharacterized ORF; Has domain(s) with predicted binding activity

CAL0000141

2.38

Predicted zinc-finger protein

CAL0004953

2.38

Enolase, enzyme of glycolysis and gluconeogenesis

CAL0003854

2.38

Uncharacterized ORF

CAL0005542

2.38

Uncharacterized ORF

CAL0001426

2.38

ALS family adhesin

CAL0003341

2.38

Uncharacterized ORF

CAL0001614

2.38

Uncharacterized ORF; Hap43p-induced gene

CAL0004511

2.38

Alpha-tubulin

CAL0000685

2.38

Putative ketol-acid reductoisomerase

CAL0003282

2.37

Uncharacterized ORF

CAL0001940

2.37

Putative mitochondrial ribosomal protein

CAL0002946

2.37

Putative mitochondrial ribosomal protein of the small subunit

CAL0005223

2.37

Putative DNA primase

CAL0003220

2.36

Uncharacterized ORF

CAL0003572

2.36

Uncharacterized ORF

CAL0004802

2.36

Protein with a potential role in beta-1,6 glucan biosynthesis

CAL0001279

2.36

Uncharacterized ORF

CAL0004944

2.36

CAL0004434

2.36

Zn2-Cys6 transcriptional regulator of ergosterol biosynthetic genes
and sterol uptake
Uncharacterized ORF

CAL0001977

2.36

Uncharacterized ORF

CAL0003593

2.36

Putative pyruvate decarboxylase

CAL0003799

2.36

Carboxypeptidase Y

P-value

1.66E-195
1.50E-192
3.40E-38
2.24E-10
0.000202792
1.86E-08
1.10E-74
7.58E-50
4.38E-206
2.15E-14
4.90E-30
1.20E-68
1.38E-28
6.86E-53
7.45E-10
1.86E-36
1.56E-27
1.47E-89
6.01E-65
1.00E-300
1.76E-08
3.54E-17
1.48E-30
8.65E-22
2.22E-22
1.00E-300
1.00E-300
2.07E-18
1.26E-174
4.96E-213
3.92E-34
3.69E-19
4.52E-15
3.98E-10
1.00E-47
3.43E-145
1.11E-37
9.64E-27
9.64E-09
5.21E-210
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Table A-5 continued

Gene ID
CAL0002735

Fold upregulated
2.36

Function

CAL0000620

2.36

Component of actomyosin ring

CAL0000963

2.35

CAL0006226

2.35

Putative plasma membrane transporter of the ATP-binding cassette
family
Uncharacterized ORF

CAL0003571

2.35

Uncharacterized ORF

CAL0000936

2.35

Cell surface mannoprotein; cell-wall glucan metabolism

CAL0004102

2.34

Predicted UDP-glucose:glycoprotein glucosyltransferase

CAL0002343

2.34

Uncharacterized ORF

CAL0002619

2.34

Uncharacterized ORF

CAL0002122

2.34

Uncharacterized ORF

CAL0004864

2.34

Na+/H+ antiporter

CAL0003540

2.34

Uncharacterized ORF

CAL0004759

2.33

Uncharacterized ORF; role in DNA replication

CAL0002588

2.33

Uncharacterized ORF

CAL0001055

2.33

CAL0004340

2.33

protein channel activity and role in protein import into mitochondrial
inner membrane, protein import into mitochondrial matrix
Uncharacterized ORF

CAL0000130

2.33

Probable subunit of DNA polymerase II

CAL0003132

2.33

B-type mitotic cyclin

CAL0005885

2.32

CAL0000041

2.32

Uncharacterized ORF; Ortholog(s) have
acetylglucosaminyltransferase activity
Uncharacterized ORF; Hap43p-repressed gene

CAL0005930

2.32

Uncharacterized ORF

CAL0002406

2.32

Uncharacterized ORF

CAL0001496

2.32

Uncharacterized ORF; Has domain(s) with predicted binding activity

CAL0003323

2.32

Uncharacterized ORF

CAL0004155

2.32

CAL0001260

2.31

Protein similar to a mitochondrial complex I intermediate-associated
protein
Putative mannosyltransferase; transcriptionally regulated by iron

CAL0002772

2.31

Uncharacterized ORF

CAL0004474

2.31

Uncharacterized ORF

CAL0005080

2.31

Transcriptional regulator of filamentous growth and hyphal genes

CAL0002685

2.31

Uncharacterized ORF

CAL0004446

2.31

Uncharacterized ORF

CAL0003287

2.31

Putative NADPH dehydrogenase

CAL0002266

2.31

Uncharacterized ORF

CAL0005826

2.30

Uncharacterized ORF

CAL0002857

2.30

CAL0000800

2.30

GATA transcription factor involved in regulation of filamentous
growth induced by nitrogen starvation
Putative GPI-anchored protein

CAL0005604

2.30

Uncharacterized ORF

CAL0005434

2.30

CAL0002875

2.30

Uncharacterized ORF; Ortholog(s) have phosphatidylinositol-4phosphate phosphatase activity
GDP-mannose transporter

CAL0002053

2.30

Putative pre-tRNA processing protein

Neutral arginine-, alanine-, leucine-specific metallo-aminopeptidase

P-value

1.00E-300
2.12E-88
2.95E-93
1.82E-33
1.29E-13
1.00E-300
4.40E-90
1.01E-16
1.19E-137
3.58E-19
4.35E-109
7.40E-63
5.89E-68
1.51E-35
1.00E-300
8.57E-248
1.69E-39
7.47E-65
5.52E-43
4.57E-14
5.36E-97
1.00E-300
4.75E-43
1.56E-88
5.58E-33
2.46E-11
8.44E-12
1.42E-27
4.86E-37
1.71E-227
0.0516619
8.97E-07
3.22E-12
9.33E-18
3.44E-59
0.0184641
1.46E-21
4.24E-85
2.27E-184
2.70E-63
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Table A-5 continued

Gene ID
CAL0004678

Fold upregulated
2.29

Function

CAL0001551

2.29

CAL0005455

2.29

Mannosyltransferase of glycosylphosphatidylinositol (GPI)
biosynthesis
Role in regulation of cell budding, protein monoubiquitination

CAL0001538

2.29

Putative peroxisomal copper amine oxidase

CAL0005436

2.29

VH1 family MAPK phosphatase

CAL0005945

2.29

Uncharacterized ORF; Putative kinase

CAL0004988

2.29

Uncharacterized ORF

CAL0003326

2.29

Uncharacterized ORF

CAL0002941

2.29

Uncharacterized ORF

CAL0002636

2.29

Uncharacterized ORF

CAL0004564

2.29

Uncharacterized ORF; Putative DNA replication factor A

CAL0002777

2.29

Putative secreted aspartyl protease

CAL0001352

2.29

Uncharacterized ORF

CAL0003053

2.28

Uncharacterized ORF

CAF0006892

2.28

Uncharacterized ORF

CAL0000595

2.28

Uncharacterized ORF

CAL0005015

2.28

Uncharacterized ORF

CAL0000101

2.28

Uncharacterized ORF; Putative heat shock protein

CAL0005740

2.28

Uncharacterized ORF

CAF0006989

2.28

CAL0004499

2.28

Cytoplasmic protein expressed specifically in white phase yeast
cells
Uncharacterized ORF

CAL0003800

2.28

NAD-dependent histone deacetylase

CAL0003915

2.27

1,3-beta-glucan-linked structural cell wall protein

CAL0004861

2.27

Triose-phosphate isomerase

CAL0001039

2.27

Uncharacterized ORF

CAL0006092

2.26

Role in mitochondrial respiratory chain complex III assembly

CAL0001476

2.26

Uncharacterized ORF; Putative protein

CAL0000235

2.26

Monooxygenase of the cytochrome P450 family

CAL0000237

2.26

CAL0003812

2.26

Uncharacterized ORF; Ortholog of <i>C. glabrata CBS138</i> :
CAGL0C02871g
Uncharacterized ORF

CAL0004007

2.26

CAL0004981

2.26

Uncharacterized ORF; Predicted ORF in Assemblies 19, 20 and 21;
Hog1p-downregulated
Putative beta-mannosyltransferase

CAL0000072

2.26

Uncharacterized ORF

CAL0001812

2.26

Uncharacterized ORF

CAL0004476

2.26

Zinc finger transcription factor

CAL0005210

2.26

Uncharacterized ORF; mitochondrion localization

CAL0001359

2.25

Protein involved in cell polarity

CAL0000328

2.25

Uncharacterized ORF; Putative RNA-binding protein

CAL0002621

2.25

CAL0003545

2.25

Protein with a role in MAP kinase kinase kinase of cell integrity
pathway
Uncharacterized ORF; role in mitochondrial fusion, mitochondrial
genome maintenance

Uncharacterized ORF

P-value

1.64E-67
5.52E-24
5.57E-46
4.08E-12
9.47E-30
2.67E-41
1.43E-17
1.34E-32
1.19E-19
9.09E-98
1.54E-197
0.00289642
3.55E-17
3.13E-14
2.60E-28
4.61E-105
3.70E-60
7.58E-42
3.29E-28
2.09E-10
4.51E-15
6.78E-102
1.82E-188
1.00E-300
8.49E-62
4.79E-143
4.20E-85
6.70E-07
2.26E-59
2.12E-54
3.51E-37
7.94E-82
7.39E-55
2.04E-49
2.16E-44
1.07E-116
7.27E-194
4.05E-148
1.42E-30
5.17E-78
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Table A-5 continued

Gene ID
CAL0000044

Fold upregulated
2.25

Function

CAL0006009

2.25

CAL0006397

2.25

CAL0003343

2.25

CAL0001625

2.25

CAL0005082

2.25

Zinc cluster DNA-binding transcription factor required for wild-type
hyphal extension
Uncharacterized ORF

CAL0005961

2.25

Putative glucokinase

CAL0004777

2.25

Putative component of the U1 snRNP, involved in splicing

CAL0000789

2.25

Uncharacterized ORF

CAL0004347

2.24

CAL0001681

2.24

Uncharacterized ORF; Ortholog(s) have tRNA adenylyltransferase
activity
Uncharacterized ORF; Putative mitochondrial protein

CAL0003512

2.24

Uncharacterized ORF

CAL0002825

2.24

Uncharacterized ORF; Hap43p-induced gene

CAL0000801

2.24

Uncharacterized ORF

CAL0003486

2.24

Uncharacterized ORF

CAL0000111

2.24

Uncharacterized ORF

CAL0004238

2.24

CAL0001732

2.24

Uncharacterized ORF; role in protein import into mitochondrial inner
membrane
Uncharacterized ORF

CAL0004553

2.24

Uncharacterized ORF; Hap43p-repressed gene

CAL0003779

2.23

CAL0006340

2.23

CAL0003180

2.23

Putative transcription factor with C3HC4 zinc finger DNA-binding
motif
Putative transcription factor with a role in colony morphology and
virulence
Phosphofructokinase beta subunit

CAL0002570

2.23

Putative magnesium ion transporter, mitochondrial

CAL0003790

2.23

Putative membrane transporter; Hap43p-induced gene

CAL0005423

2.23

Uncharacterized ORF

CAL0002649

2.23

Uncharacterized ORF

CAL0006027

2.23

Protein with similarity to ferric reductases

CAL0002629

2.23

Putative Cdc7p-Dbf4p kinase complex regulatory subunit

CAL0005441

2.23

Uncharacterized ORF

CAL0004808

2.23

CAL0005947

2.23

Protein similar Cullin-Associated Nedd8-Dissociated protein
involved in regulation of SCF complexes
Putative GPI-anchored adhesin-like protein

CAL0001554

2.23

Uncharacterized ORF; Transcriptionally regulated by iron

CAL0000270

2.23

Kinesin-like microtubule motor protein

CAL0003306

2.23

3-Keto sterol reductase of ergosterol biosynthesis

CAL0004640

2.23

Uncharacterized ORF

CAL0000537

2.23

Uncharacterized ORF

CAL0000549

2.22

Uncharacterized ORF

CAL0004070

2.22

Uncharacterized ORF

CAL0000444

2.22

Uncharacterized ORF

Putative glucosyltransferase involved in cell wall mannan
biosynthesis
Uncharacterized ORF
Delta(24)-sterol C-methyltransferase, converts zymosterol to
fecosterol in ergosterol biosynthesis
Protein involved in telomere maintenance

P-value

2.39E-31
1.62E-262
1.00E-300
0.00042065
1.34E-05
1.46E-196
1.90E-72
7.21E-21
6.74E-05
1.43E-85
1.32E-32
1.15E-19
9.81E-45
1.32E-18
1.06E-18
1.55E-20
6.37E-53
3.61E-139
6.44E-48
4.68E-179
3.48E-25
1.00E-300
7.73E-34
7.33E-25
3.11E-94
9.82E-15
1.82E-05
4.38E-52
1.37E-42
4.93E-83
0.0103604
1.81E-77
4.35E-18
1.13E-70
4.70E-38
3.73E-116
3.99E-180
3.60E-14
1.00E-300
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Table A-5 continued

Gene ID
CAL0000462

Fold upregulated
2.22

Function

CAL0004647

2.22

Activator of Chs3p chitin synthase

CAL0001930

2.22

Uncharacterized ORF

CAL0000768

2.22

DNA polymerase epsilon

CAL0003016

2.22

Protein with role in resistance to host antimicrobial peptides

CAL0005175

2.22

Uncharacterized ORF

CAL0002392

2.22

Uncharacterized ORF

CAL0000668

2.22

Protein similar to ferric reductase Fre10p

CAL0004525

2.22

Uncharacterized ORF

CAL0004177

2.22

Uncharacterized ORF

CAL0004663

2.21

Putative allantoin permease

CAL0004305

2.21

Uncharacterized ORF

CAL0000090

2.21

Uncharacterized ORF; Putative transporter

CAL0003062

2.21

CAL0002010

2.21

Plasma membrane-localized protein of unknown function; Hap43prepressed gene
Putative mitochondrial respiratory protein

CAL0001212

2.21

DNA binding protein with Cys2-His2 zinc-finger

CAL0005569

2.21

Putative U3 snoRNP protein

CAL0000217

2.21

CAL0005422

2.21

Protein kinase of Ste20p/p65PAK family, required for wild-type
mating efficiency
Protein required for chlamydospore formation

CAL0005518

2.20

Ubiquitin-activating enzyme

CAL0000415

2.20

Phosphoglycerate kinase

CAL0000516

2.20

Putative glutamate synthase

CAL0005212

2.20

Putative patatin-like phospholipase

CAL0004496

2.20

Dubious ORF

CAL0001593

2.20

Phosphoacetylglucosamine mutase

CAL0000849

2.20

Putative GPI-anchored protein

CAL0005623

2.20

Putative bud formation and morphogenesis protein

CAL0005443

2.20

Uncharacterized ORF

CAL0005185

2.20

CAL0001227

2.20

Essential protein with similarity to S. cerevisiae Cdc13p, involved in
telomere maintenance
Uncharacterized ORF

CAL0004414

2.20

Putative diacylglycerol kinase activity

CAL0001388

2.19

Member of RNase L inhibitor (RLI) subfamily of ABC family

CAL0002640

2.19

Putative mannoprotein of cell wall with role in response to stress

CAL0005578

2.19

Uncharacterized ORF

CAL0005862

2.19

Endoplasmic reticulum (ER) protein-translocation complex subunit

CAL0005255

2.19

Uncharacterized ORF

CAF0007077

2.19

Putative nuclear protein

CAL0002673

2.19

Uncharacterized ORF; Similar to thioredoxins

CAL0003775

2.19

Cell wall protein, regulated by Sef1p, Sfu1p, Hap43p

CAL0003698

2.19

Uncharacterized ORF

CAL0004726

2.19

Uncharacterized ORF

Catalase; resistance to oxidative stress

P-value

3.73E-246
5.33E-155
1.07E-113
4.90E-70
5.24E-257
5.86E-45
4.99E-17
8.74E-10
2.46E-86
3.74E-213
2.20E-08
2.38E-42
8.32E-21
2.15E-37
1.33E-22
2.60E-58
8.07E-202
7.51E-64
7.91E-44
1.00E-300
1.00E-300
1.06E-267
9.64E-10
0.0828716
1.15E-83
1.76E-19
3.27E-34
7.29E-102
1.43E-21
1.99E-05
3.90E-57
3.79E-233
6.51E-32
0.000351824
7.82E-219
6.29E-14
1.28E-15
0.00722364
3.44E-64
4.04E-21
1.40E-170
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Table A-5 continued

Gene ID
CAL0000338

Fold upregulated
2.19

Function

CAL0003091

2.18

CAL0006264

2.18

CAL0004677

2.18

Uncharacterized ORF, role in phosphatidylinositol
dephosphorylation
Uncharacterized ORF

CAL0000438

2.18

Uncharacterized ORF

CAL0000406

2.18

Copper transporter

CAL0003535

2.18

Mitochondrial ribosomal protein S9

CAL0004983

2.18

Uncharacterized ORF

CAL0002198

2.18

Uncharacterized ORF

CAL0003835

2.18

Uncharacterized ORF

CAL0004788

2.18

Uncharacterized ORF

CAL0003142

2.17

CAL0006105

2.17

Putstive role in protein import into mitochondrial matrix and
mitochondrial inner membrane presequence translocase complex
localization
Uncharacterized ORF

CAL0006372

2.17

Uncharacterized ORF

CAL0003001

2.17

Delta-12 fatty acid desaturase

CAL0003916

2.17

Uncharacterized ORF

CAL0005285

2.17

Activator of CDR1 induction by antifungal drugs

CAL0005804

2.17

CAF0007117

2.17

Putative role in mitochondrial translation and mitochondrion
localization
Role in protein refolding and mitochondrial matrix localization

CAL0002012

2.17

Uncharacterized ORF

CAL0005490

2.16

Uncharacterized ORF

CAL0001022

2.16

Uncharacterized ORF

CAL0005830

2.16

Putative mitochondrial ribosomal protein

CAL0005224

2.16

ERK-family protein kinase

CAL0002858

2.16

Verified ORF; Protein required for respiratory growth

CAL0004372

2.16

CAL0004422

2.16

Ortholog(s) have tubulin binding activity, role in microtubule
cytoskeleton organization, mitochondrion inheritance
Protein with a possible role in ER to Golgi transport

CAL0000739

2.16

Putative heat shock protein

CAL0001772

2.16

Uncharacterized ORF

CAL0005975

2.16

Uncharacterized ORF

CAL0006341

2.16

Biofilm- and planktonic growth-induced gene

CAL0005820

2.15

Uncharacterized ORF

CAL0003344

2.15

CAL0001255

2.15

Histidine kinase involved in a two-component signaling pathway that
regulates cell wall biosynthesis
Uncharacterized ORF

CAL0001626

2.15

Uncharacterized ORF

CAL0005406

2.15

Putative transporter

CAL0005404

2.15

Phosphatidylinositol 3-phosphate 5-kinase

CAL0003518

2.15

Putative RNA exonuclease

CAL0002210

2.15

Uncharacterized ORF

Ortholog(s) have structural constituent of ribosome activity and
mitochondrial large ribosomal subunit localization
Uncharacterized ORF

P-value

1.55E-256
1.01E-13
1.69E-18
0.0164763
4.79E-13
1.13E-122
3.92E-239
0.0120357
9.00E-26
6.17E-55
5.32E-18
7.31E-94
8.47E-68
2.68E-05
4.27E-247
2.36E-27
5.11E-146
1.10E-47
5.14E-263
1.17E-12
2.77E-48
1.33E-42
8.03E-262
1.50E-40
4.27E-65
1.48E-112
1.00E-300
6.77E-08
2.20E-19
4.06E-14
1.55E-23
8.99E-254
1.54E-46
1.19E-16
4.31E-21
1.21E-177
1.46E-43
1.52E-11
9.16E-07
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Table A-5 continued

Gene ID
CAL0004475

Fold upregulated
2.15

Function

CAL0005260

2.15

Putative kynurenine 3-monooxygenase

CAL0000261

2.15

Integrin-like protein

CAL0006159

2.14

Uncharacterized ORF

CAL0003115

2.14

CAL0002681

2.14

Similar to Snu114p, which is an RNA helicase involved in premRNA splicing
Uncharacterized ORF

CAL0002861

2.14

Uncharacterized ORF

CAL0000869

2.14

Uncharacterized ORF

CAL0002071

2.14

Uncharacterized ORF

CAL0006185

2.14

Uncharacterized ORF

CAL0000959

2.14

Copper-transporting P-type ATPase of Golgi

CAL0000615

2.14

Uncharacterized ORF

CAL0001739

2.14

CAL0000463

2.14

kinesin from the bipolar family; involved in formation of mitotic
spindle
Septin

CAL0005619

2.14

Uncharacterized ORF

CAL0005953

2.14

Putative class III aminotransferase

CAL0005231

2.14

CAL0001612

2.14

Putative role in cellular zinc ion homeostasis and mitochondrial
matrix localization
Uncharacterized ORF

CAL0000192

2.13

Uncharacterized ORF

CAL0002960

2.13

Uncharacterized ORF

CAL0003350

2.13

CAL0002441

2.13

Putative component of the microtubule-nucleating gamma-tubulin
complex
Verified ORF; Protein with similarity to S. cerevisiae Pin4p

CAL0004671

2.13

Uncharacterized ORF

CAL0004773

2.13

Putative acyl CoA synthetase

CAL0004150

2.13

Component of mitochondrial ribosome

CAL0003753

2.13

Hyphal cell wall protein

CAL0002204

2.13

GPI-linked chitinase required for normal filamentous growth

CAL0001958

2.13

Mannosyltransferase

CAL0003546

2.13

Uncharacterized ORF

CAL0006152

2.13

Putative RNA helicase

CAL0000977

2.13

Role in ER-associated protein catabolic process

CAL0006130

2.13

CAL0005698

2.13

Role in mitochondrial threonyl-tRNA aminoacylation and
mitochondrion localization
Uncharacterized ORF

CAL0002725

2.13

Uncharacterized ORF

CAL0005346

2.12

CAL0005954

2.12

Putative hexameric MCM complex subunit with a predicted role in
control of cell division
Putative transcriptional repressor

CAL0002606

2.12

CAL0000070

2.12

Essential transcriptional activator that regulates ribosomal protein
genes and the rDNA locus
Uncharacterized ORF

CAL0002529

2.12

Cell wall adhesin-like protein

Uncharacterized ORF

P-value

1.30E-145
3.30E-150
1.60E-85
5.80E-38
9.83E-27
3.55E-60
5.85E-122
2.30E-128
2.94E-25
1.42E-08
2.32E-24
8.83E-61
8.18E-15
1.56E-83
6.61E-38
0.00281208
2.10E-56
3.92E-08
1.02E-38
1.13E-69
2.92E-19
7.83E-64
1.03E-55
2.98E-08
2.88E-209
4.38E-05
1.00E-300
4.92E-39
0.000580363
1.20E-24
1.90E-50
1.44E-75
1.40E-14
1.23E-09
3.98E-68
4.04E-36
1.95E-52
5.86E-34
8.21E-15
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Table A-5 continued

Gene ID
CAL0000527

Fold upregulated
2.12

Function

CAL0004337

2.12

Ortholog(s) have protein binding, bridging activity

CAL0004782

2.12

Putative transcription factor with zinc cluster DNA-binding motif

CAL0000437

2.12

Uncharacterized ORF

CAL0005448

2.12

Putative mitochondrial RNA polymerase specificity factord

CAL0001479

2.12

Member of PDR subfamily of ABC family

CAL0004753

2.12

Zinc-finger protein; regulator of MDR1 transcription

CAL0004400

2.12

CAL0003395

2.11

Putative component of the MBF and SBF transcription complexes
involved in G1/S cell-cycle progression
Putative GPI-anchored adhesin-like protein

CAL0002781

2.11

Predicted membrane transporter

CAL0006077

2.11

Putative transcription factor with zinc finger DNA-binding motif

CAL0006238

2.11

Uncharacterized ORF

CAL0003451

2.11

Putative protein of unknown function

CAL0000288

2.11

Uncharacterized ORF

CAL0004686

2.11

Uncharacterized ORF

CAL0004712

2.11

Protein of beta-1,6-glucan synthesis

CAL0002610

2.11

Uncharacterized ORF; Hap43p-repressed gene

CAL0001819

2.11

Putative oxysterol-binding protein

CAL0003329

2.11

DNA topoisomerase type I activity

CAL0004461

2.11

Uncharacterized ORF

CAL0002014

2.10

Uncharacterized ORF

CAL0002015

2.10

Putative heteropentameric replication factor C subunit

CAL0003708

2.10

Putative transcription factor with zinc cluster DNA-binding motif

CAL0000074

2.10

Uncharacterized ORF

CAL0000186

2.10

Uncharacterized ORF

CAL0000531

2.10

Uncharacterized ORF

CAL0003492

2.10

Uncharacterized ORF

CAL0002327

2.10

Uncharacterized ORF

CAL0001082

2.10

Uncharacterized ORF

CAL0001228

2.10

Member of MDR subfamily of ABC family

CAL0005369

2.10

Transcriptional activator; regulates filamentous growth

CAL0005596

2.10

CNT family H(+)/nucleoside symporter

CAL0004656

2.10

Putative 3'-5' RNA exonuclease

CAL0006201

2.10

Involved in acidification of the vacuole

CAL0002234

2.10

Uncharacterized ORF

CAL0004910

2.09

Protein involved in sphingolipid biosynthesis

CAL0002186

2.09

Uncharacterized ORF

CAL0005742

2.09

Role in chaperone-mediated protein complex assembly

CAL0005679

2.09

Uncharacterized ORF

CAL0003791

2.09

CAL0000346

2.09

Protein with homology to mitochondrial intermembrane space
proteins; regulated by Sef1p-, Sfu1p-, and Hap43p
Uncharacterized ORF

Uncharacterized ORF

P-value

4.19E-08
9.23E-58
0.000378361
2.84E-16
8.09E-68
9.21E-64
1.87E-24
9.71E-50
1.27E-16
1.48E-19
7.02E-24
3.59E-15
8.38E-19
5.85E-26
2.77E-217
2.69E-72
8.97E-76
5.47E-103
4.39E-18
8.66E-11
5.70E-76
6.47E-39
1.12E-34
3.07E-17
4.21E-07
2.25E-68
1.36E-29
3.46E-158
8.89E-14
3.29E-41
3.99E-05
4.23E-183
6.17E-48
1.92E-57
4.13E-12
3.26E-44
2.09E-08
2.00E-108
2.33E-23
3.09E-47
2.07E-38
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Table A-5 continued

Gene ID
CAL0003516

Fold upregulated
2.09

Function

CAL0005087

2.09

Uncharacterized ORF

CAL0003695

2.09

Uncharacterized ORF

CAL0005435

2.08

Uncharacterized ORF

CAL0004523

2.08

Putative nuclear pore membrane glycoprotein

CAL0005915

2.08

Putative thymidylate synthase

CAL0003522

2.08

Predicted role in sphingolipid-mediated signaling pathway

CAL0005039

2.08

Ortholog(s) have ubiquitin binding activity

CAL0004451

2.08

Putative phosphatidylinositol 3-phosphate (PI3P) phosphatase

CAL0003511

2.08

NADPH-cytochrome P450 reductase

CAL0005246

2.08

Uncharacterized ORF

CAL0005461

2.08

Uncharacterized ORF

CAL0002620

2.08

Putative NAD-dependent (R,R)-butanediol dehydrogenase

CAL0005144

2.08

Putative role in regulation of biogenesis of the cell wall

CAL0003872

2.08

Putative adhesin-like protein

CAL0000767

2.08

Uncharacterized ORF

CAL0002954

2.07

Putative GTPase-activating protein

CAL0004925

2.07

Acts in regulation of glycolytic genes

CAL0003049

2.07

Uncharacterized ORF; Putative DNA polymerase III subunit

CAL0001944

2.07

Uncharacterized ORF

CAL0001642

2.07

Putative adhesin-like protein involved in cell wall maintenance

CAL0004886

2.07

CAL0006136

2.07

Uncharacterized ORF; Ortholog(s) have structural constituent of
ribosome activity and mitochondrial small ribosomal subunit
localization
Putative nuclear polyadenylated RNA-binding protein

CAL0004962

2.07

CAL0003054

2.07

Ortholog(s) have phospholipid-translocating ATPase activity and
role in intracellular protein transport
Putative cell wall protein

CAL0006042

2.07

Uncharacterized ORF

CAL0005725

2.07

Putative pre-mRNA processing RNA-helicase

CAL0006099

2.07

ER protein-translocation complex subunit

CAL0003713

2.07

Uncharacterized ORF

CAL0000105

2.07

Role in ER to Golgi vesicle-mediated transport

CAL0004157

2.07

CAL0003413

2.06

Role in mitochondrial asparaginyl-tRNA aminoacylation and
mitochondrion localization
Beta-mannosyltransferase

CAL0006031

2.06

Uncharacterized ORF; Putative cyclin-like protein

CAL0000084

2.06

Uncharacterized ORF

CAL0005879

2.06

Role in protein import into mitochondrial matrix

CAL0004527

2.06

Inositol phosphoryl transferase

CAL0004063

2.06

Predicted membrane transporter

CAL0002306

2.06

Role in mitotic cell cycle spindle orientation checkpoint

CAL0002583

2.06

Uncharacterized ORF; Putative multidrug resistance factor

CAL0004535

2.06

Uncharacterized ORF

Putative GPI transamidase

P-value

2.29E-48
3.43E-15
3.53E-70
4.98E-39
1.21E-72
5.61E-42
4.00E-35
4.00E-231
5.50E-28
5.19E-243
1.59E-27
2.66E-166
0.0546733
3.00E-24
3.75E-25
9.89E-16
1.34E-283
2.01E-144
3.87E-50
2.45E-11
1.00E-300
2.00E-99
1.04E-70
1.25E-54
8.06E-20
1.22E-33
2.15E-36
1.00E-300
9.99E-14
7.56E-254
1.22E-40
1.94E-11
3.68E-191
1.16E-22
4.04E-83
1.43E-25
1.73E-20
3.54E-09
6.41E-21
3.51E-12
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Table A-5 continued

Gene ID
CAL0004924

Fold upregulated
2.06

Function

CAL0000073

2.06

Uncharacterized ORF; Hap43p-repressed gene

CAL0005807

2.06

Ortholog(s) have role in protein targeting to vacuole

CAL0003539

2.06

Rhomboid-like protein

CAL0000177

2.06

Putative aminopeptidase

CAL0004387

2.06

Uncharacterized ORF

CAL0004319

2.06

Putative regulatory subunit of trehalose-phosphate synthase

CAL0002873

2.06

Uncharacterized ORF; Ortholog(s) have mitochondrion localization

CAL0002555

2.06

Uncharacterized ORF

CAL0006314

2.05

Protein similar to quinone oxidoreductases

CAL0005655

2.05

Uncharacterized ORF; Hap43p-induced gene

CAL0004985

2.05

Putative ammonia transport protein

CAL0001871

2.05

Uncharacterized ORF

CAL0004219

2.05

Predicted phosphotransferase activity

CAL0002638

2.05

Uncharacterized ORF

CAL0003727

2.05

Uncharacterized ORF

CAL0001431

2.05

Putative phospholipase

CAL0004037

2.05

Uncharacterized ORF;

CAL0000342

2.05

Putative vesicular transport protein

CAL0005647

2.05

Putative DNA-binding transcription factor

CAL0001274

2.05

CAL0004781

2.05

Ortholog(s) have structural constituent of ribosome activity and
mitochondrial large ribosomal subunit localization
Putative transcription factor with zinc finger DNA-binding motif

CAL0004606

2.05

Uncharacterized ORF

CAL0003093

2.05

Uncharacterized ORF

CAL0003032

2.05

Uncharacterized ORF

CAL0002576

2.05

CAL0003873

2.05

CAL0006212

2.05

Role in protein import into mitochondrial inner membrane and
mitochondrial inner membrane protein insertion complex localization
Putative vacuolar membrane protein with a predicted role in
sphingolipid metabolism
Putative casein kinase

CAL0005955

2.05

Uncharacterized ORF

CAL0005556

2.05

Uncharacterized ORF

CAL0001252

2.05

Protein part of the CCR4-NOT transcription regulatory complex

CAF0006960

2.04

Ortholog(s) have structural constituent of ribosome activity

CAL0003480

2.04

Serine/threonine protein phosphatase catalytic subunit

CAL0005343

2.04

Involved in ubiquitin-mediated protein degradation

CAL0001018

2.04

Putative serine/threonine protein kinase; Hog1p-induced

CAL0004213

2.04

Uncharacterized ORF

CAL0002501

2.04

Dubious ORF; Late-stage biofilm-induced gene

CAL0003745

2.04

Ortholog(s) have chromatin binding activity

CAL0000365

2.03

Putative cell wall assembly regulatory protein;

CAL0001016

2.03

Uncharacterized ORF; Ortholog(s) have protein anchor activity

CAL0001175

2.03

Putative mitochondrial exonuclease

Putative translation initiation factor

P-value

1.56E-297
3.63E-15
2.82E-12
7.58E-37
2.34E-12
0.0397405
4.47E-103
1.12E-25
1.09E-12
9.60E-11
1.46E-06
1.97E-72
1.92E-236
2.16E-55
8.55E-120
6.89E-09
3.09E-97
8.39E-07
3.66E-116
2.94E-12
3.64E-38
2.42E-12
1.21E-13
0.00152667
3.99E-71
4.33E-195
1.76E-44
3.60E-23
7.70E-28
9.43E-25
9.66E-129
9.86E-60
1.00E-40
2.91E-93
1.19E-35
0.0135147
0.144972
2.60E-61
2.15E-20
2.26E-83
6.43E-14
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Table A-5 continued

Gene ID
CAL0004029

Fold upregulated
2.03

Function

CAL0001427

2.03

Putative Arf3p GTPase activating protein; Hap43p-repressed gene

CAL0001302

2.03

Putative GPI-anchored adhesin-like protein

CAL0002855

2.03

Putative S-adenosyl-L-homocysteine hydrolase

CAL0004269

2.03

CAL0004406

2.03

Putative GTPase-activating protein; involved in cell signaling
pathways that control cell polarity
Uncharacterized ORF

CAL0002762

2.03

CAL0002547

2.03

Putative component of the SBF transcription complex involved in
G1/S cell-cycle progression
Putative protein disulfide-isomerase

CAL0001722

2.02

Uncharacterized ORF

CAL0000127

2.02

Uncharacterized ORF

CAL0006318

2.02

CAL0005717

2.02

Protein with similarity to fatty acid desaturase (stearoyl-CoA
desaturase)
Ortholog(s) have Rho GTPase activator activity

CAL0002765

2.02

CAL0003877

2.02

Protein with a predicted role in docking and fusion of post-Golgi
vesicles with the plasma membrane
Ortholog(s) have role in pseudohyphal growth

CAL0005023

2.02

Uncharacterized ORF

CAL0004481

2.02

Subtilisin-like protease (proprotein convertase)

CAL0001621

2.02

Putative serine palmitoyltransferase component

CAL0003712

2.02

Uncharacterized ORF; Hap43p-repressed gene

CAL0005225

2.02

Uncharacterized ORF

CAL0006108

2.02

Uncharacterized ORF; Hap43p-repressed gene

CAL0001280

2.02

Transcription factor; regulates hyphal gene expression

CAL0000071

2.01

Alpha-1,2-mannosyl transferase

CAL0005672

2.01

Ortholog(s) have trans-hexaprenyltranstransferase activity

CAL0120555

2.01

Uncharacterized ORF

CAL0003666

2.01

Putative role in nonsense-mediated mRNA decay

CAL0006369

2.01

Putative cytochrome c oxidase assembly protein

CAL0003146

2.01

Ortholog(s) have FAD transmembrane transporter activity

CAL0001700

2.01

Ortholog(s) have DNA helicase activity

CAL0001915

2.01

Putative transcription factor, regulator of purine biosynthetic genes

CAL0000132

2.01

Phosphorylated protein

CAL0004392

2.01

Putative phenylalanine-tRNA ligase

CAL0002780

2.01

Putative thiol-specific monooxygenase

CAL0004359

2.01

Putative DNA-dependent ATPase

CAL0006187

2.01

Ortholog(s) have structural constituent of ribosome activity

CAL0001654

2.01

Uncharacterized ORF; Has domain(s) with predicted binding activity

CAL0004881

2.01

Uncharacterized ORF

CAL0003506

2.01

Uncharacterized ORF; Putative acyl-CoA thioesterase

CAL0005220

2.01

Putative high-affinity, high-capacity xanthine-uric acid/H+ symporter

CAL0000068

2.01

Ortholog(s) have structural constituent of ribosome activity

CAL0004274

2.01

Uncharacterized ORF

Uncharacterized ORF

P-value

3.13E-39
1.89E-31
4.17E-24
1.00E-300
5.78E-31
2.08E-65
1.45E-57
1.00E-300
2.03E-11
2.15E-25
2.26E-33
7.35E-81
6.67E-62
6.58E-13
1.92E-24
1.68E-69
7.37E-86
8.14E-101
6.84E-30
5.78E-231
1.23E-52
1.00E-300
6.47E-113
7.04E-13
2.93E-98
2.38E-30
1.68E-07
5.70E-56
2.74E-39
2.23E-34
1.91E-92
3.24E-15
2.87E-19
1.01E-156
3.35E-16
2.13E-31
5.45E-09
2.45E-08
2.27E-156
1.93E-07
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Table A-5 continued

Gene ID
CAL0000743

Fold upregulated
2.01

Function

CAL0000027

2.01

CAL0002272

2.01

CAL0002739

2.00

Transcriptional activator that likely regulates genes involved in
phosphatidylcholine and phosphatidylinositol biosynthesis
Uncharacterized ORF; Ortholog(s) have role in translational
termination and nucleus localization
Required asymmetric inheritance of oxidatively damaged proteins

CAL0003059

2.00

Probable transcription factor required for filamentous growth

CAL0004311

2.00

Uncharacterized ORF

CAL0002493

2.00

Predicted methyltransferase activity and role in RNA capping

CAL0001948

2.00

Uncharacterized ORF

CAL0006370

2.00

Putative transcription factor with zinc cluster DNA-binding motif

CAL0001272

2.00

MAP kinase kinase kinase (MAPKKK) that regulates Hog1p
activation and signaling

Alpha-1,2-mannosyltransferase

P-value

5.09E-75
8.50E-06
5.45E-138
1.18E-07
7.61E-21
6.27E-16
3.28E-23
4.62E-17
1.42E-09
4.85E-74
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Table A-6: List of all the genes down-regulated in the psd1∆/∆psd2∆/∆ mutant compared
to the wild-type strain
Gene ID
CAL0004548

Folddownregulated
132.07

CGD Function
Alternative oxidase

CAL0000931

115.14

Uncharacterized ORF

CAL0000982

73.36

Formate dehydrogenase

CAL0001883

50.68

Uncharacterized ORF

CAF0006908

36.29

CAL0001258

19.28

Uncharacterized ORF; Hap43p-repressed gene; hypoxia
downregulated
Uncharacterized ORF; Hap43p-induced gene

CAL0005695

18.42

Uncharacterized ORF

CAL0120803

17.58

Uncharacterized ORF

CAL0000550

14.28

Glycerophosphoinositol permease

CAL0002678

13.70

Similar to heat-shock protease protein

CAL0002987

10.18

CAL0004080

9.95

Putative oxidoreductase, iron utilization; regulated by Sfu1p,
Sef1p, Hap43p
Uncharacterized ORF; Hap43p-repressed gene

CAL0000590

9.51

Uncharacterized ORF

CAL0002189

8.56

Uncharacterized ORF

CAL0005929

7.97

Putative oxidoreductase

CAL0000501

7.75

Putative potassium transporter

CAL0004550

7.70

Alternative oxidase

CAL0003857

7.53

Uncharacterized ORF; Hap43p-repressed gene

CAL0001071

7.21

Nitric oxide dioxygenase

CAL0003313

7.07

CAL0000448

6.66

Late-stage biofilm-induced gene; induced by nitric oxide;
Hap43p-repressed
UDP-glucose 4-epimerase

CAL0004676

6.29

CAL0006389

6.21

Protein similar to Pcl5p and other cyclins for Pho85p kinase;
Gcn4p-induced
Phosphoenolpyruvate carboxykinase

CAL0002175

6.15

Uncharacterized ORF

CAL0000451

5.98

CAL0003136

5.70

Putative galactose-1-phoshphate uridyl transferase;
downregulated by hypoxia
Putative high-affinity maltose transporter

CAL0005139

5.66

Uncharacterized ORF; Hap43p-repressed gene

CAL0001847

5.66

Protein of unknown function; Plc1p-regulated

CAL0000195

5.57

Uncharacterized ORF; Hap43p-induced gene

CAL0003582

5.54

CAL0003856

5.32

Putative transcription factor with zinc finger DNA-binding
motif
Dubious ORF

CAL0002350

5.29

CAL0004997

5.26

Response regulator of a two-component system involved in
stress, morphogenesis, virulence
Uncharacterized ORF

CAL0001097

5.24

Uncharacterized ORF; Similar to cell wall proteins

CAL0005709

4.92

Putative phosphatidyl synthase

CAL0003246

4.90

TEA/ATTS transcription factor involved in pheromone
response in white cells

P-value
1.00E-300
1.00E-300
1.00E-300
1.00E-300
1.00E-300
1.00E-300
3.21E-58
1.69E-195
1.00E-300
1.08E-143
1.64E-55
1.00E-300
1.00E-300
1.00E-300
1.00E-300
3.63E-224
1.80E-66
3.23E-140
1.26E-200
1.00E-300
1.00E-300
3.85E-247
1.00E-300
2.32E-135
1.00E-300
1.00E-300
1.00E-300
3.94E-55
3.36E-86
1.00E-300
5.08E-96
1.00E-300
2.49E-168
8.61E-155
1.00E-300
1.00E-300
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Table A-6 continued

Gene ID
CAL0004456

Folddownregulated
4.90

CGD Function
Copper- and zinc-containing superoxide dismutase

CAL0003028

4.88

Uncharacterized ORF

CAL0002696

4.77

High-affinity glucose transporter

CAL0005548

4.61

Plasma membrane-localized protein

CAL0004872

4.39

Uncharacterized ORF

CAL0000706

4.39

Uncharacterized ORF

CAL0003529

4.35

Uncharacterized ORF

CAL0001013

4.13

Uncharacterized ORF

CAL0002216

4.08

CAL0003860

4.07

ADP-ribosylation factor, probable GTPase involved in
intracellular transport
Predicted type 2C protein phosphatase

CAL0004432

3.94

Possible role in polyamine transport; MFS-MDR family

CAL0003510

3.88

Uncharacterized ORF

CAL0120801

3.87

Uncharacterized ORF

CAF0006934

3.80

Protein involved in ATP biosynthesis

CAL0000843

3.70

Uncharacterized ORF; Hap43p-repressed gene

CAL0004487

3.70

Major cell-surface ferric reductase under low-iron conditions

CAL0003807

3.59

Putative protein phosphatase inhibitor; Hap43p-repressed

CAL0120807

3.57

Putative adhesin-like protein

CAL0005504

3.52

CAL0006378

3.46

Protein similar to S. cerevisiae Ecm21p ; alkaline upregulated
by Rim101p
Uncharacterized ORF; Hap43p-repressed gene; biofilminduced

CAL0005271

3.35

Copper- and zinc-containing superoxide dismutase

CAL0003653

3.34

Putative alcohol dehydrogenase

CAL0004170

3.32

CAL0120629

3.26

Predicted flavin adenine dinucleotide binding, oxidoreductase
activity and role in oxidation-reduction process
Uncharacterized ORF

CAL0004199

3.25

Uncharacterized ORF; Hap43p-repressed gene

CAL0003785

3.16

Uncharacterized ORF; Beta-mannosyltransferase

CAL0003833

3.14

Uncharacterized ORF

CAL0001177

3.09

Uncharacterized ORF

CAL0120835

2.98

Uncharacterized ORF

CAL0001581

2.95

Uncharacterized ORF; Protein similar to pirin

CAL0004585

2.92

Uncharacterized ORF

CAL0005860

2.92

Uncharacterized ORF

CAL0120981

2.92

Uncharacterized ORF

CAL0120705

2.92

Uncharacterized ORF

CAL0000450

2.91

Putative UDP-glucose-4-epimerase

CAL0002961

2.89

Uncharacterized ORF; Hap43p-repressed gene

CAL0003891

2.85

Uncharacterized ORF

CAL0001598

2.85

Uncharacterized ORF

CAL0004943

2.85

Uncharacterized ORF

CAL0004792

2.85

Putative fumarate hydratase

P-value
1.00E-300
1.00E-300
1.00E-300
4.29E-20
1.00E-300
1.00E-300
4.59E-284
8.02E-133
4.88E-19
1.00E-300
3.72E-291
1.00E-300
1.00E-300
1.00E-300
8.16E-146
1.00E-300
1.00E-300
1.41E-293
8.71E-36
0.00013006
8
8.01E-254
1.58E-207
3.24E-128
1.00E-300
1.26E-41
0.00445478
4.87E-147
5.25E-29
4.26E-06
1.10E-26
1.00E-300
3.46E-79
1.24E-25
5.01E-25
1.00E-300
6.97E-14
9.13E-102
1.47E-42
8.23E-49
1.00E-300
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Table A-6 continued

Gene ID
CAL0000972

Folddownregulated
2.84

CGD Function
Putative methyltransferase

CAL0004974

2.83

Uncharacterized ORF

CAL0002816

2.82

Uncharacterized ORF

CAL0120493

2.80

Pseudogene

CAL0001619

2.78

Uncharacterized ORF; ATP sulfurlyase of sulfate assimilation

CAL0004502

2.77

CAL0004289

2.74

Protein that affects filamentous growth; late-stage biofilminduced gene
Putative subunit of the F1F0-ATPase complex

CAL0000682

2.72

Uncharacterized ORF; Similar to glutathione peroxidase

CAL0006076

2.71

Putative transmembrane protein

CAL0005475

2.70

Putative NAD-specific glutamate dehydrogenase

CAL0005645

2.70

CAL0002676

2.69

Putative glucose transporter of the major facilitator
superfamily
Putative glycerophosphoinositol permease

CAL0004471

2.67

CAL0000649

2.66

Putative protein with a predicted role in mitochondrial iron
metabolism; Hap43p-repressed gene
Ortholog(s) have oxidoreductase activity

CAL0002133

2.65

Uncharacterized ORF

CAL0005376

2.64

Ortholog(s) have oxidoreductase activity

CAL0002044

2.63

Putative glutamate decarboxylase

CAL0004247

2.60

GPI-anchored cell wall protein

CAF0007037

2.59

Protein localized to the mitochondrial membrane

CAL0001649

2.57

Uncharacterized ORF; Hap43p-induced gene

CAL0003690

2.56

CAL0004054

2.56

Putative adenylylsulfate kinase; predicted role in sulfur
metabolism
Uncharacterized ORF

CAL0003826

2.55

Uncharacterized ORF

CAF0006952

2.54

Uncharacterized ORF

CAF0007053

2.54

Uncharacterized ORF

CAL0004298

2.51

CAL0006005

2.51

Transcription factor with zinc cluster DNA-binding motif
involved in glycolysis
Uncharacterized ORF

CAL0005909

2.50

Protein with Gal4p-like DNA-binding domain

CAL0006377

2.50

Putative 3-dehydroquinate dehydratase

CAL0005485

2.49

CAL0001146

2.49

CAL0002956

2.46

Putative endoplasmic reticulum protein; possibly adherenceinduced
Putative constitutive acid phosphatase; negatively regulated
by Rim101p
Putative phosphate permease

CAL0002899

2.46

Putative GPI-anchored protein; Hap43p-repressed gene

CAL0120690

2.45

Uncharacterized ORF

CAL0120739

2.45

Uncharacterized ORF

CAL0000788

2.44

Putative glucoamylase

CAL0120789

2.44

Uncharacterized ORF

CAL0004657

2.43

Cytochrome c oxidase

CAL0000439

2.42

Putative glucose transporter of the major facilitator
superfamily

P-value
1.42E-181
1.00E-300
2.16E-229
7.08E-30
3.17E-08
1.20E-25
1.96E-15
9.16E-96
1.00E-300
1.00E-300
1.06E-08
1.00E-300
3.00E-137
3.09E-257
7.41E-284
7.60E-121
1.00E-300
6.82E-106
1.00E-300
1.00E-300
1.00E-300
1.51E-10
6.54E-61
5.91E-18
1.34E-11
1.00E-300
1.00E-300
1.00E-300
8.38E-253
8.86E-53
1.00E-300
1.77E-273
8.00E-33
1.48E-62
8.64E-06
1.23E-221
4.63E-06
1.36E-72
2.50E-104
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Table A-6 continued

Gene ID
CAL0001572

Folddownregulated
2.41

CGD Function
Uncharacterized ORF

CAL0005980

2.39

Putative F0-ATP synthase subunit 4

CAF0007126

2.38

Mitochondrial ATPase complex subunit

CAL0120954

2.35

Uncharacterized ORF

CAL0001467

2.35

Glycerol permease involved in glycerol uptake

CAF0007051

2.34

Putative mitochondrial F1F0 ATP synthase subunit

CAL0002512

2.33

CAL0000917

2.33

Protein similar to S. cerevisiae Sds24p; transcription
regulated by Mig1p and Tup1p
Nucleoside diphosphate kinase

CAL0120750

2.32

Uncharacterized ORF

CAL0003972

2.29

Uncharacterized ORF

CAL0002995

2.29

CAL0005201

2.28

CAL0000320

2.27

Transcriptional repressor; regulates chlamydospore
development
Transcription factor that binds upstream of ribosomal protein
genes
Putative proline oxidase; alkaline upregulated by Rim101p

CAL0000857

2.27

Uncharacterized ORF; Hap43p-repressed gene

CAL0003212

2.26

Uncharacterized ORF; Hap43p-repressed gene

CAL0001980

2.26

Uncharacterized ORF

CAL0000358

2.26

Uncharacterized ORF

CAL0004380

2.25

Uncharacterized ORF

CAL0003363

2.24

Putative alcohol dehydrogenase

CAL0003390

2.23

Putative constitutive acid phosphatase

CAL0001669

2.23

Uncharacterized ORF

CAL0003361

2.23

Uncharacterized ORF

CAL0000446

2.23

Galactokinase

CAL0000301

2.22

CAL0006052

2.22

CAF0007033

2.21

Uncharacterized ORF; Hap43p-repressed gene; repressed
by nitric oxide
Uncharacterized ORF; Hap43p-repressed gene; repressed
by nitric oxide
Putative cytochrome c oxidase

CAL0003939

2.20

Uncharacterized ORF

CAL0003242

2.20

CAL0120612

2.19

Imidazoleglycerol-phosphate dehydratase, enzyme of
histidine biosynthesis
Uncharacterized ORF

CAL0004762

2.19

CAL0000684

2.19

Putative NADH dehydrogenase that could act alternatively to
complex I in respiration
Uncharacterized ORF; Putative thiol peroxidase

CAL0004848

2.17

Putative DNA-binding transcription factor

CAL0005196

2.17

Uncharacterized ORF

CAL0003019

2.16

Uncharacterized ORF

CAL0001782

2.15

Putative inducible acid phosphatase

CAL0003397

2.14

Uncharacterized ORF

CAL0005651

2.13

CAF0007449

2.13

Uncharacterized ORF; Ortholog(s) have role in iron-sulfur
cluster assembly
Uncharacterized ORF

CAL0004062

2.12

Uncharacterized ORF; Hap43p-repressed gene

P-value
1.00E-300
6.46E-30
3.60E-46
1.00E-300
1.00E-300
1.03E-64
2.30E-89
1.00E-300
1.00E-300
1.00E-300
9.44E-250
1.87E-51
1.00E-300
1.00E-300
1.10E-223
1.83E-17
1.53E-92
1.03E-44
2.39E-58
3.73E-48
1.00E-300
3.96E-96
7.24E-43
2.33E-68
1.00E-300
1.00E-300
1.00E-300
1.00E-300
1.00E-300
3.92E-136
0.0109287
1.00E-300
1.03E-14
2.82E-67
0.00392063
6.48E-14
1.61E-08
2.92E-131
2.93E-102
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Table A-6 continued

Gene ID
CAL0005907

Folddownregulated
2.12

CGD Function
Uncharacterized ORF

CAL0003434

2.11

Plasma membrane-localized protein; repressed by nitric
oxide
Ortholog(s) have omega peptidase activity, role in glutathione
catabolic process
Protein related to flavohemoglobins

CAL0002597

2.11

CAL0001093

2.11

CAL0000792

2.08

CAL0004747

2.07

CAL0003892

2.06

CAL0002622

2.06

CAL0003655

2.06

CAL0120862

2.05

Glutathione-dependent formaldehyde dehydrogenase
involved in glycine catabolism
Uncharacterized ORF; regulated by Sef1p-, Sfu1p-, and
Hap43p
Protein involved in proteolytic activation of Rim101p, which
regulates pH response
Putative homocitrate synthase; repressed by nitric oxide and
by hypoxia
Mitochondrial ADP/ATP carrier protein involved in ATP
biosynthesis
Uncharacterized ORF

CAL0005662

2.05

Zinc cluster transcription factor

CAL0001727

2.04

Uncharacterized ORF

CAL0120825

2.04

Uncharacterized ORF

CAL0001540

2.04

Uncharacterized ORF

CAL0004908

2.02

Uncharacterized ORF

CAL0005780

2.02

CAL0120936

2.02

Putative NADH-cytochrome-b5 reductase; soluble protein in
hyphae;
Uncharacterized ORF

CAL0004024

2.01

Putative cation conductance protein

CAF0007034

2.01

Putative subunit VIIa of cytochrome c oxidase

CAL0000596

2.01

CAL0001616

2.01

CAL0003729

2.01

Putative ubiquinol-cytochrome-c reductase, subunit 7;
Hap43p-repressed gene
Ortholog(s) have inorganic cation transmembrane transporter
activity
Ortholog(s) have phosphoprotein phosphatase activity

CAL0003252

2.00

F1-ATP synthase complex subunit

P-value
2.22E-131
6.59E-11
1.00E-300
1.00E-300
6.32E-88
1.44E-87
1.00E-300
3.19E-47
1.44E-64
7.09E-209
1.00E-300
1.00E-300
6.11E-141
6.20E-09
1.00E-300
2.61E-09
1.00E-300
1.00E-300
2.46E-49
2.42E-107
1.70E-273
1.00E-300
5.08E-171
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